ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,6/33,108/10899,7.335675114063879e-7,1.6578625757784367e-4,1.389917390033156e-4,IL1B/MYC/IL6/HMOX1/IL10/PTGS2,6
R-HSA-6783783,Interleukin-10 signaling,4/33,47/10899,1.133317560642332e-5,0.0012806488435258352,0.0010736692679769462,IL1B/IL6/IL10/PTGS2,4
R-HSA-445355,Smooth Muscle Contraction,3/33,45/10899,3.2908927433676193e-4,0.021269413608930855,0.017831832555228477,MYLK/ACTG2/ACTA2,3
R-HSA-449147,Signaling by Interleukins,7/33,473/10899,4.433421326609175e-4,0.021269413608930855,0.017831832555228477,IL1B/CNN2/MYC/IL6/HMOX1/IL10/PTGS2,7
R-HSA-8848021,Signaling by PTK6,3/33,54/10899,5.646746975822351e-4,0.021269413608930855,0.017831832555228477,PTPN1/HBEGF/GPNMB,3
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,3/33,54/10899,5.646746975822351e-4,0.021269413608930855,0.017831832555228477,PTPN1/HBEGF/GPNMB,3
R-HSA-9658195,Leishmania infection,4/33,164/10899,0.0014390081645745494,0.04645940645626402,0.03895059693585246,IL1B/IL6/HMOX1/IL10,4
R-HSA-112409,RAF-independent MAPK1/3 activation,2/33,23/10899,0.0021615591562836583,0.06106404616501335,0.0511948221225077,DUSP1/IL6,2
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,2/33,26/10899,0.0027609969189478166,0.06239853036822066,0.052313625832695484,IL1B/HMOX1,2
R-HSA-9664424,Cell recruitment (pro-inflammatory response),2/33,26/10899,0.0027609969189478166,0.06239853036822066,0.052313625832695484,IL1B/HMOX1,2
R-HSA-416476,G alpha (q) signalling events,4/33,216/10899,0.003912034936003536,0.08037453595789083,0.06738433382589823,HBEGF/RGS16/RGS2/BDKRB2,4
R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,2/33,38/10899,0.005838409486924761,0.10995671200374967,0.0921854129514436,CNN2/IL10,2
R-HSA-9020591,Interleukin-12 signaling,2/33,47/10899,0.008826651903603443,0.1534479484780291,0.12864755810919998,CNN2/IL10,2
R-HSA-447115,Interleukin-12 family signaling,2/33,57/10899,0.012788784890137711,0.20644752751222303,0.17308129926502167,CNN2/IL10,2
R-HSA-6798695,Neutrophil degranulation,5/33,482/10899,0.014117026340737254,0.2126965302004413,0.17832033272510214,CNN2/HSPA6/ADAM8/FCGR3B/PPBP,5
R-HSA-5683057,MAPK family signaling cascades,4/33,325/10899,0.016064781693753426,0.21691258200980515,0.18185498258856514,DUSP1/HBEGF/MYC/IL6,4
R-HSA-9009391,Extra-nuclear estrogen signaling,2/33,77/10899,0.022582234888815285,0.21691258200980515,0.18185498258856514,CAV1/HBEGF,2
R-HSA-397014,Muscle contraction,3/33,205/10899,0.02364165194311944,0.21691258200980515,0.18185498258856514,MYLK/ACTG2/ACTA2,3
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,2/33,79/10899,0.023689569916907547,0.21691258200980515,0.18185498258856514,IL6/IL10,2
R-HSA-9664433,Leishmania parasite growth and survival,2/33,79/10899,0.023689569916907547,0.21691258200980515,0.18185498258856514,IL6/IL10,2
R-HSA-9759194,Nuclear events mediated by NFE2L2,2/33,79/10899,0.023689569916907547,0.21691258200980515,0.18185498258856514,MYC/HMOX1,2
R-HSA-8939211,ESR-mediated signaling,3/33,223/10899,0.02937288009050472,0.21691258200980515,0.18185498258856514,CAV1/HBEGF/MYC,3
R-HSA-110056,MAPK3 (ERK1) activation,1/33,10/10899,0.029880951194835914,0.21691258200980515,0.18185498258856514,IL6,1
R-HSA-1250342,PI3K events in ERBB4 signaling,1/33,10/10899,0.029880951194835914,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-1059683,Interleukin-6 signaling,1/33,11/10899,0.032820975862902,0.21691258200980515,0.18185498258856514,IL6,1
R-HSA-9755779,SARS-CoV-2 targets host intracellular signalling and regulatory pathways,1/33,12/10899,0.0357523597531042,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-4420097,VEGFA-VEGFR2 Pathway,2/33,99/10899,0.03593010905036359,0.21691258200980515,0.18185498258856514,CAV1/SHB,2
R-HSA-9755511,KEAP1-NFE2L2 pathway,2/33,102/10899,0.03793921046683868,0.21691258200980515,0.18185498258856514,MYC/HMOX1,2
R-HSA-179812,GRB2 events in EGFR signaling,1/33,13/10899,0.03867512746947677,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-203615,eNOS activation,1/33,13/10899,0.03867512746947677,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-75205,Dissolution of Fibrin Clot,1/33,13/10899,0.03867512746947677,0.21691258200980515,0.18185498258856514,SERPINB8,1
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,1/33,13/10899,0.03867512746947677,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-1250347,SHC1 events in ERBB4 signaling,1/33,14/10899,0.0415893035482483,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-180336,SHC1 events in EGFR signaling,1/33,14/10899,0.0415893035482483,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-877312,Regulation of IFNG signaling,1/33,14/10899,0.0415893035482483,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-194138,Signaling by VEGF,2/33,108/10899,0.04208403223901825,0.21691258200980515,0.18185498258856514,CAV1/SHB,2
R-HSA-189483,Heme degradation,1/33,15/10899,0.04449491245802428,0.21691258200980515,0.18185498258856514,HMOX1,1
R-HSA-2162123,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),1/33,15/10899,0.04449491245802428,0.21691258200980515,0.18185498258856514,PTGS2,1
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/33,15/10899,0.04449491245802428,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-9648895,Response of EIF2AK1 (HRI) to heme deficiency,1/33,15/10899,0.04449491245802428,0.21691258200980515,0.18185498258856514,ATF3,1
R-HSA-9735871,SARS-CoV-1 targets host intracellular signalling and regulatory pathways,1/33,15/10899,0.04449491245802428,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-1963640,GRB2 events in ERBB2 signaling,1/33,16/10899,0.04739197859996469,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-1963642,PI3K events in ERBB2 signaling,1/33,16/10899,0.04739197859996469,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-844456,The NLRP3 inflammasome,1/33,16/10899,0.04739197859996469,0.21691258200980515,0.18185498258856514,HMOX1,1
R-HSA-9651496,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),1/33,16/10899,0.04739197859996469,0.21691258200980515,0.18185498258856514,F12,1
R-HSA-9671793,Diseases of hemostasis,1/33,16/10899,0.04739197859996469,0.21691258200980515,0.18185498258856514,F12,1
R-HSA-180292,GAB1 signalosome,1/33,17/10899,0.050280526307967977,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-202131,Metabolism of nitric oxide: NOS3 activation and regulation,1/33,17/10899,0.050280526307967977,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-9018677,Biosynthesis of DHA-derived SPMs,1/33,17/10899,0.050280526307967977,0.21691258200980515,0.18185498258856514,PTGS2,1
R-HSA-9022699,MECP2 regulates neuronal receptors and channels,1/33,17/10899,0.050280526307967977,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/33,17/10899,0.050280526307967977,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-5676594,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,1/33,18/10899,0.05316057984884648,0.21691258200980515,0.18185498258856514,TNFRSF11A,1
R-HSA-881907,Gastrin-CREB signalling pathway via PKC and MAPK,1/33,18/10899,0.05316057984884648,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-5684996,MAPK1/MAPK3 signaling,3/33,286/10899,0.05469876507344522,0.21691258200980515,0.18185498258856514,DUSP1/HBEGF/IL6,3
R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/33,19/10899,0.056032163422506054,0.21691258200980515,0.18185498258856514,MYC,1
R-HSA-197264,Nicotinamide salvaging,1/33,19/10899,0.056032163422506054,0.21691258200980515,0.18185498258856514,PTGS2,1
R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),1/33,19/10899,0.056032163422506054,0.21691258200980515,0.18185498258856514,PTGS2,1
R-HSA-9013695,NOTCH4 Intracellular Domain Regulates Transcription,1/33,20/10899,0.05889530116212549,0.21691258200980515,0.18185498258856514,ACTA2,1
R-HSA-9006931,Signaling by Nuclear Receptors,3/33,299/10899,0.0609104908173218,0.21691258200980515,0.18185498258856514,CAV1/HBEGF/MYC,3
R-HSA-622312,Inflammasomes,1/33,21/10899,0.06175001713433337,0.21691258200980515,0.18185498258856514,HMOX1,1
R-HSA-6807004,Negative regulation of MET activity,1/33,21/10899,0.06175001713433337,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-1250196,SHC1 events in ERBB2 signaling,1/33,22/10899,0.06459633533938591,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,1/33,22/10899,0.06459633533938591,0.21691258200980515,0.18185498258856514,HMOX1,1
R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,1/33,22/10899,0.06459633533938591,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-140837,Intrinsic Pathway of Fibrin Clot Formation,1/33,23/10899,0.06743427971134519,0.21691258200980515,0.18185498258856514,F12,1
R-HSA-156584,Cytosolic sulfonation of small molecules,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,SLC26A2,1
R-HSA-163560,Triglyceride catabolism,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-5627123,RHO GTPases activate PAKs,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,MYLK,1
R-HSA-6783589,Interleukin-6 family signaling,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,IL6,1
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-982772,Growth hormone receptor signaling,1/33,24/10899,0.07026387411825274,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-418594,G alpha (i) signalling events,3/33,318/10899,0.0705645519454673,0.21691258200980515,0.18185498258856514,RGS16/BDKRB2/PPBP,3
R-HSA-1643713,Signaling by EGFR in Cancer,1/33,25/10899,0.07308514236230779,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-210991,Basigin interactions,1/33,25/10899,0.07308514236230779,0.21691258200980515,0.18185498258856514,CAV1,1
R-HSA-9664565,Signaling by ERBB2 KD Mutants,1/33,25/10899,0.07308514236230779,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-1227990,Signaling by ERBB2 in Cancer,1/33,26/10899,0.0758981081800425,0.21691258200980515,0.18185498258856514,HBEGF,1
R-HSA-912694,Regulation of IFNA/IFNB signaling,1/33,26/10899,0.0758981081800425,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-1538133,G0 and Early G1,1/33,27/10899,0.07870279524249568,0.21691258200980515,0.18185498258856514,MYC,1
R-HSA-189445,Metabolism of porphyrins,1/33,27/10899,0.07870279524249568,0.21691258200980515,0.18185498258856514,HMOX1,1
R-HSA-201556,Signaling by ALK,1/33,27/10899,0.07870279524249568,0.21691258200980515,0.18185498258856514,MYC,1
R-HSA-354192,Integrin signaling,1/33,27/10899,0.07870279524249568,0.21691258200980515,0.18185498258856514,PTPN1,1
R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,1/33,27/10899,0.07870279524249568,0.21691258200980515,0.18185498258856514,ATF3,1
R-HSA-3295583,TRP channels,1/33,28/10899,0.08149922715539126,0.2192717302037908,0.18383284320764945,TRPV2,1
R-HSA-5620971,Pyroptosis,1/33,28/10899,0.08149922715539126,0.2192717302037908,0.18383284320764945,IL1B,1
R-HSA-5218920,VEGFR2 mediated vascular permeability,1/33,29/10899,0.08428742745930717,0.2214995186721328,0.18570057457374897,CAV1,1
R-HSA-8863795,Downregulation of ERBB2 signaling,1/33,29/10899,0.08428742745930717,0.2214995186721328,0.18570057457374897,HBEGF,1
R-HSA-182971,EGFR downregulation,1/33,31/10899,0.08983922707784497,0.2255962813288107,0.1891352149007263,HBEGF,1
R-HSA-196807,Nicotinate metabolism,1/33,31/10899,0.08983922707784497,0.2255962813288107,0.1891352149007263,PTGS2,1
R-HSA-4641262,Disassembly of the destruction complex and recruitment of AXIN to the membrane,1/33,31/10899,0.08983922707784497,0.2255962813288107,0.1891352149007263,CAV1,1
R-HSA-5339562,Uptake and actions of bacterial toxins,1/33,31/10899,0.08983922707784497,0.2255962813288107,0.1891352149007263,HBEGF,1
R-HSA-1251985,Nuclear signaling by ERBB4,1/33,32/10899,0.09260287314947113,0.22748097099761386,0.19071529939250348,HBEGF,1
R-HSA-381042,PERK regulates gene expression,1/33,32/10899,0.09260287314947113,0.22748097099761386,0.19071529939250348,ATF3,1
R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,1/33,36/10899,0.10357630834397036,0.25170156651330433,0.21102134127803812,MYC,1
R-HSA-8979227,Triglyceride metabolism,1/33,37/10899,0.10629949547686657,0.2550417412371902,0.21382167406937233,CAV1,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/33,38/10899,0.10901465996308124,0.2550417412371902,0.21382167406937233,MYC,1
R-HSA-9013407,RHOH GTPase cycle,1/33,38/10899,0.10901465996308124,0.2550417412371902,0.21382167406937233,CAV1,1
R-HSA-140877,Formation of Fibrin Clot (Clotting Cascade),1/33,39/10899,0.11172182470124703,0.2550417412371902,0.21382167406937233,F12,1
R-HSA-76009,Platelet Aggregation (Plug Formation),1/33,39/10899,0.11172182470124703,0.2550417412371902,0.21382167406937233,PTPN1,1
R-HSA-8853884,Transcriptional Regulation by VENTX,1/33,39/10899,0.11172182470124703,0.2550417412371902,0.21382167406937233,IL6,1
R-HSA-9664323,FCGR3A-mediated IL10 synthesis,1/33,40/10899,0.11442101252674064,0.25565635694640404,0.214336955055206,IL10,1
R-HSA-9711123,Cellular response to chemical stress,2/33,194/10899,0.11632456439506039,0.25565635694640404,0.214336955055206,MYC/HMOX1,2
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/33,41/10899,0.11711224621185101,0.25565635694640404,0.214336955055206,SLC26A2,1
R-HSA-9035034,RHOF GTPase cycle,1/33,42/10899,0.11979554846595042,0.25565635694640404,0.214336955055206,CAV1,1
R-HSA-9696264,RND3 GTPase cycle,1/33,42/10899,0.11979554846595042,0.25565635694640404,0.214336955055206,CAV1,1
R-HSA-9696273,RND1 GTPase cycle,1/33,42/10899,0.11979554846595042,0.25565635694640404,0.214336955055206,CAV1,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/33,43/10899,0.12247094193565866,0.25565635694640404,0.214336955055206,DUSP1,1
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,1/33,43/10899,0.12247094193565866,0.25565635694640404,0.214336955055206,IL6,1
R-HSA-9696270,RND2 GTPase cycle,1/33,43/10899,0.12247094193565866,0.25565635694640404,0.214336955055206,CAV1,1
R-HSA-375276,Peptide ligand-binding receptors,2/33,201/10899,0.12330328719981434,0.25565635694640404,0.214336955055206,BDKRB2/PPBP,2
R-HSA-9707616,Heme signaling,1/33,47/10899,0.13309387871610967,0.27344742354400714,0.22925261405645686,HMOX1,1
R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,1/33,48/10899,0.13573006577862046,0.27388388273185915,0.22961853233225268,MYC,1
R-HSA-418597,G alpha (z) signalling events,1/33,48/10899,0.13573006577862046,0.27388388273185915,0.22961853233225268,RGS16,1
R-HSA-1227986,Signaling by ERBB2,1/33,50/10899,0.14097913947647556,0.27948496071652174,0.23431435924067961,HBEGF,1
R-HSA-177929,Signaling by EGFR,1/33,50/10899,0.14097913947647556,0.27948496071652174,0.23431435924067961,HBEGF,1
R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,1/33,51/10899,0.1435920704744731,0.28218963414983406,0.23658190101057353,MYC,1
R-HSA-9013405,RHOD GTPase cycle,1/33,54/10899,0.1513847049542607,0.2833106357391708,0.23752172535188984,CAV1,1
R-HSA-9013409,RHOJ GTPase cycle,1/33,55/10899,0.15396693683406815,0.2833106357391708,0.23752172535188984,CAV1,1
R-HSA-201681,TCF dependent signaling in response to WNT,2/33,233/10899,0.15640892402543832,0.2833106357391708,0.23752172535188984,CAV1/MYC,2
R-HSA-168643,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",1/33,57/10899,0.15910856234042958,0.2833106357391708,0.23752172535188984,HMOX1,1
R-HSA-5218859,Regulated Necrosis,1/33,57/10899,0.15910856234042958,0.2833106357391708,0.23752172535188984,IL1B,1
R-HSA-157118,Signaling by NOTCH,2/33,236/10899,0.1595994936611225,0.2833106357391708,0.23752172535188984,MYC/ACTA2,2
R-HSA-1236394,Signaling by ERBB4,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,HBEGF,1
R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,MYC,1
R-HSA-2644603,Signaling by NOTCH1 in Cancer,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,MYC,1
R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,MYC,1
R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,MYC,1
R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,MYC,1
R-HSA-917937,Iron uptake and transport,1/33,58/10899,0.16166799947774424,0.2833106357391708,0.23752172535188984,HMOX1,1
R-HSA-2142753,Arachidonic acid metabolism,1/33,59/10899,0.16421988177801494,0.2833106357391708,0.23752172535188984,PTGS2,1
R-HSA-380108,Chemokine receptors bind chemokines,1/33,59/10899,0.16421988177801494,0.2833106357391708,0.23752172535188984,PPBP,1
R-HSA-9013406,RHOQ GTPase cycle,1/33,59/10899,0.16421988177801494,0.2833106357391708,0.23752172535188984,CAV1,1
R-HSA-8986944,Transcriptional Regulation by MECP2,1/33,62/10899,0.17183041540934374,0.294194499109937,0.24664652929570874,PTPN1,1
R-HSA-9707564,Cytoprotection by HMOX1,1/33,64/10899,0.1768667248147665,0.30054044968524235,0.2519668418413769,HMOX1,1
R-HSA-9614085,FOXO-mediated transcription,1/33,65/10899,0.17937372971380783,0.30252584265164606,0.2536313538765547,CAV1,1
R-HSA-76002,"Platelet activation, signaling and aggregation",2/33,263/10899,0.18883557244426288,0.31410414192549074,0.2633383583911893,PTPN1/PPBP,2
R-HSA-3371453,Regulation of HSF1-mediated heat shock response,1/33,69/10899,0.1893279124049213,0.31410414192549074,0.2633383583911893,HSPA6,1
R-HSA-400253,Circadian Clock,1/33,70/10899,0.19179810436158284,0.31410414192549074,0.2633383583911893,NFIL3,1
R-HSA-9013026,RHOB GTPase cycle,1/33,70/10899,0.19179810436158284,0.31410414192549074,0.2633383583911893,CAV1,1
R-HSA-909733,Interferon alpha/beta signaling,1/33,72/10899,0.19671661071253932,0.3186222058640251,0.2671262089218655,PTPN1,1
R-HSA-1980143,Signaling by NOTCH1,1/33,74/10899,0.20160608601130792,0.3186222058640251,0.2671262089218655,MYC,1
R-HSA-6807505,RNA polymerase II transcribes snRNA genes,1/33,74/10899,0.20160608601130792,0.3186222058640251,0.2671262089218655,ELL2,1
R-HSA-9013106,RHOC GTPase cycle,1/33,74/10899,0.20160608601130792,0.3186222058640251,0.2671262089218655,CAV1,1
R-HSA-9013408,RHOG GTPase cycle,1/33,74/10899,0.20160608601130792,0.3186222058640251,0.2671262089218655,CAV1,1
R-HSA-5673001,RAF/MAP kinase cascade,2/33,280/10899,0.20762974564570008,0.3258633508050571,0.27319703374434223,DUSP1/HBEGF,2
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/33,78/10899,0.21129860664956024,0.3293343800193146,0.2761070722099517,HBEGF,1
R-HSA-6806834,Signaling by MET,1/33,79/10899,0.21370385071023512,0.330801851099405,0.2773373693427709,PTPN1,1
R-HSA-9013694,Signaling by NOTCH4,1/33,82/10899,0.22087698350975693,0.33957958008983036,0.28469643416939666,ACTA2,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/33,83/10899,0.22325389573534393,0.3409147326769441,0.2858157982387049,MYC,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/33,85/10899,0.22798664348971087,0.3458052444877494,0.2899159012938746,MYC,1
R-HSA-9013404,RAC2 GTPase cycle,1/33,88/10899,0.2350333749003234,0.35292932364009405,0.2958885806018488,CAV1,1
R-HSA-3371556,Cellular response to heat stress,1/33,89/10899,0.23736839466059423,0.35292932364009405,0.2958885806018488,HSPA6,1
R-HSA-5687128,MAPK6/MAPK4 signaling,1/33,89/10899,0.23736839466059423,0.35292932364009405,0.2958885806018488,MYC,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/33,90/10899,0.23969650224396166,0.3538395387470712,0.2966516859546941,MYC,1
R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,1/33,91/10899,0.24201771747441314,0.3538395387470712,0.2966516859546941,MYC,1
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,1/33,92/10899,0.24433206012091058,0.3538395387470712,0.2966516859546941,FCGR3B,1
R-HSA-877300,Interferon gamma signaling,1/33,92/10899,0.24433206012091058,0.3538395387470712,0.2966516859546941,PTPN1,1
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/33,93/10899,0.24663954989753778,0.3538395387470712,0.2966516859546941,MYC,1
R-HSA-381119,Unfolded Protein Response (UPR),1/33,94/10899,0.24894020646364745,0.3538395387470712,0.2966516859546941,ATF3,1
R-HSA-9013423,RAC3 GTPase cycle,1/33,94/10899,0.24894020646364745,0.3538395387470712,0.2966516859546941,CAV1,1
R-HSA-9692914,SARS-CoV-1-host interactions,1/33,95/10899,0.2512340494240083,0.35486809481141174,0.2975140058968519,CAV1,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/33,96/10899,0.25352109832895164,0.35587433678473956,0.2983576181707179,MYC,1
R-HSA-5619102,SLC transporter disorders,1/33,98/10899,0.25807489190259936,0.36003040475300896,0.3018419788334496,SLC26A2,1
R-HSA-5607764,CLEC7A (Dectin-1) signaling,1/33,101/10899,0.2648551124917502,0.3636446255275151,0.3048720661152898,IL1B,1
R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,1/33,101/10899,0.2648551124917502,0.3636446255275151,0.3048720661152898,ATF3,1
R-HSA-195721,Signaling by WNT,2/33,332/10899,0.26615129683630323,0.3636446255275151,0.3048720661152898,CAV1/MYC,2
R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,1/33,102/10899,0.26710180459100663,0.3636446255275151,0.3048720661152898,TNFRSF11A,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),2/33,335/10899,0.2695502892424957,0.36478063095092234,0.3058244693580159,BDKRB2/PPBP,2
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/33,104/10899,0.27157523176421305,0.36533334749233426,0.30628785537317266,HBEGF,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/33,106/10899,0.276022176771874,0.366947129120256,0.3076408162163302,HBEGF,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/33,106/10899,0.276022176771874,0.366947129120256,0.3076408162163302,HBEGF,1
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,1/33,108/10899,0.2804427915143194,0.36711137663202587,0.307778517902956,SLC26A2,1
R-HSA-8957275,Post-translational protein phosphorylation,1/33,108/10899,0.2804427915143194,0.36711137663202587,0.307778517902956,IL6,1
R-HSA-156580,Phase II - Conjugation of compounds,1/33,109/10899,0.2826432722742146,0.36711137663202587,0.307778517902956,SLC26A2,1
R-HSA-2672351,Stimuli-sensing channels,1/33,109/10899,0.2826432722742146,0.36711137663202587,0.307778517902956,TRPV2,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/33,112/10899,0.289205633592702,0.373488418239718,0.3131248965214218,IL6,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/33,113/10899,0.2913801227084378,0.3741585666596986,0.31368673497319866,HBEGF,1
R-HSA-9020702,Interleukin-1 signaling,1/33,115/10899,0.29570976560276196,0.37757292105211415,0.3165492584507711,IL1B,1
R-HSA-9006936,Signaling by TGFB family members,1/33,122/10899,0.31066243094715096,0.3944365696295287,0.3306873895357018,MYC,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/33,124/10899,0.31487777172345843,0.39534653560834226,0.3314502860246931,SLC26A2,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/33,124/10899,0.31487777172345843,0.39534653560834226,0.3314502860246931,PTGS2,1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/33,125/10899,0.3169760578982267,0.3957822601381173,0.3318155883784868,IL6,1
R-HSA-114608,Platelet degranulation ,1/33,129/10899,0.3253070602063656,0.403952723113399,0.3386655340494263,PPBP,1
R-HSA-69206,G1/S Transition,1/33,131/10899,0.32943552577244606,0.4068438733583214,0.34108941408708826,MYC,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/33,134/10899,0.3355823283859405,0.4121826424740356,0.34556532671321105,PPBP,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/33,137/10899,0.3416744779033708,0.4173969297630368,0.34993687637329585,CAV1,1
R-HSA-1474228,Degradation of the extracellular matrix,1/33,140/10899,0.3477124452074627,0.42248931514455146,0.3542062260177888,ADAM8,1
R-HSA-9678108,SARS-CoV-1 Infection,1/33,141/10899,0.3497131413045119,0.4226479675658807,0.35433923689733826,CAV1,1
R-HSA-5621481,C-type lectin receptors (CLRs),1/33,142/10899,0.3517078862698355,0.42279777817544056,0.3544648349863964,IL1B,1
R-HSA-3781865,Diseases of glycosylation,1/33,143/10899,0.35369669725366926,0.4229389078271389,0.35458315514152305,SLC26A2,1
R-HSA-8856828,Clathrin-mediated endocytosis,1/33,146/10899,0.35962769710184017,0.427767681815873,0.3586314984949099,HBEGF,1
R-HSA-8980692,RHOA GTPase cycle,1/33,147/10899,0.3615929427073121,0.427853429590851,0.3587033876402104,CAV1,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/33,149/10899,0.3655059039476498,0.4302309077717128,0.3606966157378123,MYC,1
R-HSA-9018519,Estrogen-dependent gene expression,1/33,150/10899,0.36745365326576396,0.43028251625939196,0.36073988321700307,MYC,1
R-HSA-446652,Interleukin-1 family signaling,1/33,153/10899,0.37326217712566645,0.4348311960329929,0.3645534014249591,IL1B,1
R-HSA-9013148,CDC42 GTPase cycle,1/33,155/10899,0.3771057562808292,0.43529842651430495,0.364945117711108,CAV1,1
R-HSA-9711097,Cellular response to starvation,1/33,156/10899,0.3790189645871149,0.43529842651430495,0.364945117711108,ATF3,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/33,433/10899,0.37944154877574365,0.43529842651430495,0.364945117711108,HBEGF/MYC,2
R-HSA-69242,S Phase,1/33,163/10899,0.39225277291267624,0.4454729983832404,0.3734752664600991,MYC,1
R-HSA-9609507,Protein localization,1/33,163/10899,0.39225277291267624,0.4454729983832404,0.3734752664600991,HMOX1,1
R-HSA-5619115,Disorders of transmembrane transporters,1/33,176/10899,0.41610797468681504,0.4675569680260085,0.39199000579730564,SLC26A2,1
R-HSA-500792,GPCR ligand binding,2/33,467/10899,0.4162884641635479,0.4675569680260085,0.39199000579730564,BDKRB2/PPBP,2
R-HSA-8978868,Fatty acid metabolism,1/33,177/10899,0.4179049006250164,0.4675569680260085,0.39199000579730564,PTGS2,1
R-HSA-9013149,RAC1 GTPase cycle,1/33,185/10899,0.4320885388052782,0.4806241770677976,0.4029452811933096,CAV1,1
R-HSA-983712,Ion channel transport,1/33,186/10899,0.4338377527514633,0.4806241770677976,0.4029452811933096,TRPV2,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/33,190/10899,0.4407825100721293,0.48593584037220117,0.40739846887282816,PTGS2,1
R-HSA-2559583,Cellular Senescence,1/33,197/10899,0.452737565413579,0.49669266885179053,0.41641676941463585,IL6,1
R-HSA-913531,Interferon Signaling,1/33,200/10899,0.4577849511388413,0.4998038596974789,0.4190251269005413,PTPN1,1
R-HSA-9705683,SARS-CoV-2-host interactions,1/33,202/10899,0.4611247652482042,0.501029793010068,0.4200529238090929,CAV1,1
R-HSA-5357801,Programmed Cell Death,1/33,210/10899,0.474285651658383,0.5128639104057157,0.4299744008990629,IL1B,1
R-HSA-5689880,Ub-specific processing proteases,1/33,220/10899,0.49029896852686805,0.5276550804146294,0.44237500919717426,MYC,1
R-HSA-211859,Biological oxidations,1/33,222/10899,0.49344438113407707,0.5285233655748882,0.44310296135761473,SLC26A2,1
R-HSA-8951664,Neddylation,1/33,240/10899,0.5209188999308754,0.5553192046432918,0.4655680337018747,SPSB1,1
R-HSA-5668914,Diseases of metabolism,1/33,249/10899,0.5341086741070253,0.5655832500621779,0.47417319520816037,SLC26A2,1
R-HSA-425407,SLC-mediated transmembrane transport,1/33,250/10899,0.5355522810323278,0.5655832500621779,0.47417319520816037,SLC26A2,1
R-HSA-1257604,PIP3 activates AKT signaling,1/33,267/10899,0.5594400814541587,0.5880625972494877,0.4930194108286344,HBEGF,1
R-HSA-71387,Metabolism of carbohydrates,1/33,295/10899,0.5962107950689266,0.6217125930669319,0.521230865170227,SLC26A2,1
R-HSA-5688426,Deubiquitination,1/33,298/10899,0.5999692450292912,0.6217125930669319,0.521230865170227,MYC,1
R-HSA-9694516,SARS-CoV-2 Infection,1/33,298/10899,0.5999692450292912,0.6217125930669319,0.521230865170227,CAV1,1
R-HSA-1474244,Extracellular matrix organization,1/33,300/10899,0.6024560083259207,0.6217125930669319,0.521230865170227,ADAM8,1
R-HSA-446203,Asparagine N-linked glycosylation,1/33,304/10899,0.607384643003631,0.623949678721912,0.5231063911036058,ASGR2,1
R-HSA-9006925,Intracellular signaling by second messengers,1/33,309/10899,0.6134621628014503,0.6245155351041791,0.5235807932871553,HBEGF,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/33,309/10899,0.6134621628014503,0.6245155351041791,0.5235807932871553,SPSB1,1
R-HSA-195258,RHO GTPase Effectors,1/33,327/10899,0.6345950020387725,0.6431321545325677,0.539188578555483,MYLK,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,1/33,381/10899,0.6914885460768018,0.6976625509524875,0.584905725064964,SPSB1,1
R-HSA-9679506,SARS-CoV Infections,1/33,413/10899,0.7210442669275439,0.7242489081138885,0.6071951721495107,CAV1,1
R-HSA-9012999,RHO GTPase cycle,1/33,449/10899,0.7510155504863528,0.7510155504863528,0.629635766593123,CAV1,1
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,11/30,200/4383,3.465446377585476e-8,1.0742883770514976e-6,7.295676584390475e-7,IL1B/DUSP1/FOSL2/SPSB1/HBEGF/MYC/NFIL3/ATF3/IL6/SERPINB8/PTGS2,11
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,7/30,200/4383,3.079562959199275e-4,0.003182215057839251,0.0021610968134731755,CAV1/DUSP1/FOSL2/NFIL3/ATF3/IL6/HMOX1,7
HALLMARK_KRAS_SIGNALING_UP,HALLMARK_KRAS_SIGNALING_UP,7/30,200/4383,3.079562959199275e-4,0.003182215057839251,0.0021610968134731755,IL1B/HBEGF/RGS16/ADAM8/GPNMB/PPBP/PTGS2,7
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,6/30,161/4383,6.383403437143148e-4,0.004947137663785939,0.003359686019549025,IL1B/CAV1/PRF1/ATF3/IL6/HMOX1,6
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,6/30,200/4383,0.0019828299501700388,0.012293545691054241,0.008348757684926478,IL1B/HBEGF/MYC/RGS16/IL6/IL10,6
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,4/30,87/4383,0.0026764167169884873,0.013828153037773851,0.009390935849082412,IL1B/PTPN1/IL6/HMOX1,4
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,4/30,199/4383,0.04483280148470291,0.1283183720395237,0.0871432068180127,MYC/NFIL3/RGS16/IL10,4
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,4/30,200/4383,0.04553232556241164,0.1283183720395237,0.0871432068180127,IL1B/PRF1/IL6/IL10,4
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,4/30,200/4383,0.04553232556241164,0.1283183720395237,0.0871432068180127,MYLK/TAGLN/IL6/ACTA2,4
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,4/30,200/4383,0.04553232556241164,0.1283183720395237,0.0871432068180127,MYLK/TAGLN/HBEGF/BDKRB2,4
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,4/30,200/4383,0.04553232556241164,0.1283183720395237,0.0871432068180127,HBEGF/ATF3/RGS16/HMOX1,4
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,3/30,144/4383,0.07392251522131248,0.19096649765505724,0.12968862319528504,CAV1/DUSP1/MYC,3
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,2/30,74/4383,0.09034500295543177,0.20334442277939863,0.1380946844002707,NFIL3/ATF3,2
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,3/30,158/4383,0.09183296512618001,0.20334442277939863,0.1380946844002707,ATF3/IL6/HMOX1,3
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,2/30,100/4383,0.1487302034594726,0.2824159062857963,0.19179348474417407,ELL2/SLC26A2,2
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,3/30,200/4383,0.15487323893092056,0.2824159062857963,0.19179348474417407,OLFML3/MYC/SLC26A2,3
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,3/30,200/4383,0.15487323893092056,0.2824159062857963,0.19179348474417407,PTPN1/IL6/PTGS2,3
HALLMARK_WNT_BETA_CATENIN_SIGNALING,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1/30,42/4383,0.251605579288242,0.4333207198853057,0.2942755313312772,MYC,1
HALLMARK_MYC_TARGETS_V2,HALLMARK_MYC_TARGETS_V2,1/30,58/4383,0.33033347740520835,0.53896514734534,0.3660204735791782,MYC,1
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,2/30,200/4383,0.4007719596882383,0.5916157500159709,0.4017764006899632,CNN2/ACTG2,2
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,2/30,200/4383,0.4007719596882383,0.5916157500159709,0.4017764006899632,CAV1/SLC26A2,2
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,1/30,113/4383,0.5444392828811335,0.7548558913280424,0.5126355798492648,ATF3,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/30,138/4383,0.6182499659105434,0.7548558913280424,0.5126355798492648,F12,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,MYLK,1
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,IL6,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,MYC,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,MYC,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,ELL2,1
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,NFIL3,1
HALLMARK_MYC_TARGETS_V1,HALLMARK_MYC_TARGETS_V1,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,MYC,1
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,1/30,200/4383,0.7548558913280424,0.7548558913280424,0.5126355798492648,HMOX1,1
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,7/38,36/21728,2.2418347285699902e-13,3.7550731703547333e-10,2.0270905598332858e-10,DUSP1/FOSL2/HBEGF/ATF3/RGS2/ELL2/PTGS2,7
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,11/38,316/21728,4.390782950309687e-12,3.677280720884363e-9,1.9850960812189586e-9,CAV1/SHB/CNN2/DUSP1/FOSL2/SPSB1/TAGLN/HBEGF/MYC/ACTA2/PPBP,11
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,9/38,232/21728,1.9234800977481067e-10,1.0739430545760262e-7,5.7974365051425396e-8,IL1B/DUSP1/FOSL2/HBEGF/ATF3/RGS2/IL6/ELL2/PTGS2,9
SESTO_RESPONSE_TO_UV_C3,SESTO_RESPONSE_TO_UV_C3,5/38,22/21728,3.2070087636594946e-10,1.3429349197824135e-7,7.249527705219753e-8,IL1B/DUSP1/HBEGF/ATF3/PTGS2,5
PID_AP1_PATHWAY,PID_AP1_PATHWAY,6/38,70/21728,2.285869712189097e-9,7.657663535833474e-7,4.133814911095651e-7,DUSP1/FOSL2/MYC/ATF3/IL6/IL10,6
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,7/38,158/21728,9.825293014849451e-9,2.7428942999788052e-6,1.4806888946939786e-6,IL1B/CNN2/ATF3/RGS16/RGS2/IL6/ACTA2,7
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,5/38,46/21728,1.6193411941228384e-8,3.8544888846044825e-6,2.0807578644934802e-6,DUSP1/MYC/RGS2/IL6/PTGS2,5
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,7/38,173/21728,1.8409499150349767e-8,3.8544888846044825e-6,2.0807578644934802e-6,DUSP1/HBEGF/MYC/NFIL3/ATF3/RGS2/SERPINB8,7
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,8/38,279/21728,2.3415512475556705e-8,4.357887044061942e-6,2.3525058732752293e-6,IL1B/ATF3/RGS16/IL6/HMOX1/IL10/ACTA2/PTGS2,8
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,9/38,414/21728,3.033763820111821e-8,5.081554398687301e-6,2.74316118050111e-6,IL1B/CAV1/SPSB1/HBEGF/NFIL3/RGS16/IL6/IL10/PTGS2,9
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,6/38,111/21728,3.747961614385616e-8,5.707123367359915e-6,3.080860312686358e-6,IL1B/MYC/IL6/HMOX1/IL10/PTGS2,6
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,8/38,309/21728,5.1584589191515387e-8,7.200348907982357e-6,3.886944045220326e-6,TNFRSF11A/OLFML3/TAGLN/NFIL3/ATF3/RGS2/HMOX1/ACTA2,8
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,9/38,454/21728,6.678885889023186e-8,8.605487587779874e-6,4.645476096089811e-6,IL1B/DUSP1/PTPN1/SPSB1/RGS16/IL6/SERPINB8/IL10/PTGS2,9
LEI_MYB_TARGETS,LEI_MYB_TARGETS,8/38,323/21728,7.255666871554456e-8,8.68088714989551e-6,4.686178829071638e-6,IL1B/CAV1/MYC/HSPA6/RGS2/IL6/HMOX1/ACTA2,8
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,6/38,131/21728,1.0086409230926832e-7,9.793925761129068e-6,5.287027323682557e-6,DUSP1/HBEGF/ATF3/RGS2/HMOX1/ACTA2,6
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,7/38,222/21728,1.0195220647066166e-7,9.793925761129068e-6,5.287027323682557e-6,IL1B/DUSP1/SPSB1/ATF3/RGS2/IL6/PTGS2,7
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,9/38,480/21728,1.0727564005776519e-7,9.793925761129068e-6,5.287027323682557e-6,IL1B/CAV1/MYLK/TAGLN/MYC/IL6/ACTG2/ACTA2/PTGS2,9
DAZARD_RESPONSE_TO_UV_NHEK_UP,DAZARD_RESPONSE_TO_UV_NHEK_UP,7/38,224/21728,1.0837918170042884e-7,9.793925761129068e-6,5.287027323682557e-6,DUSP1/TAGLN/HBEGF/ATF3/IL6/PPBP/PTGS2,7
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,5/38,67/21728,1.1109527729041926e-7,9.793925761129068e-6,5.287027323682557e-6,CAV1/NFIL3/ATF3/F12/ELL2,5
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,5/38,72/21728,1.5993321950189262e-7,1.2463763457122543e-5,6.728278277874792e-6,CAV1/MYLK/TAGLN/ATF3/ACTG2,5
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,7/38,238/21728,1.637031618248931e-7,1.2463763457122543e-5,6.728278277874792e-6,DUSP1/ATF3/HSPA6/SERPINB8/ELL2/HMOX1/ACTA2,7
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,7/38,238/21728,1.637031618248931e-7,1.2463763457122543e-5,6.728278277874792e-6,CAV1/OLFML3/MYLK/DUSP1/TAGLN/GPNMB/SLC26A2,7
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,5/38,77/21728,2.2441957319632244e-7,1.6203584097188267e-5,8.747135107295976e-6,IL1B/DUSP1/HBEGF/MYC/IL6,5
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,7/38,251/21728,2.347826533349744e-7,1.6203584097188267e-5,8.747135107295976e-6,CAV1/DUSP1/FOSL2/PTPN1/HBEGF/MYC/HMOX1,7
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,4/38,31/21728,2.4184453876400397e-7,1.6203584097188267e-5,8.747135107295976e-6,FOSL2/NFIL3/IL6/ELL2,4
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,6/38,154/21728,2.631566806857357e-7,1.695336308263874e-5,9.151886182552508e-6,IL1B/FOSL2/HBEGF/MYC/IL6/IL10,6
PLASARI_TGFB1_TARGETS_1HR_UP,PLASARI_TGFB1_TARGETS_1HR_UP,4/38,33/21728,3.1373023959548614e-7,1.8352817206558835e-5,9.907349555653757e-6,SPSB1/HBEGF/IL6/PTGS2,4
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,4/38,33/21728,3.1373023959548614e-7,1.8352817206558835e-5,9.907349555653757e-6,CAV1/TNFRSF11A/PTPN1/MYC,4
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,6/38,159/21728,3.177502680538544e-7,1.8352817206558835e-5,9.907349555653757e-6,MYLK/HBEGF/HSPA6/RGS16/HMOX1/PPBP,6
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,7/38,265/21728,3.388341692882999e-7,1.8918241118596746e-5,1.0212580751531566e-5,IL1B/NFIL3/RGS2/IL6/FCGR3B/GPNMB/PTGS2,7
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,4/38,35/21728,4.004355560219017e-7,2.1636437301183398e-5,1.1679936931165149e-5,CAV1/DUSP1/HBEGF/SERPINB8,4
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,7/38,286/21728,5.661576911199106e-7,2.963481664455782e-5,1.599767949578958e-5,IL1B/HBEGF/ATF3/HSPA6/RGS2/IL6/SERPINB8,7
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,8/38,428/21728,6.186232017266036e-7,3.139981402703215e-5,1.6950473055283973e-5,DUSP1/HBEGF/MYC/ATF3/HSPA6/RGS16/RGS2/GPNMB,8
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,6/38,182/21728,7.027090534180649e-7,3.461875483750761e-5,1.8688144795235844e-5,CAV1/MYLK/CNN2/TAGLN/ACTG2/ACTA2,6
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,8/38,446/21728,8.433482200924715e-7,3.9480704683306256e-5,2.1312757469260064e-5,IL1B/HBEGF/MYC/ATF3/IL6/ACTG2/IL10/ACTA2,8
AMIT_EGF_RESPONSE_40_HELA,AMIT_EGF_RESPONSE_40_HELA,4/38,42/21728,8.485405185665823e-7,3.9480704683306256e-5,2.1312757469260064e-5,DUSP1/ATF3/IL6/PTGS2,4
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,5/38,101/21728,8.72747631605877e-7,3.950952116053633e-5,2.1328313386897534e-5,CAV1/MYC/NFIL3/ATF3/F12,5
WP_IL10_ANTIINFLAMMATORY_SIGNALING_PATHWAY,WP_IL10_ANTIINFLAMMATORY_SIGNALING_PATHWAY,3/38,12/21728,1.073955830581799e-6,4.733884253222404e-5,2.5554793863428407e-5,IL6/HMOX1/IL10,3
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,5/38,107/21728,1.1624710324216386e-6,4.9090407183334155e-5,2.6500336069432232e-5,MYC/ATF3/HSPA6/RGS16/HMOX1,5
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,6/38,200/21728,1.218739261331267e-6,4.9090407183334155e-5,2.6500336069432232e-5,FOSL2/TAGLN/HBEGF/RGS2/ADAM8/ACTA2,6
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,7/38,321/21728,1.2255476914069388e-6,4.9090407183334155e-5,2.6500336069432232e-5,IL1B/HBEGF/MYC/RGS2/HMOX1/SLC26A2/PTGS2,7
REACTOME_INTERLEUKIN_10_SIGNALING,REACTOME_INTERLEUKIN_10_SIGNALING,4/38,46/21728,1.2309236428059907e-6,4.9090407183334155e-5,2.6500336069432232e-5,IL1B/IL6/IL10/PTGS2,4
BIOCARTA_IL10_PATHWAY,BIOCARTA_IL10_PATHWAY,3/38,13/21728,1.3944563087129365e-6,5.4318937606841136e-5,2.9322838902923194e-5,IL6/HMOX1/IL10,3
HALMOS_CEBPA_TARGETS_UP,HALMOS_CEBPA_TARGETS_UP,4/38,48/21728,1.4640689256866167e-6,5.4495898900557395e-5,2.941836741905974e-5,NFIL3/RGS2/HMOX1/PTGS2,4
WOOD_EBV_EBNA1_TARGETS_DN,WOOD_EBV_EBNA1_TARGETS_DN,4/38,48/21728,1.4640689256866167e-6,5.4495898900557395e-5,2.941836741905974e-5,MYLK/RGS2/GPNMB/PTGS2,4
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,7/38,339/21728,1.7615287322390639e-6,6.414262231522677e-5,3.4625930915179776e-5,IL1B/DUSP1/HBEGF/ATF3/IL6/BDKRB2/PTGS2,7
WP_COVID19_ADVERSE_OUTCOME_PATHWAY,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,3/38,15/21728,2.2130978818337056e-6,7.887104153343524e-5,4.257673192598327e-5,IL1B/IL6/IL10,3
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,5/38,123/21728,2.315296069090615e-6,8.079418574430791e-5,4.361489744186049e-5,IL6/ACTG2/HMOX1/ADAM8/TRPV2,5
CROONQUIST_STROMAL_STIMULATION_UP,CROONQUIST_STROMAL_STIMULATION_UP,4/38,56/21728,2.7360405958914616e-6,9.352791832894282e-5,5.0488912392497656e-5,DUSP1/RGS2/IL6/ACTA2,4
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,4/38,57/21728,2.938852727694129e-6,9.845156637775333e-5,5.314683143345805e-5,DUSP1/HBEGF/MYC/ATF3,4
MATTHEWS_AP1_TARGETS,MATTHEWS_AP1_TARGETS,3/38,17/21728,3.2995033908251017e-6,1.0836604273788325e-4,5.849893524703328e-5,CAV1/HBEGF/PTGS2,3
TENEDINI_MEGAKARYOCYTE_MARKERS,TENEDINI_MEGAKARYOCYTE_MARKERS,4/38,62/21728,4.1244391575044576e-06,1.3285453055423012e-4,7.171848656470302e-5,IL1B/MYC/IL6/PPBP,4
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,4/38,63/21728,4.398552587374917e-6,1.37436274302521e-4,7.419183637132163e-5,IL1B/HBEGF/ATF3/PTGS2,4
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,6/38,250/21728,4.430781380499184e-6,1.37436274302521e-4,7.419183637132163e-5,IL1B/DUSP1/HBEGF/ADAM8/PPBP/PTGS2,6
WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,3/38,19/21728,4.690444233776781e-6,1.4262547016027064e-4,7.699310533710763e-5,IL6/HMOX1/PTGS2,3
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,7/38,395/21728,4.829721600285502e-6,1.4262547016027064e-4,7.699310533710763e-5,CAV1/MYLK/CNN2/TAGLN/ACTG2/HMOX1/ACTA2,7
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,6/38,254/21728,4.853523462170404e-6,1.4262547016027064e-4,7.699310533710763e-5,CNN2/PTPN1/RGS16/ACTG2/BDKRB2/PPBP,6
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,5/38,145/21728,5.191529051792347e-6,1.4992777865089967e-4,8.093508993629086e-5,DUSP1/NFIL3/ATF3/ADAM8/PTGS2,5
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,4/38,66/21728,5.302044610485473e-6,1.5052414784005367e-4,8.125702623384516e-5,ATF3/RGS2/IL6/GPNMB,4
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,5/38,148/21728,5.7376328696115235e-6,1.6017558427665503e-4,8.64671339473035e-5,DUSP1/ATF3/HSPA6/RGS2/HMOX1,5
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,6/38,274/21728,7.489380194659375e-6,2.02938795634829e-4,1.0955187773782757e-4,CNN2/TAGLN/ADAM8/ACTA2/TRPV2/PTGS2,6
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,4/38,72/21728,7.511764375736954e-6,2.02938795634829e-4,1.0955187773782757e-4,IL1B/IL10/FCGR3B/PTGS2,4
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,5/38,157/21728,7.650425444846475e-6,2.0340416857329914e-4,1.0980309869879903e-4,HBEGF/MYC/NFIL3/IL6/PTGS2,5
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,5/38,164/21728,9.457090521535821e-6,2.4750979099332035e-4,1.3361251246709328e-4,IL1B/IL6/HMOX1/IL10/PTGS2,5
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,6/38,289/21728,1.0146589598443794e-5,2.6146980888297467e-4,1.4114850955567964e-4,DUSP1/FOSL2/PTPN1/HBEGF/NFIL3/ATF3,6
HARRIS_HYPOXIA,HARRIS_HYPOXIA,4/38,81/21728,1.2011821604176756e-5,3.0484547253024344e-4,1.6456387173824298e-4,TAGLN/IL6/HMOX1/PTGS2,4
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,5/38,173/21728,1.225232626523133e-5,3.0630815663078325e-4,1.6535346837130734e-4,DUSP1/PRF1/HBEGF/NFIL3/RGS2,5
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,3/38,26/21728,1.2479326570409932e-5,3.073951765505388e-4,1.6594027126907326e-4,IL1B/IL6/IL10,3
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,4/38,83/21728,1.3234031035551454e-5,3.2126089832679253e-4,1.7342536475268802e-4,MYC/RGS2/ELL2/PTGS2,4
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,7/38,463/21728,1.3583876527246266e-5,3.250427597591071e-4,1.7546691634442925e-4,IL1B/CNN2/MYC/IL6/HMOX1/IL10/PTGS2,7
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,4/38,84/21728,1.3878354376860738e-5,3.2741188142593994e-4,1.76745832612652e-4,MYLK/CNN2/TAGLN/ACTA2,4
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,7/38,466/21728,1.4162615252564374e-5,3.294775076117407e-4,1.7786091377123973e-4,CAV1/MYLK/FOSL2/RGS2/IL6/ACTA2/PTGS2,7
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,3/38,28/21728,1.5686015831355444e-5,3.599188564043886e-4,1.9429398124202348e-4,PTPN1/MYC/PTGS2,3
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,4/38,87/21728,1.5950241554867808e-5,3.6103587303248084e-4,1.9489697717825673e-4,MYC/RGS2/HMOX1/ADAM8,4
WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,3/38,29/21728,1.7474824028697862e-5,0.00039027106997425223,2.1067893109686267e-4,IL1B/F12/BDKRB2,3
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,5/38,187/21728,1.784032605356694e-5,3.9319139657532405e-4,2.1225540277027704e-4,IL1B/IL6/HMOX1/FCGR3B/PPBP,5
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,3/38,30/21728,1.9393037502999664e-5,4.2186153009771994e-4,2.277323200967425e-4,TAGLN/MYC/ACTG2,3
DANG_MYC_TARGETS_DN,DANG_MYC_TARGETS_DN,3/38,31/21728,2.1444951034882007e-5,4.6051657671060723e-4,2.485993648982948e-4,PTPN1/MYC/HMOX1,3
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,5/38,195/21728,2.1823938947701028e-5,4.627227561696104e-4,2.497903205339798e-4,HBEGF/NFIL3/RGS16/IL6/PTGS2,5
WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,3/38,32/21728,2.3634837573711838e-5,4.887450979749053e-4,2.6383788792486645e-4,IL1B/IL6/HMOX1,3
WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,3/38,32/21728,2.3634837573711838e-5,4.887450979749053e-4,2.6383788792486645e-4,IL1B/NFIL3/IL6,3
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,3/38,33/21728,2.5966948307123476e-5,5.30422419688193e-4,2.8633643897071974e-4,DUSP1/ATF3/RGS2,3
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,5/38,206/21728,2.8395518210448485e-5,5.730420843674845e-4,3.0934369236240017e-4,MYLK/DUSP1/TAGLN/ATF3/ACTG2,5
WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,3/38,35/21728,3.1074738715457986e-5,6.196450874808587e-4,3.3450126010749887e-4,IL1B/IL6/PTGS2,3
DAZARD_RESPONSE_TO_UV_SCC_UP,DAZARD_RESPONSE_TO_UV_SCC_UP,4/38,105/21728,3.349120406541703e-5,6.594594310679072e-4,3.559941249252677e-4,IL1B/ATF3/IL6/PTGS2,4
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,3/38,36/21728,3.3858812580202994e-5,6.594594310679072e-4,3.559941249252677e-4,MYC/NFIL3/ELL2,3
WANG_HCP_PROSTATE_CANCER,WANG_HCP_PROSTATE_CANCER,4/38,106/21728,3.476107265830184e-5,6.692505368121332e-4,3.6127962992717823e-4,DUSP1/FOSL2/ATF3/RGS2,4
PID_FRA_PATHWAY,PID_FRA_PATHWAY,3/38,37/21728,3.6801899156978876e-5,7.004906941811321e-4,3.781439159790055e-4,FOSL2/IL6/HMOX1,3
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,5/38,221/21728,3.972567506883147e-5,7.398684737615371e-4,3.9940111168022656e-4,IL1B/DUSP1/IL6/IL10/PTGS2,5
REACTOME_SMOOTH_MUSCLE_CONTRACTION,REACTOME_SMOOTH_MUSCLE_CONTRACTION,3/38,38/21728,3.9908141861387124e-5,7.398684737615371e-4,3.9940111168022656e-4,MYLK/ACTG2/ACTA2,3
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,4/38,110/21728,4.019583947002978e-5,7.398684737615371e-4,3.9940111168022656e-4,IL1B/CNN2/TAGLN/IL6,4
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,3/38,41/21728,5.024692108123716e-5,8.953573703305558e-4,4.833382442192914e-4,HBEGF/HSPA6/RGS2,3
KEGG_GRAFT_VERSUS_HOST_DISEASE,KEGG_GRAFT_VERSUS_HOST_DISEASE,3/38,41/21728,5.024692108123716e-5,8.953573703305558e-4,4.833382442192914e-4,IL1B/PRF1/IL6,3
LEONARD_HYPOXIA,LEONARD_HYPOXIA,3/38,41/21728,5.024692108123716e-5,8.953573703305558e-4,4.833382442192914e-4,DUSP1/FOSL2/NFIL3,3
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,6/38,389/21728,5.387533436350426e-5,9.440205051219707e-4,5.096079270383491e-4,CAV1/MYLK/NFIL3/RGS2/ACTG2/ACTA2,6
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,4/38,119/21728,5.466865014736189e-5,9.440205051219707e-4,5.096079270383491e-4,IL1B/MYC/IL6/PTGS2,4
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,4/38,119/21728,5.466865014736189e-5,9.440205051219707e-4,5.096079270383491e-4,MYLK/CNN2/TAGLN/ACTA2,4
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,4/38,123/21728,6.21905640587456e-5,0.0010443619370065506,5.637749592387287e-4,ATF3/HSPA6/HMOX1/GPNMB,4
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,3/38,44/21728,6.22012267435206e-5,0.0010443619370065506,5.637749592387287e-4,MYC/ATF3/RGS16,3
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,5/38,243/21728,6.234996638845078e-5,0.0010443619370065506,5.637749592387287e-4,NFIL3/IL6/ELL2/HMOX1/PTGS2,5
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,5/38,244/21728,6.357374628528148e-5,0.0010543170794836286,5.69149015727533e-4,FOSL2/ATF3/RGS2/HMOX1/GPNMB,5
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,4/38,125/21728,6.622215882508568e-5,0.0010874717258041032,5.87046794950966e-4,IL1B/DUSP1/ATF3/PTGS2,4
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,4/38,126/21728,6.830790109251462e-5,0.0011108323721355532,5.996575067804809e-4,IL1B/NFIL3/ATF3/IL6,4
OSADA_ASCL1_TARGETS_UP,OSADA_ASCL1_TARGETS_UP,3/38,46/21728,7.112190048735162e-5,0.001145472916503019,6.183574141562252e-4,ATF3/RGS16/BDKRB2,3
WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,4/38,128/21728,7.262257533732624e-5,0.0011585029875240138,6.253914006492555e-4,IL1B/IL6/IL10/PPBP,4
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,4/38,129/21728,7.485283645282222e-5,0.0011828160477214832,6.385162513701517e-4,PTPN1/TAGLN/MYC/ACTA2,4
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,3/38,48/21728,8.08405308977652e-5,0.001259917612500835,6.801377716500973e-4,TAGLN/HBEGF/ACTA2,3
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,5/38,257/21728,8.123647889557622e-5,0.001259917612500835,6.801377716500973e-4,OLFML3/DUSP1/TAGLN/HMOX1/ACTA2,5
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,6/38,423/21728,8.557475603032223e-5,0.001315024920649447,7.098861943992931e-4,IL1B/CAV1/DUSP1/TAGLN/RGS2/ACTA2,6
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,6/38,425/21728,8.782277826298414e-5,0.0013373013962772586,7.219116414153434e-4,IL1B/DUSP1/IL6/SERPINB8/GPNMB/PTGS2,6
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,3/38,50/21728,9.138849929057572e-5,0.0013790606874929218,7.444544418265012e-4,MYC/IL6/PTGS2,3
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,5/38,265/21728,9.384868618454088e-5,0.001401278324580186,7.564481261991391e-4,IL1B/TNFRSF11A/IL6/IL10/PPBP,5
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,4/38,137/21728,9.453400040451404e-5,0.001401278324580186,7.564481261991391e-4,CAV1/DUSP1/ATF3/BDKRB2,4
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,3/38,51/21728,9.698320167873566e-5,0.0014249724808059845,7.692388757343854e-4,NFIL3/RGS2/HMOX1,3
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,4/38,139/21728,9.99901838097278e-5,0.0014563787641851658,7.861928411217958e-4,HBEGF/NFIL3/ATF3/HSPA6,4
BIOCARTA_PPARA_PATHWAY,BIOCARTA_PPARA_PATHWAY,3/38,52/21728,1.0279685727279818e-4,0.0014843511718270427,8.012931070538443e-4,DUSP1/MYC/PTGS2,3
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,4/38,144/21728,1.1462917798320894e-4,0.001633782634301491,8.819602720282676e-4,IL1B/HBEGF/IL6/ADAM8,4
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,3/38,54/21728,1.1509632886422444e-4,0.001633782634301491,8.819602720282676e-4,PTPN1/HBEGF/GPNMB,3
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,4/38,145/21728,1.177337921372914e-4,0.0016571773263022109,8.945893626354119e-4,FOSL2/NFIL3/ATF3/RGS2,4
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,4/38,146/21728,1.2089900266387264e-4,0.0016875485788498891,9.109845902479526e-4,MYLK/HBEGF/RGS16/ELL2,4
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,3/38,56/21728,1.2831731260810062e-4,0.001776293377012963,9.588914443702343e-4,MYC/ATF3/ACTA2,3
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,3/38,58/21728,1.424898836709601e-4,0.0019404110174703914,0.0010474866073885726,HBEGF/ELL2/PTGS2,3
LIANG_SILENCED_BY_METHYLATION_2,LIANG_SILENCED_BY_METHYLATION_2,3/38,58/21728,1.424898836709601e-4,0.0019404110174703914,0.0010474866073885726,HBEGF/IL6/PTGS2,3
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,3/38,59/21728,1.4994232502754638e-4,0.001993280908104287,0.001076027211350563,SHB/RGS2/ELL2,3
ONDER_CDH1_TARGETS_3_DN,ONDER_CDH1_TARGETS_3_DN,3/38,59/21728,1.4994232502754638e-4,0.001993280908104287,0.001076027211350563,IL1B/HBEGF/PTGS2,3
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,3/38,59/21728,1.4994232502754638e-4,0.001993280908104287,0.001076027211350563,DUSP1/ATF3/IL6,3
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,3/38,60/21728,1.5764379593164745e-4,0.0020791603006733027,0.0011223872416517625,CAV1/FOSL2/SLC26A2,3
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,3/38,61/21728,1.6559796575788468e-4,0.002167004630034819,0.0011698079982403204,TAGLN/GPNMB/TRPV2,3
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,4/38,162/21728,1.803747661545952e-4,0.0023130097921259594,0.0012486255531413664,TAGLN/IL6/HMOX1/ACTA2,4
LINDSTEDT_DENDRITIC_CELL_MATURATION_C,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,3/38,63/21728,1.8227898063320993e-4,0.0023130097921259594,0.0012486255531413664,TNFRSF11A/NFIL3/ATF3,3
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,3/38,63/21728,1.8227898063320993e-4,0.0023130097921259594,0.0012486255531413664,DUSP1/ATF3/IL6,3
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,3/38,63/21728,1.8227898063320993e-4,0.0023130097921259594,0.0012486255531413664,IL1B/IL6/HMOX1,3
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,4/38,164/21728,1.8906215421395314e-4,0.0023810459271306128,0.0012853533080315455,DUSP1/FOSL2/RGS2/IL6,4
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,2/38,12/21728,1.9440696647213135e-4,0.002412086435857926,0.0013021098183201626,ADAM8/PPBP,2
SHIN_B_CELL_LYMPHOMA_CLUSTER_6,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,2/38,12/21728,1.9440696647213135e-4,0.002412086435857926,0.0013021098183201626,IL1B/PTGS2,2
ONDER_CDH1_TARGETS_1_DN,ONDER_CDH1_TARGETS_1_DN,4/38,170/21728,2.1693882915111034e-4,0.002671856903147866,0.0014423409770960044,IL1B/HBEGF/SERPINB8/PTGS2,4
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,4/38,172/21728,2.268562369570785e-4,0.002765559363176246,0.0014929241118418824,CAV1/DUSP1/NFIL3/ATF3,4
WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,3/38,68/21728,2.2865680554472428e-4,0.002765559363176246,0.0014929241118418824,IL6/IL10/PPBP,3
BIOCARTA_IL5_PATHWAY,BIOCARTA_IL5_PATHWAY,2/38,13/21728,2.2950015013820785e-4,0.002765559363176246,0.0014929241118418824,IL1B/IL6,2
WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,3/38,71/21728,2.5983127748702926e-4,0.003108695641362671,0.0016781584012132192,RGS2/SLC26A2/PTGS2,3
BIOCARTA_RANKL_PATHWAY,BIOCARTA_RANKL_PATHWAY,2/38,14/21728,2.674547386448439e-4,0.0031772105477313015,0.0017151446098986258,TNFRSF11A/FOSL2,2
MARKS_HDAC_TARGETS_DN,MARKS_HDAC_TARGETS_DN,2/38,15/21728,3.082611449160757e-4,0.0036361789981297662,0.0019629082541357235,IL1B/IL6,2
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,5/38,343/21728,3.115365190904305e-4,0.0036491165697655316,0.001969892306946484,IL1B/HBEGF/IL6/IL10/PPBP,5
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,3/38,77/21728,3.301498626987615e-4,0.003840284861252955,0.0020730901466245334,OLFML3/TAGLN/IL6,3
LEE_LIVER_CANCER_HEPATOBLAST,LEE_LIVER_CANCER_HEPATOBLAST,2/38,16/21728,3.519098051364922e-4,0.004029623279421993,0.002175300170949563,IL6/PTGS2,2
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,5/38,353/21728,3.554436872862503e-4,0.004029623279421993,0.002175300170949563,OLFML3/RGS2/HMOX1/FCGR3B/GPNMB,5
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,3/38,79/21728,3.5605029573400294e-4,0.004029623279421993,0.002175300170949563,IL1B/DUSP1/PTGS2,3
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,3/38,79/21728,3.5605029573400294e-4,0.004029623279421993,0.002175300170949563,TAGLN/ACTG2/ACTA2,3
LIAN_LIPA_TARGETS_6M,LIAN_LIPA_TARGETS_6M,3/38,80/21728,3.6947694579739313e-4,0.004153516001413647,0.0022421808296712166,HMOX1/ADAM8/GPNMB,3
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,3/38,81/21728,3.832256044202089e-4,0.00425905322510018,0.00229915269150734,CAV1/MYC/ELL2,3
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,5/38,359/21728,3.839504698448521e-4,0.00425905322510018,0.00229915269150734,CAV1/MYLK/ATF3/RGS16/PTGS2,5
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,3/38,82/21728,3.9729953802732185e-4,0.004333150807317036,0.0023391525803521346,MYC/ATF3/IL10,3
HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,2/38,17/21728,3.9839117870258127e-4,0.004333150807317036,0.0023391525803521346,MYLK/ACTA2,2
LEI_HOXC8_TARGETS_DN,LEI_HOXC8_TARGETS_DN,2/38,17/21728,3.9839117870258127e-4,0.004333150807317036,0.0023391525803521346,TAGLN/ACTA2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,3/38,83/21728,4.1170199453951367e-4,0.0044205182106005474,0.002386315879280987,DUSP1/FOSL2/MYC,3
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,3/38,83/21728,4.1170199453951367e-4,0.0044205182106005474,0.002386315879280987,MYC/IL6/HMOX1,3
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,5/38,366/21728,4.193626711551974e-4,0.004474092192260863,0.002415236570716155,DUSP1/PRF1/NFIL3/ELL2/ADAM8,5
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,3/38,84/21728,4.264362034344261e-4,0.004520763549067492,0.0024404310376427182,ATF3/RGS16/PTGS2,3
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,4/38,204/21728,4.3371404205684024e-4,0.00456900012858621,0.002466470454331849,IL1B/ATF3/RGS2/IL6,4
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,3/38,85/21728,4.415053758073563e-4,0.0045933012700454775,0.0024795888709939133,IL1B/DUSP1/TRPV2,3
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,3/38,85/21728,4.415053758073563e-4,0.0045933012700454775,0.0024795888709939133,PTPN1/ACTG2/ACTA2,3
AMIT_DELAYED_EARLY_GENES,AMIT_DELAYED_EARLY_GENES,2/38,18/21728,4.4769574817417503e-4,0.004628952951800884,0.0024988346178142717,FOSL2/ATF3,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,3/38,86/21728,4.569127044318821e-4,0.004652166659626432,0.002511366008244528,IL1B/ATF3/IL6,3
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,3/38,86/21728,4.569127044318821e-4,0.004652166659626432,0.002511366008244528,PTPN1/ACTG2/ACTA2,3
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,4/38,207/21728,4.582731336348425e-4,0.004652166659626432,0.002511366008244528,TNFRSF11A/PRF1/NFIL3/IL6,4
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,3/38,87/21728,4.7266136382034856e-4,0.004740765176042418,0.00255919389550381,MYC/IL10/ACTA2,3
WP_ACUTE_VIRAL_MYOCARDITIS,WP_ACUTE_VIRAL_MYOCARDITIS,3/38,87/21728,4.7266136382034856e-4,0.004740765176042418,0.00255919389550381,CAV1/IL6/IL10,3
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,4/38,210/21728,4.8381029602019137e-4,0.004814465198073366,0.002598979170554609,MYLK/TAGLN/ACTA2/GPNMB,4
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,5/38,378/21728,4.857579811787456e-4,0.004814465198073366,0.002598979170554609,DUSP1/SPSB1/HBEGF/IL6/PTGS2,5
ABE_VEGFA_TARGETS,ABE_VEGFA_TARGETS,2/38,19/21728,4.99814019225987e-4,0.004895839077213616,0.0026429070022476017,HBEGF/PTGS2,2
BIOCARTA_CYTOKINE_PATHWAY,BIOCARTA_CYTOKINE_PATHWAY,2/38,19/21728,4.99814019225987e-4,0.004895839077213616,0.0026429070022476017,IL6/IL10,2
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,3/38,89/21728,5.051952819940083e-4,0.004919779635697465,0.0026558307664189297,IL1B/PRF1/IL10,3
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,3/38,90/21728,5.219867990397652e-4,0.005053918430009288,0.0027282425334661294,DUSP1/NFIL3/RGS16,3
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,4/38,216/21728,5.379077338535562e-4,0.005101956914386867,0.002754175013013869,SHB/FOSL2/HBEGF/MYC,4
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,4/38,216/21728,5.379077338535562e-4,0.005101956914386867,0.002754175013013869,HBEGF/RGS16/RGS2/BDKRB2,4
LU_IL4_SIGNALING,LU_IL4_SIGNALING,3/38,91/21728,5.391321634904331e-4,0.005101956914386867,0.002754175013013869,TNFRSF11A/NFIL3/IL6,3
WP_SELENIUM_MICRONUTRIENT_NETWORK,WP_SELENIUM_MICRONUTRIENT_NETWORK,3/38,91/21728,5.391321634904331e-4,0.005101956914386867,0.002754175013013869,IL1B/IL6/PTGS2,3
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,2/38,20/21728,5.547365205992338e-4,0.0051054047912292115,0.00275603627064628,OLFML3/RGS2,2
DAZARD_UV_RESPONSE_CLUSTER_G28,DAZARD_UV_RESPONSE_CLUSTER_G28,2/38,20/21728,5.547365205992338e-4,0.0051054047912292115,0.00275603627064628,ATF3/PTGS2,2
MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,2/38,20/21728,5.547365205992338e-4,0.0051054047912292115,0.00275603627064628,TAGLN/ACTG2,2
WP_HYPERTROPHY_MODEL,WP_HYPERTROPHY_MODEL,2/38,20/21728,5.547365205992338e-4,0.0051054047912292115,0.00275603627064628,HBEGF/ATF3,2
WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,2/38,20/21728,5.547365205992338e-4,0.0051054047912292115,0.00275603627064628,IL1B/IL6,2
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,4/38,220/21728,5.762836915219693e-4,0.005274727777591795,0.0028474414208649506,PTPN1/NFIL3/HMOX1/TRPV2,4
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,4/38,223/21728,6.063167056487641e-4,0.005489624226819891,0.002963448365020133,FOSL2/NFIL3/ATF3/PTGS2,4
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,4/38,223/21728,6.063167056487641e-4,0.005489624226819891,0.002963448365020133,IL1B/SPSB1/HBEGF/ATF3,4
GESERICK_TERT_TARGETS_DN,GESERICK_TERT_TARGETS_DN,2/38,21/21728,6.124538040533564e-4,0.005493380308170658,0.0029654759998231552,HBEGF/NFIL3,2
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,5/38,398/21728,6.136960087412403e-4,0.005493380308170658,0.0029654759998231552,DUSP1/RGS2/ADAM8/FCGR3B/GPNMB,5
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,4/38,224/21728,6.165704465290053e-4,0.005493380308170658,0.0029654759998231552,TNFRSF11A/ASGR2/F12/HMOX1,4
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,4/38,225/21728,6.269469461848702e-4,0.005556275845818294,0.0029994287205391454,CAV1/FOSL2/ATF3/PTGS2,4
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,3/38,97/21728,6.496066059363968e-4,0.005696811858342746,0.0030752938798532096,DUSP1/IL6/ACTA2,3
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,3/38,97/21728,6.496066059363968e-4,0.005696811858342746,0.0030752938798532096,MYC/NFIL3/ATF3,3
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,2/38,22/21728,6.72956444317833e-4,0.005780523303755745,0.003120483593355026,ATF3/PTGS2,2
PID_PDGFRA_PATHWAY,PID_PDGFRA_PATHWAY,2/38,22/21728,6.72956444317833e-4,0.005780523303755745,0.003120483593355026,CAV1/SHB,2
WP_PI3KAKTMTOR_VITD3_SIGNALING,WP_PI3KAKTMTOR_VITD3_SIGNALING,2/38,22/21728,6.72956444317833e-4,0.005780523303755745,0.003120483593355026,MYC/IL10,2
WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,2/38,22/21728,6.72956444317833e-4,0.005780523303755745,0.003120483593355026,DUSP1/IL6,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,5/38,407/21728,6.788926175168692e-4,0.005801760889493653,0.0031319482193715932,CAV1/MYLK/CNN2/DUSP1/ELL2,5
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,5/38,409/21728,6.940611187920785e-4,0.005901281086176303,0.003185671926488889,IL1B/PTPN1/SPSB1/IL6/PTGS2,5
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,3/38,100/21728,7.09866574358367e-4,0.005975007598242536,0.0032254715015807315,NFIL3/ATF3/ELL2,3
WINZEN_DEGRADED_VIA_KHSRP,WINZEN_DEGRADED_VIA_KHSRP,3/38,100/21728,7.09866574358367e-4,0.005975007598242536,0.0032254715015807315,HBEGF/IL6/PTGS2,3
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,2/38,23/21728,7.362350390440814e-4,0.0060271220195911605,0.0032536042826889597,IL1B/DUSP1,2
GENTILE_UV_HIGH_DOSE_UP,GENTILE_UV_HIGH_DOSE_UP,2/38,23/21728,7.362350390440814e-4,0.0060271220195911605,0.0032536042826889597,HBEGF/ATF3,2
ONO_FOXP3_TARGETS_UP,ONO_FOXP3_TARGETS_UP,2/38,23/21728,7.362350390440814e-4,0.0060271220195911605,0.0032536042826889597,RGS2/IL10,2
REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,2/38,23/21728,7.362350390440814e-4,0.0060271220195911605,0.0032536042826889597,DUSP1/IL6,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,4/38,235/21728,7.376477695619033e-4,0.0060271220195911605,0.0032536042826889597,TAGLN/ADAM8/ACTA2/GPNMB,4
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,4/38,235/21728,7.376477695619033e-4,0.0060271220195911605,0.0032536042826889597,IL6/ACTG2/ELL2/GPNMB,4
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,3/38,102/21728,7.519544324520187e-4,0.006114192593966656,0.0033006073453054887,FOSL2/NFIL3/ATF3,3
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,3/38,103/21728,7.735814485459269e-4,0.006259656648861969,0.003379132795834992,IL1B/ELL2/ADAM8,3
WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,2/38,24/21728,8.022802087574505e-4,0.00646066995033043,0.0034876452394870957,IL1B/IL6,2
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,3/38,105/21728,8.180160207497118e-4,0.0065558700227548675,0.003539036826109305,IL1B/IL6/PTGS2,3
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,4/38,242/21728,8.229413182322637e-4,0.006563936704947817,0.0035433914404085936,IL1B/DUSP1/RGS2/IL6,4
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,4/38,245/21728,8.615470193691493e-4,0.006839295058973105,0.003692037364121224,ATF3/IL6/SERPINB8/ELL2,4
WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,2/38,25/21728,8.710825968093061e-4,0.0068823742908282436,0.003715292704365412,IL1B/HBEGF,2
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,5/38,434/21728,9.059224829264401e-4,0.007124038304703226,0.0038457495074564474,OLFML3/HBEGF/RGS2/SLC26A2/PTGS2,5
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,4/38,249/21728,9.149910066441686e-4,0.007153635759690697,0.003861727018114256,IL1B/DUSP1/MYC/HSPA6,4
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,3/38,110/21728,9.36121016741484e-4,0.007153635759690697,0.003861727018114256,CAV1/SHB/HBEGF,3
CHEN_ETV5_TARGETS_SERTOLI,CHEN_ETV5_TARGETS_SERTOLI,2/38,26/21728,9.426328693292161e-4,0.007153635759690697,0.003861727018114256,IL6/GPNMB,2
DALESSIO_TSA_RESPONSE,DALESSIO_TSA_RESPONSE,2/38,26/21728,9.426328693292161e-4,0.007153635759690697,0.003861727018114256,FOSL2/ATF3,2
PID_IL27_PATHWAY,PID_IL27_PATHWAY,2/38,26/21728,9.426328693292161e-4,0.007153635759690697,0.003861727018114256,IL1B/IL6,2
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,2/38,26/21728,9.426328693292161e-4,0.007153635759690697,0.003861727018114256,IL1B/HMOX1,2
TIAN_TNF_SIGNALING_VIA_NFKB,TIAN_TNF_SIGNALING_VIA_NFKB,2/38,26/21728,9.426328693292161e-4,0.007153635759690697,0.003861727018114256,IL6/PTGS2,2
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,5/38,438/21728,9.438528375472502e-4,0.007153635759690697,0.003861727018114256,CAV1/SHB/PTPN1/HBEGF/PTGS2,5
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,4/38,256/21728,0.0010140866308192833,0.00760421371840094,0.0041049612468854095,MYLK/TAGLN/SERPINB8/ACTA2,4
GROSS_ELK3_TARGETS_UP,GROSS_ELK3_TARGETS_UP,2/38,27/21728,0.0010169217151772003,0.00760421371840094,0.0041049612468854095,CAV1/CNN2,2
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,2/38,27/21728,0.0010169217151772003,0.00760421371840094,0.0041049612468854095,HBEGF/RGS2,2
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,3/38,115/21728,0.0010645300524939245,0.007918261530343834,0.0042744927915571735,MYLK/ACTG2/ACTA2,3
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,3/38,116/21728,0.0010914782703548382,0.007918261530343834,0.0042744927915571735,MYC/ADAM8/TRPV2,3
BIOCARTA_NO1_PATHWAY,BIOCARTA_NO1_PATHWAY,2/38,28/21728,0.001093939845896111,0.007918261530343834,0.0042744927915571735,CAV1/BDKRB2,2
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,2/38,28/21728,0.001093939845896111,0.007918261530343834,0.0042744927915571735,FOSL2/PTGS2,2
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,2/38,28/21728,0.001093939845896111,0.007918261530343834,0.0042744927915571735,IL1B/PELO,2
WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,2/38,28/21728,0.001093939845896111,0.007918261530343834,0.0042744927915571735,F12/ACTA2,2
WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,2/38,28/21728,0.001093939845896111,0.007918261530343834,0.0042744927915571735,PRF1/MYC,2
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,5/38,453/21728,0.0010967383134565787,0.007918261530343834,0.0042744927915571735,DUSP1/HMOX1/IL10/FCGR3B/GPNMB,5
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,3/38,118/21728,0.0011466624484133985,0.008243174253615634,0.004449889510671377,TAGLN/HMOX1/SLC26A2,3
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,2/38,29/21728,0.0011736779956640667,0.008365577203137497,0.004515965949721986,HBEGF/PTGS2,2
BIOCARTA_INFLAM_PATHWAY,BIOCARTA_INFLAM_PATHWAY,2/38,29/21728,0.0011736779956640667,0.008365577203137497,0.004515965949721986,IL6/IL10,2
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,4/38,267/21728,0.001184742307345268,0.008408658325437815,0.004539222310479863,IL1B/DUSP1/MYC/HSPA6,4
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,2/38,30/21728,0.001256126921247002,0.008766719137869703,0.0047325132690840994,HBEGF/PTGS2,2
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,2/38,30/21728,0.001256126921247002,0.008766719137869703,0.0047325132690840994,FOSL2/HBEGF,2
PID_IL2_STAT5_PATHWAY,PID_IL2_STAT5_PATHWAY,2/38,30/21728,0.001256126921247002,0.008766719137869703,0.0047325132690840994,PRF1/MYC,2
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,2/38,30/21728,0.001256126921247002,0.008766719137869703,0.0047325132690840994,SPSB1/HMOX1,2
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,5/38,473/21728,0.0013283831656095773,0.0092325385991537,0.004983975275206932,IL1B/HBEGF/ADAM8/BDKRB2/PTGS2,5
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,2/38,31/21728,0.0013412774019512862,0.009283634910200017,0.005011558452701848,IL1B/IL6,2
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,5/38,479/21728,0.0014044633736924955,0.009680971814547036,0.005226051713241731,CNN2/HSPA6/ADAM8/FCGR3B/PPBP,5
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,2/38,32/21728,0.001429120239576459,0.00973624183656761,0.005255887973361558,ATF3/HMOX1,2
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,2/38,32/21728,0.001429120239576459,0.00973624183656761,0.005255887973361558,CAV1/PTGS2,2
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,4/38,281/21728,0.0014299196965944074,0.00973624183656761,0.005255887973361558,SHB/OLFML3/ATF3/RGS16,4
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,4/38,282/21728,0.001448686478965697,0.009824088470718795,0.005303309974138222,MYC/ATF3/HSPA6/HMOX1,4
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,5/38,484/21728,0.0014702917218865602,0.00993039771838705,0.005360698595503206,CAV1/MYLK/PRF1/IL6/ACTA2,5
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,3/38,130/21728,0.0015149098494923777,0.01010082334431129,0.00545269898052688,IL1B/CAV1/IL6,3
DORN_ADENOVIRUS_INFECTION_12HR_DN,DORN_ADENOVIRUS_INFECTION_12HR_DN,2/38,33/21728,0.0015196462583680268,0.01010082334431129,0.00545269898052688,MYC/IL6,2
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,2/38,33/21728,0.0015196462583680268,0.01010082334431129,0.00545269898052688,IL6/PTGS2,2
WP_PROSTAGLANDIN_SIGNALING,WP_PROSTAGLANDIN_SIGNALING,2/38,33/21728,0.0015196462583680268,0.01010082334431129,0.00545269898052688,IL1B/IL6,2
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,5/38,491/21728,0.0015662548050225345,0.010369473511512827,0.00559772364266427,CAV1/MYLK/TAGLN/ACTG2/ACTA2,5
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,2/38,34/21728,0.0016128463049703814,0.010458989967989418,0.0056460470589177764,NFIL3/IL6,2
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,2/38,34/21728,0.0016128463049703814,0.010458989967989418,0.0056460470589177764,TAGLN/ACTA2,2
SCHOEN_NFKB_SIGNALING,SCHOEN_NFKB_SIGNALING,2/38,34/21728,0.0016128463049703814,0.010458989967989418,0.0056460470589177764,IL1B/PTGS2,2
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,3/38,133/21728,0.0016172408368413489,0.010458989967989418,0.0056460470589177764,CAV1/NFIL3/ATF3,3
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,3/38,133/21728,0.0016172408368413489,0.010458989967989418,0.0056460470589177764,OLFML3/TAGLN/GPNMB,3
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,3/38,133/21728,0.0016172408368413489,0.010458989967989418,0.0056460470589177764,CAV1/MYC/ATF3,3
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,5/38,497/21728,0.0016521292609932505,0.010643525046783441,0.005745664110093937,IL1B/MYLK/ELL2/HMOX1/PPBP,5
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,4/38,293/21728,0.0016666401247974944,0.010695870532704228,0.005773921626138527,MYC/ATF3/HSPA6/HMOX1,4
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,2/38,35/21728,0.0017087112483797694,0.010800344683155147,0.005830319612147853,HBEGF/PTGS2,2
KEGG_PRION_DISEASES,KEGG_PRION_DISEASES,2/38,35/21728,0.0017087112483797694,0.010800344683155147,0.005830319612147853,IL1B/IL6,2
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,2/38,35/21728,0.0017087112483797694,0.010800344683155147,0.005830319612147853,MYLK/ACTG2,2
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,2/38,35/21728,0.0017087112483797694,0.010800344683155147,0.005830319612147853,IL1B/IL6,2
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,3/38,137/21728,0.0017602871939126497,0.011084515224825895,0.005983722594265795,HSPA6/RGS16/IL6,3
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,4/38,299/21728,0.0017946824822703763,0.01123277453574293,0.006063756999970575,MYLK/DUSP1/GPNMB/SLC26A2,4
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,3/38,138/21728,0.0017972439257188688,0.01123277453574293,0.006063756999970575,IL1B/HSPA6/IL6,3
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,2/38,36/21728,0.001807231979897392,0.011253210283747702,0.006074788772184933,DUSP1/ATF3,2
KEGG_ALLOGRAFT_REJECTION,KEGG_ALLOGRAFT_REJECTION,2/38,37/21728,0.0019083994130825604,0.011795457626986305,0.006367508626288287,PRF1/IL10,2
PID_IL23_PATHWAY,PID_IL23_PATHWAY,2/38,37/21728,0.0019083994130825604,0.011795457626986305,0.006367508626288287,IL1B/IL6,2
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,3/38,143/21728,0.0019893134752337594,0.01225036790814907,0.00661308156047136,HBEGF/ATF3/RGS16,3
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,4/38,308/21728,0.00199935806304569,0.012267123646892053,0.006622126763663959,IL1B/IL6/HMOX1/IL10,4
REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,2/38,38/21728,0.002012204483705955,0.012300885073749908,0.006640352099513698,CNN2/IL10,2
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,3/38,144/21728,0.002029200375175258,0.012359675012431117,0.006672088506317882,IL1B/IL6/IL10,3
AMIT_EGF_RESPONSE_60_MCF10A,AMIT_EGF_RESPONSE_60_MCF10A,2/38,39/21728,0.0021186381497029943,0.012726403468641647,0.006870058494619436,IL6/PTGS2,2
DORN_ADENOVIRUS_INFECTION_48HR_DN,DORN_ADENOVIRUS_INFECTION_48HR_DN,2/38,39/21728,0.0021186381497029943,0.012726403468641647,0.006870058494619436,IL6/ELL2,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_1,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,2/38,39/21728,0.0021186381497029943,0.012726403468641647,0.006870058494619436,DUSP1/ATF3,2
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,4/38,313/21728,0.002119800935970758,0.012726403468641647,0.006870058494619436,MYLK/DUSP1/ATF3/PTGS2,4
BROWNE_HCMV_INFECTION_2HR_UP,BROWNE_HCMV_INFECTION_2HR_UP,2/38,40/21728,0.0022276913911272503,0.013326368143350515,0.007193935733001158,ATF3/RGS2,2
AMIT_EGF_RESPONSE_120_MCF10A,AMIT_EGF_RESPONSE_120_MCF10A,2/38,41/21728,0.0023393552101039668,0.013748842024295244,0.007421998616728744,IL1B/HBEGF,2
BILBAN_B_CLL_LPL_DN,BILBAN_B_CLL_LPL_DN,2/38,41/21728,0.0023393552101039668,0.013748842024295244,0.007421998616728744,DUSP1/RGS2,2
CHANGOLKAR_H2AFY_TARGETS_DN,CHANGOLKAR_H2AFY_TARGETS_DN,2/38,41/21728,0.0023393552101039668,0.013748842024295244,0.007421998616728744,MYLK/ELL2,2
WP_BLADDER_CANCER,WP_BLADDER_CANCER,2/38,41/21728,0.0023393552101039668,0.013748842024295244,0.007421998616728744,HBEGF/MYC,2
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,2/38,41/21728,0.0023393552101039668,0.013748842024295244,0.007421998616728744,IL6/PTGS2,2
DORN_ADENOVIRUS_INFECTION_24HR_DN,DORN_ADENOVIRUS_INFECTION_24HR_DN,2/38,42/21728,0.00245362063078371,0.014369980967002498,0.007757306300490273,IL6/ELL2,2
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,4/38,327/21728,0.0024836595809110463,0.014495225777094086,0.007824916853117874,DUSP1/HBEGF/MYC/IL6,4
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,3/38,155/21728,0.0025011816340738797,0.014546802906506071,0.007852759589435172,MYC/IL6/IL10,3
KEGG_TYPE_I_DIABETES_MELLITUS,KEGG_TYPE_I_DIABETES_MELLITUS,2/38,43/21728,0.002570478699296031,0.014846730418347765,0.008014668612324104,IL1B/PRF1,2
MA_MYELOID_DIFFERENTIATION_DN,MA_MYELOID_DIFFERENTIATION_DN,2/38,43/21728,0.002570478699296031,0.014846730418347765,0.008014668612324104,FOSL2/HBEGF,2
MARTIN_NFKB_TARGETS_UP,MARTIN_NFKB_TARGETS_UP,2/38,44/21728,0.0026899204837032955,0.015377531775436926,0.008301209612003344,MYC/IL10,2
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,2/38,44/21728,0.0026899204837032955,0.015377531775436926,0.008301209612003344,CAV1/PTPN1,2
STREICHER_LSM1_TARGETS_UP,STREICHER_LSM1_TARGETS_UP,2/38,44/21728,0.0026899204837032955,0.015377531775436926,0.008301209612003344,MYLK/IL6,2
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,2/38,45/21728,0.002811937073954524,0.015912143915114283,0.008589807775700342,CAV1/ACTA2,2
PID_NFAT_TFPATHWAY,PID_NFAT_TFPATHWAY,2/38,45/21728,0.002811937073954524,0.015912143915114283,0.008589807775700342,PTPN1/PTGS2,2
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/38,45/21728,0.002811937073954524,0.015912143915114283,0.008589807775700342,CAV1/ATF3,2
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,3/38,162/21728,0.0028340875486089026,0.01598349038356873,0.008628322538561219,IL1B/IL6/IL10,3
JIANG_TIP30_TARGETS_UP,JIANG_TIP30_TARGETS_UP,2/38,46/21728,0.002936519581839399,0.016450402339735763,0.008880374303115803,DUSP1/NFIL3,2
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,2/38,46/21728,0.002936519581839399,0.016450402339735763,0.008880374303115803,SHB/MYC,2
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,RGS2/ACTG2,2
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,DUSP1/MYC,2
PID_DELTA_NP63_PATHWAY,PID_DELTA_NP63_PATHWAY,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,FOSL2/BDKRB2,2
PID_IL6_7_PATHWAY,PID_IL6_7_PATHWAY,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,MYC/IL6,2
REACTOME_INTERLEUKIN_12_SIGNALING,REACTOME_INTERLEUKIN_12_SIGNALING,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,CNN2/IL10,2
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,ATF3/HMOX1,2
WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING_PATHWAY,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,MYC/IL6,2
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,2/38,47/21728,0.0030636591409422794,0.016715404107746964,0.00902342946020716,MYLK/DUSP1,2
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,3/38,167/21728,0.0030878432463712193,0.01679265401841491,0.009065131061629792,MYLK/HBEGF/HSPA6,3
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,3/38,168/21728,0.0031402160672634512,0.016967296492471876,0.009159407815888981,TAGLN/ACTG2/ACTA2,3
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,3/38,168/21728,0.0031402160672634512,0.016967296492471876,0.009159407815888981,ATF3/RGS16/ACTA2,3
APRELIKOVA_BRCA1_TARGETS,APRELIKOVA_BRCA1_TARGETS,2/38,48/21728,0.00319334690659639,0.016980495455710964,0.009166532974991811,TAGLN/ACTA2,2
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,2/38,48/21728,0.00319334690659639,0.016980495455710964,0.009166532974991811,IL6/IL10,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,2/38,48/21728,0.00319334690659639,0.016980495455710964,0.009166532974991811,MYC/PELO,2
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,2/38,48/21728,0.00319334690659639,0.016980495455710964,0.009166532974991811,MYC/PTGS2,2
WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,2/38,48/21728,0.00319334690659639,0.016980495455710964,0.009166532974991811,ACTG2/ACTA2,2
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,2/38,49/21728,0.0033255740558380143,0.017627647289647705,0.009515883124466537,MYLK/PELO,2
TSUNODA_CISPLATIN_RESISTANCE_DN,TSUNODA_CISPLATIN_RESISTANCE_DN,2/38,50/21728,0.0034603317873608203,0.01819901381939392,0.009824322306902986,ELL2/PTGS2,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,2/38,50/21728,0.0034603317873608203,0.01819901381939392,0.009824322306902986,MYC/NFIL3,2
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,3/38,174/21728,0.003465961437842782,0.01819901381939392,0.009824322306902986,NFIL3/ATF3/PTGS2,3
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,2/38,51/21728,0.0035976113214702945,0.018772582440693904,0.010133950238212766,HBEGF/IL6,2
ZHOU_TNF_SIGNALING_30MIN,ZHOU_TNF_SIGNALING_30MIN,2/38,51/21728,0.0035976113214702945,0.018772582440693904,0.010133950238212766,DUSP1/PTGS2,2
KEGG_AUTOIMMUNE_THYROID_DISEASE,KEGG_AUTOIMMUNE_THYROID_DISEASE,2/38,52/21728,0.0037374039000381974,0.019321455347419695,0.01043024675156859,PRF1/IL10,2
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,2/38,52/21728,0.0037374039000381974,0.019321455347419695,0.01043024675156859,CAV1/PTPN1,2
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,2/38,52/21728,0.0037374039000381974,0.019321455347419695,0.01043024675156859,IL1B/NFIL3,2
KRIEG_HYPOXIA_VIA_KDM3A,KRIEG_HYPOXIA_VIA_KDM3A,2/38,53/21728,0.0038797007864571536,0.01987308506824383,0.010728031468104604,SERPINB8/HMOX1,2
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,2/38,53/21728,0.0038797007864571536,0.01987308506824383,0.010728031468104604,ATF3/RGS16,2
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,2/38,53/21728,0.0038797007864571536,0.01987308506824383,0.010728031468104604,IL1B/IL6,2
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,3/38,182/21728,0.003931480952501289,0.02007692254707213,0.010838068479456378,MYLK/DUSP1/MYC,3
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,2/38,54/21728,0.004024493265595341,0.02048944139778783,0.011060757367289708,MYC/RGS2,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,3/38,184/21728,0.004053523693205485,0.02052500671039629,0.011079956489697038,RGS2/HMOX1/ACTA2,3
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,4/38,375/21728,0.0040559864006812964,0.02052500671039629,0.011079956489697038,DUSP1/ATF3/RGS2/IL10,4
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,3/38,185/21728,0.004115403752981525,0.020762955681457997,0.011208407811703014,TAGLN/HMOX1/SLC26A2,3
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,2/38,55/21728,0.004171772643751218,0.02092382558134835,0.011295249756090014,IL1B/IL6,2
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,4/38,378/21728,0.004172273280101701,0.02092382558134835,0.011295249756090014,TNFRSF11A/MYLK/RGS16/HMOX1,4
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,2/38,56/21728,0.004321530248608372,0.021607651243041863,0.011664397434578451,RGS2/ADAM8,2
REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,2/38,57/21728,0.004473757429190441,0.02230221337468449,0.012039340951361496,CNN2/IL10,2
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,3/38,192/21728,0.004564744710690899,0.022678042616199965,0.012242223790929,TAGLN/HMOX1/SLC26A2,3
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,4/38,388/21728,0.004576225913000351,0.022678042616199965,0.012242223790929,IL1B/DUSP1/IL6/TRPV2,4
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,2/38,58/21728,0.0046284455558161354,0.02273503315540184,0.01227298883298676,MYLK/GPNMB,2
CROMER_TUMORIGENESIS_UP,CROMER_TUMORIGENESIS_UP,2/38,58/21728,0.0046284455558161354,0.02273503315540184,0.01227298883298676,IL1B/IL6,2
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,2/38,58/21728,0.0046284455558161354,0.02273503315540184,0.01227298883298676,ATF3/ACTA2,2
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,3/38,195/21728,0.004766074636026486,0.023234366908959456,0.012542542764993666,MYLK/ACTG2/ACTA2,3
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/38,59/21728,0.0047855860200543355,0.023234366908959456,0.012542542764993666,IL1B/PTGS2,2
RAMASWAMY_METASTASIS_DN,RAMASWAMY_METASTASIS_DN,2/38,59/21728,0.0047855860200543355,0.023234366908959456,0.012542542764993666,MYLK/ACTG2,2
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,2/38,59/21728,0.0047855860200543355,0.023234366908959456,0.012542542764993666,MYLK/HBEGF,2
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,2/38,60/21728,0.00494517023467926,0.023870778510339367,0.012886095045015878,TAGLN/PTGS2,2
LEE_LIVER_CANCER_DENA_UP,LEE_LIVER_CANCER_DENA_UP,2/38,60/21728,0.00494517023467926,0.023870778510339367,0.012886095045015878,RGS2/PPBP,2
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,4/38,400/21728,0.005094954683362757,0.02447151749191136,0.013210390275287894,MYLK/HBEGF/ELL2/IL10,4
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,2/38,61/21728,0.005107189633625743,0.02447151749191136,0.013210390275287894,IL1B/IL6,2
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,3/38,200/21728,0.0051134514162202846,0.02447151749191136,0.013210390275287894,CAV1/DUSP1/HMOX1,3
DAZARD_UV_RESPONSE_CLUSTER_G1,DAZARD_UV_RESPONSE_CLUSTER_G1,2/38,62/21728,0.005271635671944616,0.024873210564809105,0.013427235114011638,IL6/PPBP,2
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,2/38,62/21728,0.005271635671944616,0.024873210564809105,0.013427235114011638,DUSP1/ATF3,2
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,2/38,62/21728,0.005271635671944616,0.024873210564809105,0.013427235114011638,IL1B/IL6,2
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,2/38,62/21728,0.005271635671944616,0.024873210564809105,0.013427235114011638,MYC/NFIL3,2
WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,2/38,62/21728,0.005271635671944616,0.024873210564809105,0.013427235114011638,IL1B/IL6,2
SANSOM_WNT_PATHWAY_REQUIRE_MYC,SANSOM_WNT_PATHWAY_REQUIRE_MYC,2/38,63/21728,0.005438499825758102,0.025516770891161965,0.013774646470075806,MYC/PTGS2,2
WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,2/38,63/21728,0.005438499825758102,0.025516770891161965,0.013774646470075806,IL6/IL10,2
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,2/38,64/21728,0.005607773592215385,0.026091724352668804,0.014085021975769054,IL1B/PTGS2,2
LEE_LIVER_CANCER_MYC_E2F1_DN,LEE_LIVER_CANCER_MYC_E2F1_DN,2/38,64/21728,0.005607773592215385,0.026091724352668804,0.014085021975769054,RGS16/TRPV2,2
LIAN_LIPA_TARGETS_3M,LIAN_LIPA_TARGETS_3M,2/38,64/21728,0.005607773592215385,0.026091724352668804,0.014085021975769054,HMOX1/GPNMB,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,3/38,207/21728,0.005624922874874081,0.0260990188792634,0.014088959759489244,IL10/GPNMB/PPBP,3
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,4/38,412/21728,0.005651958872026966,0.02615201964266621,0.014117571012129003,IL1B/HBEGF/IL10/GPNMB,4
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,3/38,209/21728,0.005776504877655057,0.026377591879634073,0.014239341036672848,MYC/HSPA6/ADAM8,3
DELPUECH_FOXO3_TARGETS_UP,DELPUECH_FOXO3_TARGETS_UP,2/38,65/21728,0.005779448489448182,0.026377591879634073,0.014239341036672848,CAV1/SERPINB8,2
LEE_LIVER_CANCER_MYC_TGFA_DN,LEE_LIVER_CANCER_MYC_TGFA_DN,2/38,65/21728,0.005779448489448182,0.026377591879634073,0.014239341036672848,RGS16/TRPV2,2
PID_LYSOPHOSPHOLIPID_PATHWAY,PID_LYSOPHOSPHOLIPID_PATHWAY,2/38,65/21728,0.005779448489448182,0.026377591879634073,0.014239341036672848,HBEGF/IL6,2
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,2/38,65/21728,0.005779448489448182,0.026377591879634073,0.014239341036672848,CAV1/ELL2,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,2/38,66/21728,0.005953516056526484,0.02709820487685288,0.014628347518753576,OLFML3/RGS2,2
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,4/38,421/21728,0.006095577760038163,0.027669628043533668,0.014936817275346691,IL1B/HBEGF/ADAM8/TRPV2,4
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,2/38,67/21728,0.006129967853414277,0.027675730874579283,0.014940111749419388,HBEGF/GPNMB,2
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,2/38,67/21728,0.006129967853414277,0.027675730874579283,0.014940111749419388,PTPN1/MYC,2
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,2/38,68/21728,0.00630879546092547,0.02833038176152859,0.015293510091533735,TAGLN/HBEGF,2
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,2/38,68/21728,0.00630879546092547,0.02833038176152859,0.015293510091533735,MYLK/MYC,2
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,3/38,216/21728,0.006326334054640636,0.02833318059230766,0.015295020976460193,TNFRSF11A/CNN2/BDKRB2,3
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,2/38,69/21728,0.0064899904806798225,0.028911526742390167,0.015607227947659485,F12/BDKRB2,2
PID_VEGFR1_2_PATHWAY,PID_VEGFR1_2_PATHWAY,2/38,69/21728,0.0064899904806798225,0.028911526742390167,0.015607227947659485,CAV1/SHB,2
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,3/38,219/21728,0.00657123944106694,0.029195825102883623,0.01576069992985202,CAV1/HBEGF/MYC,3
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,2/38,70/21728,0.00667354453505895,0.02941628183216774,0.015879708464309247,CAV1/PRF1,2
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,2/38,70/21728,0.00667354453505895,0.02941628183216774,0.015879708464309247,FOSL2/RGS2,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,2/38,70/21728,0.00667354453505895,0.02941628183216774,0.015879708464309247,DUSP1/SPSB1,2
RAGHAVACHARI_PLATELET_SPECIFIC_GENES,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,2/38,71/21728,0.006859449267162484,0.030077428069364295,0.016236613173029966,MYLK/PPBP,2
WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,2/38,71/21728,0.006859449267162484,0.030077428069364295,0.016236613173029966,CAV1/IL6,2
PEDRIOLI_MIR31_TARGETS_UP,PEDRIOLI_MIR31_TARGETS_UP,3/38,223/21728,0.006906508066495135,0.030204702379580554,0.016305319304986455,OLFML3/TAGLN/RGS2,3
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,4/38,437/21728,0.006940701469070638,0.030275195210138852,0.016343373250909208,MYLK/DUSP1/FOSL2/GPNMB,4
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,2/38,72/21728,0.007047696340764254,0.030662055508519803,0.01655221095479561,IL1B/MYC,2
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,2/38,73/21728,0.007238277440268584,0.031328461789276174,0.01691195517799732,IL6/IL10,2
WP_FOLATE_METABOLISM,WP_FOLATE_METABOLISM,2/38,73/21728,0.007238277440268584,0.031328461789276174,0.01691195517799732,IL1B/IL6,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,3/38,228/21728,0.007339728434520927,0.03168568331913029,0.017104793069054467,OLFML3/MYC/SLC26A2,3
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,2/38,74/21728,0.007431184270666622,0.031915983726581006,0.01722911548853611,MYC/PTGS2,2
WP_CYTOSOLIC_DNASENSING_PATHWAY,WP_CYTOSOLIC_DNASENSING_PATHWAY,2/38,74/21728,0.007431184270666622,0.031915983726581006,0.01722911548853611,IL1B/IL6,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,2/38,75/21728,0.0076264085574928985,0.032587332484185216,0.01759152779507626,ATF3/RGS2,2
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,2/38,75/21728,0.0076264085574928985,0.032587332484185216,0.01759152779507626,CAV1/HBEGF,2
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,2/38,76/21728,0.007823942046781732,0.03317747576799848,0.017910103179708217,FOSL2/RGS2,2
WP_LEPTIN_SIGNALING_PATHWAY,WP_LEPTIN_SIGNALING_PATHWAY,2/38,76/21728,0.007823942046781732,0.03317747576799848,0.017910103179708217,IL1B/PTPN1,2
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,2/38,76/21728,0.007823942046781732,0.03317747576799848,0.017910103179708217,PTPN1/MYC,2
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,3/38,235/21728,0.007972876534955603,0.03372365706073393,0.018204946686674276,PRF1/FCGR3B/PPBP,3
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,4/38,456/21728,0.008041460986120444,0.03392807846788853,0.018315298918407698,CAV1/RGS2/ELL2/PTGS2,4
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,2/38,78/21728,0.00822590371912353,0.03461906715962792,0.01868831339520527,CAV1/MYC,2
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,3/38,238/21728,0.008253821309821833,0.03464950048609416,0.018704742132006215,F12/SERPINB8/ADAM8,3
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,3/38,240/21728,0.008444337151869916,0.03536066182345527,0.019088646351200677,HBEGF/RGS2/ADAM8,3
HUANG_DASATINIB_SENSITIVITY_UP,HUANG_DASATINIB_SENSITIVITY_UP,2/38,80/21728,0.008637003664317418,0.036077259695091464,0.019475485359361232,CAV1/ELL2,2
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,3/38,243/21728,0.008734959895313539,0.036395666230473085,0.019647369861414847,CAV1/OLFML3/MYLK,3
HINATA_NFKB_TARGETS_FIBROBLAST_UP,HINATA_NFKB_TARGETS_FIBROBLAST_UP,2/38,81/21728,0.008845960070897104,0.03667570078899171,0.019798540127411706,IL1B/IL6,2
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,2/38,81/21728,0.008845960070897104,0.03667570078899171,0.019798540127411706,CAV1/ELL2,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,3/38,247/21728,0.009131548969169843,0.03776628277372713,0.020387265924670293,ADAM8/ACTA2/SLC26A2,3
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,2/38,83/21728,0.00927064509260599,0.038153146265638906,0.020596105352511437,HSPA6/GPNMB,2
NELSON_RESPONSE_TO_ANDROGEN_UP,NELSON_RESPONSE_TO_ANDROGEN_UP,2/38,83/21728,0.00927064509260599,0.038153146265638906,0.020596105352511437,ELL2/SLC26A2,2
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,4/38,476/21728,0.009318768748187907,0.0382572001304283,0.02065227645689735,DUSP1/RGS16/HMOX1/IL10,4
GHANDHI_BYSTANDER_IRRADIATION_UP,GHANDHI_BYSTANDER_IRRADIATION_UP,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,IL1B/PTGS2,2
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,IL1B/IL6,2
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,RGS16/PTGS2,2
KEGG_SMALL_CELL_LUNG_CANCER,KEGG_SMALL_CELL_LUNG_CANCER,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,MYC/PTGS2,2
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,TAGLN/ACTA2,2
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,MYC/PTGS2,2
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,2/38,84/21728,0.009486357504536998,0.03828831040987824,0.02066907063131841,MYC/IL6,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,4/38,483/21728,0.00979546565524341,0.039440877337819015,0.021291257585663182,NFIL3/ATF3/ADAM8/BDKRB2,4
WP_APOPTOSIS,WP_APOPTOSIS,2/38,86/21728,0.00992448177346399,0.039864525109237846,0.021519954167374903,PRF1/MYC,2
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,2/38,87/21728,0.010146877547808545,0.040466714029950744,0.02184503211420436,HBEGF/MYC,2
KEGG_HEMATOPOIETIC_CELL_LINEAGE,KEGG_HEMATOPOIETIC_CELL_LINEAGE,2/38,87/21728,0.010146877547808545,0.040466714029950744,0.02184503211420436,IL1B/IL6,2
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,2/38,87/21728,0.010146877547808545,0.040466714029950744,0.02184503211420436,CAV1/MYC,2
HOEBEKE_LYMPHOID_STEM_CELL_DN,HOEBEKE_LYMPHOID_STEM_CELL_DN,2/38,88/21728,0.0103714850603091,0.04116643951662972,0.022222762950375445,IL1B/RGS2,2
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,2/38,88/21728,0.0103714850603091,0.04116643951662972,0.022222762950375445,ACTG2/TRPV2,2
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,3/38,262/21728,0.010712248984517461,0.04241848002143439,0.022898648445192234,FOSL2/PRF1/PTGS2,3
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,3/38,265/21728,0.01104626987153289,0.04337935481427431,0.02341735477483842,ELL2/HMOX1/PTGS2,3
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,2/38,91/21728,0.011058498212355302,0.04337935481427431,0.02341735477483842,MYLK/ACTG2,2
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,2/38,91/21728,0.011058498212355302,0.04337935481427431,0.02341735477483842,HBEGF/MYC,2
WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,WP_TCELL_RECEPTOR_TCR_SIGNALING_PATHWAY,2/38,91/21728,0.011058498212355302,0.04337935481427431,0.02341735477483842,IL1B/IL6,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,3/38,266/21728,0.011158944623883615,0.04356930593241272,0.023519895551260033,SHB/MYLK/ASGR2,3
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,3/38,266/21728,0.011158944623883615,0.04356930593241272,0.023519895551260033,IL1B/IL6/PTGS2,3
GAVIN_FOXP3_TARGETS_CLUSTER_P7,GAVIN_FOXP3_TARGETS_CLUSTER_P7,2/38,92/21728,0.011291872962419758,0.043985784214076964,0.023744721847536288,PRF1/IL10,2
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,3/38,269/21728,0.011500982494405468,0.04469639368475443,0.024128328154095244,NFIL3/ACTG2/ACTA2,3
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,2/38,94/21728,0.01176513050967226,0.04561711482338202,0.024625358449825708,IL1B/ADAM8,2
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,2/38,96/21728,0.012247012936121973,0.04737585835566814,0.025574776011009544,MYLK/ACTA2,2
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,2/38,98/21728,0.012737457496362101,0.04893403969359293,0.026415924648418746,RGS2/IL6,2
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,2/38,98/21728,0.012737457496362101,0.04893403969359293,0.026415924648418746,RGS2/SERPINB8,2
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,2/38,98/21728,0.012737457496362101,0.04893403969359293,0.026415924648418746,MYC/PTGS2,2
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,3/38,280/21728,0.012806894629157272,0.049088211679264145,0.026499150876661683,FOSL2/NFIL3/ELL2,3
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,3/38,283/21728,0.013177249446016517,0.05039244936547412,0.02720321382871471,TNFRSF11A/PRF1/GPNMB,3
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,2/38,100/21728,0.013236401758018351,0.05050335522706318,0.027263083827209603,MYC/NFIL3,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,2/38,101/21728,0.013489041852028169,0.05135032977760723,0.027720303710268415,FOSL2/SLC26A2,2
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,2/38,102/21728,0.013743783600419685,0.05208334282964473,0.028116004078972398,IL1B/IL6,2
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,2/38,102/21728,0.013743783600419685,0.05208334282964473,0.028116004078972398,HMOX1/GPNMB,2
WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,2/38,103/21728,0.0140006192865954,0.05293687879243182,0.028576765990698468,MYC/ATF3,2
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,2/38,104/21728,0.014259541213273979,0.05379444038791422,0.029039701048369723,IL1B/IL6,2
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,3/38,295/21728,0.014719965765023452,0.05528238263770019,0.029842932716910894,CAV1/HBEGF/MYC,3
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,3/38,295/21728,0.014719965765023452,0.05528238263770019,0.029842932716910894,MYLK/TAGLN/ACTA2,3
REACTOME_SIGNALING_BY_VEGF,REACTOME_SIGNALING_BY_VEGF,2/38,106/21728,0.014783613095348903,0.055397207907627324,0.029904918518555774,CAV1/SHB,2
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,3/38,296/21728,0.01485297051115401,0.055409188432478766,0.029911385931499935,DUSP1/HBEGF/HSPA6,3
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,3/38,296/21728,0.01485297051115401,0.055409188432478766,0.029911385931499935,MYLK/F12/ADAM8,3
TAVAZOIE_METASTASIS,TAVAZOIE_METASTASIS,2/38,107/21728,0.015048747752394013,0.055890582007228316,0.030171255267374162,RGS2/PTGS2,2
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,2/38,107/21728,0.015048747752394013,0.055890582007228316,0.030171255267374162,IL6/PTGS2,2
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,3/38,303/21728,0.015803239495576694,0.058562889723652575,0.03161383960572981,PRF1/NFIL3/RGS16,3
SUNG_METASTASIS_STROMA_UP,SUNG_METASTASIS_STROMA_UP,2/38,110/21728,0.015856455199650326,0.05863038070510882,0.03165027307191735,SPSB1/PTGS2,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,3/38,304/21728,0.015941745284051307,0.058815910464286206,0.03175042707859975,FCGR3B/ACTA2/PTGS2,3
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,3/38,307/21728,0.016361401082035,0.06023153145584313,0.03251461776626505,PTPN1/NFIL3/ACTA2,3
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,3/38,309/21728,0.016644624047556313,0.06113979227994918,0.033004921645546796,MYC/F12/SLC26A2,3
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,3/38,311/21728,0.016930612298008536,0.06136290230487516,0.033125362501107786,ATF3/RGS16/ACTA2,3
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,2/38,114/21728,0.016961824034849995,0.06136290230487516,0.033125362501107786,PRF1/IL10,2
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/38,114/21728,0.016961824034849995,0.06136290230487516,0.033125362501107786,DUSP1/SLC26A2,2
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,2/38,114/21728,0.016961824034849995,0.06136290230487516,0.033125362501107786,MYC/RGS2,2
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,2/38,114/21728,0.016961824034849995,0.06136290230487516,0.033125362501107786,MYC/PTGS2,2
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,2/38,115/21728,0.017243192069935957,0.06136290230487516,0.033125362501107786,MYC/IL10,2
BAKER_HEMATOPOESIS_STAT1_TARGETS,BAKER_HEMATOPOESIS_STAT1_TARGETS,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,MYC,1
BIOCARTA_SET_PATHWAY,BIOCARTA_SET_PATHWAY,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,PRF1,1
HOFFMAN_CLOCK_TARGETS_DN,HOFFMAN_CLOCK_TARGETS_DN,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,BDKRB2,1
IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,ATF3,1
MAINA_VHL_TARGETS_UP,MAINA_VHL_TARGETS_UP,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,TAGLN,1
MURAKAMI_UV_RESPONSE_1HR_DN,MURAKAMI_UV_RESPONSE_1HR_DN,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,IL6,1
PYEON_HPV_POSITIVE_TUMORS_DN,PYEON_HPV_POSITIVE_TUMORS_DN,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,CAV1,1
REACTOME_MAPK3_ERK1_ACTIVATION,REACTOME_MAPK3_ERK1_ACTIVATION,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,IL6,1
REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,HBEGF,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,RGS2,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_INVOLUTION_STAGE_4_OF_4,1/38,10/21728,0.017355522194028805,0.06136290230487516,0.033125362501107786,MYC,1
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,3/38,314/21728,0.017364785488066165,0.06136290230487516,0.033125362501107786,RGS16/BDKRB2/PPBP,3
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,2/38,116/21728,0.017526555469928595,0.061804169288695573,0.03336357041256214,SHB/DUSP1,2
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,2/38,118/21728,0.018099238583850936,0.0635560264736904,0.034309270536307966,FOSL2/HMOX1,2
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,2/38,118/21728,0.018099238583850936,0.0635560264736904,0.034309270536307966,CAV1/IL6,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,3/38,321/21728,0.01840212339802333,0.06448442822529095,0.03481044703567946,IL1B/HBEGF/RGS2,3
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,3/38,322/21728,0.018553092078707374,0.0648777228222022,0.03502275814879603,CNN2/ELL2/PPBP,3
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,3/38,325/21728,0.01901017009406549,0.06574153022392713,0.035489064862437344,MYC/IL6/PTGS2,3
AGARWAL_AKT_PATHWAY_TARGETS,AGARWAL_AKT_PATHWAY_TARGETS,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,PTGS2,1
DORN_ADENOVIRUS_INFECTION_32HR_UP,DORN_ADENOVIRUS_INFECTION_32HR_UP,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,MYC,1
FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,GPNMB,1
REACTOME_ENOS_ACTIVATION,REACTOME_ENOS_ACTIVATION,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,CAV1,1
REACTOME_INTERLEUKIN_6_SIGNALING,REACTOME_INTERLEUKIN_6_SIGNALING,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,IL6,1
WP_SEROTONIN_TRANSPORTER_ACTIVITY,WP_SEROTONIN_TRANSPORTER_ACTIVITY,1/38,11/21728,0.01907485593362901,0.06574153022392713,0.035489064862437344,IL1B,1
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,2/38,123/21728,0.019565346054311435,0.06729354135723133,0.03632688265568685,MYC/PELO,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/38,125/21728,0.020165394428359455,0.06921523702356985,0.03736426620785326,ATF3/ACTA2,2
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,3/38,336/21728,0.02073974583671266,0.06993044406664853,0.03775035440895591,IL1B/IL6/PTGS2,3
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,2/38,127/21728,0.020773129640590943,0.06993044406664853,0.03775035440895591,PTPN1/ELL2,2
BIOCARTA_D4GDI_PATHWAY,BIOCARTA_D4GDI_PATHWAY,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,PRF1,1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,SLC26A2,1
DORN_ADENOVIRUS_INFECTION_24HR_UP,DORN_ADENOVIRUS_INFECTION_24HR_UP,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,MYC,1
FUNG_IL2_SIGNALING_2,FUNG_IL2_SIGNALING_2,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,MYC,1
ITO_PTTG1_TARGETS_UP,ITO_PTTG1_TARGETS_UP,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,GPNMB,1
KIM_GERMINAL_CENTER_T_HELPER_DN,KIM_GERMINAL_CENTER_T_HELPER_DN,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,ELL2,1
TURJANSKI_MAPK1_AND_MAPK2_TARGETS,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,MYC,1
ZHENG_RESPONSE_TO_ARSENITE_DN,ZHENG_RESPONSE_TO_ARSENITE_DN,1/38,12/21728,0.020791260385188637,0.06993044406664853,0.03775035440895591,MYC,1
MIKKELSEN_MEF_LCP_WITH_H3K4ME3,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,2/38,129/21728,0.021388493650769533,0.07179504381771337,0.03875691603419688,ACTG2/SERPINB8,2
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,3/38,341/21728,0.021553817721008242,0.07220528936537761,0.038978377731254905,IL10/ADAM8/GPNMB,3
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,2/38,130/21728,0.021699018397664506,0.07254661839538533,0.03916263641893857,IL1B/PPBP,2
ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,ACTA2,1
BIOCARTA_CTL_PATHWAY,BIOCARTA_CTL_PATHWAY,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,PRF1,1
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,CAV1,1
COLLIS_PRKDC_REGULATORS,COLLIS_PRKDC_REGULATORS,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,PTPN1,1
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,PPBP,1
INAMURA_LUNG_CANCER_SCC_DN,INAMURA_LUNG_CANCER_SCC_DN,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,CAV1,1
MARTINELLI_IMMATURE_NEUTROPHIL_DN,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,FCGR3B,1
NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,IL10,1
ONGUSAHA_BRCA1_TARGETS_UP,ONGUSAHA_BRCA1_TARGETS_UP,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,HMOX1,1
REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,SERPINB8,1
REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,HBEGF,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_1,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,IL10,1
WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,TNFRSF11A,1
WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,IL10,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,MYC,1
WU_HBX_TARGETS_3_DN,WU_HBX_TARGETS_3_DN,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,IL6,1
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,1/38,13/21728,0.022504740404775903,0.07277112003474832,0.03928382850579659,SPSB1,1
QI_HYPOXIA,QI_HYPOXIA,2/38,133/21728,0.022641877367731458,0.07307349632167667,0.039447059444034725,DUSP1/HMOX1,2
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,2/38,135/21728,0.023279782453998765,0.07498776078932294,0.040480431433167895,RGS16/RGS2,2
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,2/38,137/21728,0.0239250870946913,0.07620934657856117,0.04113987664476609,PRF1/FCGR3B,2
LI_INDUCED_T_TO_NATURAL_KILLER_DN,LI_INDUCED_T_TO_NATURAL_KILLER_DN,2/38,137/21728,0.0239250870946913,0.07620934657856117,0.04113987664476609,OLFML3/ACTA2,2
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,OLFML3,1
DORN_ADENOVIRUS_INFECTION_48HR_UP,DORN_ADENOVIRUS_INFECTION_48HR_UP,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,MYC,1
REACTOME_REGULATION_OF_IFNG_SIGNALING,REACTOME_REGULATION_OF_IFNG_SIGNALING,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,PTPN1,1
REACTOME_REPRESSION_OF_WNT_TARGET_GENES,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,MYC,1
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,HBEGF,1
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,HBEGF,1
SINGH_NFE2L2_TARGETS,SINGH_NFE2L2_TARGETS,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,HMOX1,1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,IL10,1
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,MYC,1
ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,1/38,14/21728,0.02421530084063217,0.07620934657856117,0.04113987664476609,FOSL2,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,2/38,138/21728,0.024250496553058568,0.07620934657856117,0.04113987664476609,FOSL2/RGS2,2
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,2/38,139/21728,0.024577734702059456,0.07709308169653481,0.04161694088127158,IL10/FCGR3B,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,2/38,141/21728,0.02523766897513285,0.07767609202697998,0.04193166570380254,DUSP1/ATF3,2
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,2/38,141/21728,0.02523766897513285,0.07767609202697998,0.04193166570380254,DUSP1/MYC,2
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,2/38,143/21728,0.025904833898492092,0.07767609202697998,0.04193166570380254,ACTG2/ACTA2,2
BAKER_HEMATOPOIESIS_STAT3_TARGETS,BAKER_HEMATOPOIESIS_STAT3_TARGETS,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,MYC,1
BIOCARTA_ASBCELL_PATHWAY,BIOCARTA_ASBCELL_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL10,1
BIOCARTA_CD40_PATHWAY,BIOCARTA_CD40_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,DUSP1,1
BIOCARTA_ERYTH_PATHWAY,BIOCARTA_ERYTH_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL6,1
BIOCARTA_IL17_PATHWAY,BIOCARTA_IL17_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL6,1
BIOCARTA_STEM_PATHWAY,BIOCARTA_STEM_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL6,1
LUND_SILENCED_BY_METHYLATION,LUND_SILENCED_BY_METHYLATION,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HMOX1,1
MATZUK_OVULATION,MATZUK_OVULATION,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,PTGS2,1
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,CNN2,1
PID_ERBB_NETWORK_PATHWAY,PID_ERBB_NETWORK_PATHWAY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HBEGF,1
REACTOME_ERBB2_REGULATES_CELL_MOTILITY,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HBEGF,1
REACTOME_HEME_DEGRADATION,REACTOME_HEME_DEGRADATION,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HMOX1,1
REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,CAV1,1
REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,ATF3,1
REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,PTGS2,1
SA_MMP_CYTOKINE_CONNECTION,SA_MMP_CYTOKINE_CONNECTION,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL1B,1
TRAYNOR_RETT_SYNDROM_DN,TRAYNOR_RETT_SYNDROM_DN,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,SLC26A2,1
WP_FOXP3_IN_COVID19,WP_FOXP3_IN_COVID19,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,IL6,1
WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,MYC,1
WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HMOX1,1
ZHANG_RESPONSE_TO_CANTHARIDIN_UP,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,NFIL3,1
ZHENG_RESPONSE_TO_ARSENITE_UP,ZHENG_RESPONSE_TO_ARSENITE_UP,1/38,15/21728,0.025922946533183167,0.07767609202697998,0.04193166570380254,HMOX1,1
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,2/38,145/21728,0.02657917374104531,0.07935849557263974,0.04283987286529303,CAV1/ACTA2,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/38,145/21728,0.02657917374104531,0.07935849557263974,0.04283987286529303,HBEGF/HMOX1,2
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,2/38,146/21728,0.02691901691849923,0.08023016608271567,0.04331042429854062,DUSP1/PTGS2,2
BIOCARTA_CDMAC_PATHWAY,BIOCARTA_CDMAC_PATHWAY,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,MYC,1
DASU_IL6_SIGNALING_SCAR_DN,DASU_IL6_SIGNALING_SCAR_DN,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,HMOX1,1
GHO_ATF5_TARGETS_DN,GHO_ATF5_TARGETS_DN,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,DUSP1,1
LY_AGING_MIDDLE_DN,LY_AGING_MIDDLE_DN,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,PTGS2,1
REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,F12,1
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,HBEGF,1
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,HBEGF,1
REACTOME_THE_NLRP3_INFLAMMASOME,REACTOME_THE_NLRP3_INFLAMMASOME,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,HMOX1,1
WANG_RECURRENT_LIVER_CANCER_DN,WANG_RECURRENT_LIVER_CANCER_DN,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,ELL2,1
WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,MYC,1
WP_OSTEOCLAST_SIGNALING,WP_OSTEOCLAST_SIGNALING,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,TNFRSF11A,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,PTGS2,1
WU_HBX_TARGETS_1_UP,WU_HBX_TARGETS_1_UP,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,IL6,1
WU_HBX_TARGETS_2_DN,WU_HBX_TARGETS_2_DN,1/38,16/21728,0.027627682315053415,0.0803409164543654,0.04337021035934007,IL6,1
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,2/38,150/21728,0.028296050434940292,0.08179121867035079,0.0441531229145837,IL1B/ELL2,2
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,2/38,150/21728,0.028296050434940292,0.08179121867035079,0.0441531229145837,HBEGF/MYC,2
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,2/38,150/21728,0.028296050434940292,0.08179121867035079,0.0441531229145837,MYLK/BDKRB2,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,2/38,151/21728,0.028644689712301843,0.08179121867035079,0.0441531229145837,GPNMB/PPBP,2
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,2/38,152/21728,0.02899506768876454,0.08179121867035079,0.0441531229145837,RGS16/RGS2,2
BIOCARTA_ARF_PATHWAY,BIOCARTA_ARF_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,MYC,1
BIOCARTA_DC_PATHWAY,BIOCARTA_DC_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,IL10,1
BIOCARTA_LAIR_PATHWAY,BIOCARTA_LAIR_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,IL6,1
BIOCARTA_TEL_PATHWAY,BIOCARTA_TEL_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,MYC,1
BIOCARTA_TNFR2_PATHWAY,BIOCARTA_TNFR2_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,DUSP1,1
COLLIS_PRKDC_SUBSTRATES,COLLIS_PRKDC_SUBSTRATES,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,MYC,1
EHRLICH_ICF_SYNDROM_DN,EHRLICH_ICF_SYNDROM_DN,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,HMOX1,1
GENTILE_UV_RESPONSE_CLUSTER_D1,GENTILE_UV_RESPONSE_CLUSTER_D1,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,DUSP1,1
GOUYER_TATI_TARGETS_DN,GOUYER_TATI_TARGETS_DN,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,TAGLN,1
NELSON_RESPONSE_TO_ANDROGEN_DN,NELSON_RESPONSE_TO_ANDROGEN_DN,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,MYC,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,CAV1,1
REACTOME_GAB1_SIGNALOSOME,REACTOME_GAB1_SIGNALOSOME,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,HBEGF,1
REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,TNFRSF11A,1
RUAN_RESPONSE_TO_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,RGS2,1
WP_ACE_INHIBITOR_PATHWAY,WP_ACE_INHIBITOR_PATHWAY,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,BDKRB2,1
WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,MYLK,1
WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,IL6,1
WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,IL6,1
WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1/38,17/21728,0.029329513011075004,0.08179121867035079,0.0441531229145837,IL1B,1
WILCOX_RESPONSE_TO_PROGESTERONE_UP,WILCOX_RESPONSE_TO_PROGESTERONE_UP,2/38,153/21728,0.029347177564704965,0.08179121867035079,0.0441531229145837,RGS2/HMOX1,2
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,2/38,154/21728,0.029701012557854893,0.08250281266070804,0.04453726069162495,HBEGF/RGS2,2
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/38,154/21728,0.029701012557854893,0.08250281266070804,0.04453726069162495,MYC/IL6,2
BIOCARTA_CARDIACEGF_PATHWAY,BIOCARTA_CARDIACEGF_PATHWAY,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,MYC,1
DORMOY_ELAVL1_TARGETS,DORMOY_ELAVL1_TARGETS,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,IL6,1
PID_ANTHRAX_PATHWAY,PID_ANTHRAX_PATHWAY,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,IL1B,1
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,HBEGF,1
REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,PTPN1,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,NFIL3,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,MYLK,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,ADAM8,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,MYC,1
WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,MYLK,1
WU_HBX_TARGETS_3_UP,WU_HBX_TARGETS_3_UP,1/38,18/21728,0.031028443438304243,0.08464599797908731,0.04569421037802733,MYC,1
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,2/38,160/21728,0.03185987234848505,0.0866319580904423,0.04676628562431419,SHB/MYLK,2
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,2/38,160/21728,0.03185987234848505,0.0866319580904423,0.04676628562431419,IL1B/IL6,2
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,MYC,1
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,MYC,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,FOSL2,1
MANN_RESPONSE_TO_AMIFOSTINE_UP,MANN_RESPONSE_TO_AMIFOSTINE_UP,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,MYC,1
MARSON_FOXP3_CORE_DIRECT_TARGETS,MARSON_FOXP3_CORE_DIRECT_TARGETS,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,MYC,1
REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,PTGS2,1
REACTOME_NICOTINAMIDE_SALVAGING,REACTOME_NICOTINAMIDE_SALVAGING,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,PTGS2,1
REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,MYC,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,PRF1,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_5,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,IL6,1
STREICHER_LSM1_TARGETS_DN,STREICHER_LSM1_TARGETS_DN,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,IL6,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,PPBP,1
UROSEVIC_RESPONSE_TO_IMIQUIMOD,UROSEVIC_RESPONSE_TO_IMIQUIMOD,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,IL6,1
WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY_CGL,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,CAV1,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/38,19/21728,0.032724478406030766,0.08686767247242716,0.04689353065440058,SLC26A2,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,3/38,402/21728,0.032891593183136315,0.08717313066733122,0.047058425290329935,RGS2/SERPINB8/GPNMB,3
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,2/38,164/21728,0.0333327641712671,0.0882028119855804,0.04761427525254584,FOSL2/TRPV2,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,3/38,405/21728,0.03351604348863477,0.0883794603161654,0.04770963482267782,TNFRSF11A/ELL2/PTGS2,3
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,2/38,165/21728,0.03370513275036704,0.0883794603161654,0.04770963482267782,IL1B/CNN2,2
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,MYC,1
BIOCARTA_ARENRF2_PATHWAY,BIOCARTA_ARENRF2_PATHWAY,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,HMOX1,1
DAZARD_UV_RESPONSE_CLUSTER_G4,DAZARD_UV_RESPONSE_CLUSTER_G4,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,DUSP1,1
FERRANDO_TAL1_NEIGHBORS,FERRANDO_TAL1_NEIGHBORS,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,FCGR3B,1
FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,FOSL2,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,PPBP,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,IL10,1
LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,RGS16,1
MCGOWAN_RSP6_TARGETS_UP,MCGOWAN_RSP6_TARGETS_UP,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,GPNMB,1
MURAKAMI_UV_RESPONSE_24HR,MURAKAMI_UV_RESPONSE_24HR,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,IL6,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,RGS2,1
PID_WNT_CANONICAL_PATHWAY,PID_WNT_CANONICAL_PATHWAY,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,CAV1,1
REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,ACTA2,1
WALLACE_PROSTATE_CANCER_UP,WALLACE_PROSTATE_CANCER_UP,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,MYC,1
WP_ASPIRIN_AND_MIRNAS,WP_ASPIRIN_AND_MIRNAS,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,PTGS2,1
WP_NANOMATERIAL_INDUCED_APOPTOSIS,WP_NANOMATERIAL_INDUCED_APOPTOSIS,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,PRF1,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/38,20/21728,0.03441762271579074,0.0883794603161654,0.04770963482267782,MYC,1
KIM_WT1_TARGETS_8HR_UP,KIM_WT1_TARGETS_8HR_UP,2/38,167/21728,0.034454798559078216,0.0883794603161654,0.04770963482267782,HBEGF/HSPA6,2
SASAKI_ADULT_T_CELL_LEUKEMIA,SASAKI_ADULT_T_CELL_LEUKEMIA,2/38,168/21728,0.03483208268548556,0.08907440992089818,0.04808478750796641,CAV1/CNN2,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,2/38,168/21728,0.03483208268548556,0.08907440992089818,0.04808478750796641,TAGLN/ATF3,2
DARWICHE_PAPILLOMA_RISK_LOW_DN,DARWICHE_PAPILLOMA_RISK_LOW_DN,2/38,169/21728,0.03521099225248735,0.08973397766366133,0.04844084010248866,ACTG2/ACTA2,2
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,2/38,169/21728,0.03521099225248735,0.08973397766366133,0.04844084010248866,CNN2/ATF3,2
BIOCARTA_IL6_PATHWAY,BIOCARTA_IL6_PATHWAY,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,IL6,1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,PRF1,1
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,IL6,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,ATF3,1
LANDEMAINE_LUNG_METASTASIS,LANDEMAINE_LUNG_METASTASIS,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,SPSB1,1
MALTA_CURATED_STEMNESS_MARKERS,MALTA_CURATED_STEMNESS_MARKERS,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,MYC,1
MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,MYLK,1
MURAKAMI_UV_RESPONSE_6HR_DN,MURAKAMI_UV_RESPONSE_6HR_DN,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,IL6,1
PID_S1P_S1P1_PATHWAY,PID_S1P_S1P1_PATHWAY,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,PTGS2,1
REACTOME_INFLAMMASOMES,REACTOME_INFLAMMASOMES,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,HMOX1,1
REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,PTPN1,1
REACTOME_RHO_GTPASES_ACTIVATE_PAKS,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,MYLK,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,NFIL3,1
SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,PTGS2,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,IL6,1
WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,MYC,1
WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,1/38,21/21728,0.03610788116137775,0.08973397766366133,0.04844084010248866,IL6,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,3/38,419/21728,0.03651235039214354,0.0906047213434673,0.04891089120756538,PTPN1/PELO/HMOX1,3
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,2/38,173/21728,0.03674275498492266,0.09069779088228501,0.04896113267423901,HSPA6/SERPINB8,2
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,3/38,422/21728,0.03717197597526268,0.09069779088228501,0.04896113267423901,IL1B/IL10/GPNMB,3
BIOCARTA_CASPASE_PATHWAY,BIOCARTA_CASPASE_PATHWAY,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,PRF1,1
BIOCARTA_EICOSANOID_PATHWAY,BIOCARTA_EICOSANOID_PATHWAY,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,PTGS2,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,GPNMB,1
GAVIN_PDE3B_TARGETS,GAVIN_PDE3B_TARGETS,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,IL10,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,GPNMB,1
KANNAN_TP53_TARGETS_DN,KANNAN_TP53_TARGETS_DN,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,FOSL2,1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,RGS2,1
LU_TUMOR_ENDOTHELIAL_MARKERS_UP,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,HSPA6,1
MATZUK_IMPLANTATION_AND_UTERINE,MATZUK_IMPLANTATION_AND_UTERINE,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,PTGS2,1
REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,HMOX1,1
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,HBEGF,1
SAGIV_CD24_TARGETS_UP,SAGIV_CD24_TARGETS_UP,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,CAV1,1
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,MYC,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,RGS16,1
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,ATF3,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,HMOX1,1
WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,MYC,1
WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,IL1B,1
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,IL6,1
XU_CREBBP_TARGETS_UP,XU_CREBBP_TARGETS_UP,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,HMOX1,1
YANG_BREAST_CANCER_ESR1_BULK_DN,YANG_BREAST_CANCER_ESR1_BULK_DN,1/38,22/21728,0.03779525852885668,0.09069779088228501,0.04896113267423901,RGS16,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,2/38,176/21728,0.037908326854162,0.09083898065911494,0.04903735075329442,SERPINB8/HMOX1,2
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,2/38,177/21728,0.03830000700067622,0.09164644532304667,0.04947324212568553,IL6/GPNMB,2
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,2/38,178/21728,0.038693254600542126,0.09245535157761493,0.04990991170788451,MYLK/BDKRB2,2
BIOCARTA_GLEEVEC_PATHWAY,BIOCARTA_GLEEVEC_PATHWAY,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,MYC,1
BIOCARTA_HER2_PATHWAY,BIOCARTA_HER2_PATHWAY,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,IL6,1
BIOCARTA_INTRINSIC_PATHWAY,BIOCARTA_INTRINSIC_PATHWAY,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,F12,1
CHEOK_RESPONSE_TO_HD_MTX_UP,CHEOK_RESPONSE_TO_HD_MTX_UP,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,MYLK,1
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,MYC,1
HINATA_NFKB_TARGETS_KERATINOCYTE_DN,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,RGS2,1
REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,F12,1
WP_BLOOD_CLOTTING_CASCADE,WP_BLOOD_CLOTTING_CASCADE,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,F12,1
WP_NRF2ARE_REGULATION,WP_NRF2ARE_REGULATION,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,HMOX1,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,1/38,23/21728,0.03947975959657557,0.09288822300815408,0.05014358747148743,HMOX1,1
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,2/38,180/21728,0.03948442673540639,0.09288822300815408,0.05014358747148743,ATF3/RGS16,2
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,3/38,434/21728,0.03987213415935713,0.09366875836875622,0.05056494167400572,MYLK/DUSP1/RGS2,3
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,2/38,182/21728,0.04028179257277731,0.09423464044609216,0.05087042019996429,ACTG2/ACTA2,2
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,2/38,182/21728,0.04028179257277731,0.09423464044609216,0.05087042019996429,ACTG2/ACTA2,2
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,2/38,182/21728,0.04028179257277731,0.09423464044609216,0.05087042019996429,ATF3/HMOX1,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,2/38,183/21728,0.04068278236204081,0.09431645253272249,0.050914584587970844,OLFML3/ACTG2,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,2/38,184/21728,0.041085301688071944,0.09431645253272249,0.050914584587970844,CAV1/PTGS2,2
BIOCARTA_CTCF_PATHWAY,BIOCARTA_CTCF_PATHWAY,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,MYC,1
BIOCARTA_WNT_PATHWAY,BIOCARTA_WNT_PATHWAY,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,MYC,1
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,IL1B,1
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,DUSP1,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,OLFML3,1
ONO_AML1_TARGETS_UP,ONO_AML1_TARGETS_UP,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,RGS2,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,DUSP1,1
REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,SLC26A2,1
REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,HBEGF,1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,PTPN1,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,IL6,1
REACTOME_TRIGLYCERIDE_CATABOLISM,REACTOME_TRIGLYCERIDE_CATABOLISM,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,CAV1,1
WANG_TNF_TARGETS,WANG_TNF_TARGETS,1/38,24/21728,0.041161389135176196,0.09431645253272249,0.050914584587970844,IL6,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,2/38,185/21728,0.04148934428845548,0.09493804874749033,0.0512501391196193,MYC/RGS2,2
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,3/38,445/21728,0.0424334834075084,0.09618934912231102,0.05192562507215407,DUSP1/HBEGF/RGS2,3
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,HSPA6,1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,MYC,1
LA_MEN1_TARGETS,LA_MEN1_TARGETS,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,RGS16,1
PID_INTEGRIN_A9B1_PATHWAY,PID_INTEGRIN_A9B1_PATHWAY,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,ADAM8,1
PID_MYC_PATHWAY,PID_MYC_PATHWAY,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,MYC,1
REACTOME_BASIGIN_INTERACTIONS,REACTOME_BASIGIN_INTERACTIONS,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,CAV1,1
REACTOME_SIGNALING_BY_EGFR_IN_CANCER,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,HBEGF,1
STEGER_ADIPOGENESIS_DN,STEGER_ADIPOGENESIS_DN,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,OLFML3,1
WANG_BARRETTS_ESOPHAGUS_DN,WANG_BARRETTS_ESOPHAGUS_DN,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,GPNMB,1
WP_IL7_SIGNALING_PATHWAY,WP_IL7_SIGNALING_PATHWAY,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,MYC,1
WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,PTGS2,1
WP_UNFOLDED_PROTEIN_RESPONSE,WP_UNFOLDED_PROTEIN_RESPONSE,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,IL1B,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,1/38,25/21728,0.04284015190760837,0.09618934912231102,0.05192562507215407,HBEGF,1
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,HMOX1,1
BIOCARTA_VIP_PATHWAY,BIOCARTA_VIP_PATHWAY,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,MYC,1
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,PPBP,1
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,CAV1,1
HOEGERKORP_CD44_TARGETS_DIRECT_UP,HOEGERKORP_CD44_TARGETS_DIRECT_UP,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,IL6,1
JI_METASTASIS_REPRESSED_BY_STK11,JI_METASTASIS_REPRESSED_BY_STK11,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,BDKRB2,1
PID_ALK1_PATHWAY,PID_ALK1_PATHWAY,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,CAV1,1
PID_VEGFR1_PATHWAY,PID_VEGFR1_PATHWAY,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,CAV1,1
REACTOME_REGULATION_OF_IFNA_SIGNALING,REACTOME_REGULATION_OF_IFNA_SIGNALING,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,PTPN1,1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,HBEGF,1
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,ELL2,1
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,IL1B,1
TERAMOTO_OPN_TARGETS_CLUSTER_6,TERAMOTO_OPN_TARGETS_CLUSTER_6,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,OLFML3,1
WEINMANN_ADAPTATION_TO_HYPOXIA_UP,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,HMOX1,1
WILLIAMS_ESR1_TARGETS_UP,WILLIAMS_ESR1_TARGETS_UP,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,SLC26A2,1
WP_EICOSANOID_SYNTHESIS,WP_EICOSANOID_SYNTHESIS,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,PTGS2,1
WP_PPARALPHA_PATHWAY,WP_PPARALPHA_PATHWAY,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,MYC,1
WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,WP_WNTBETACATENIN_SIGNALING_PATHWAY_IN_LEUKEMIA,1/38,26/21728,0.044516052669139605,0.0975973667811634,0.05268571127416771,MYC,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,3/38,456/21728,0.045076659260552605,0.09843783263388202,0.053139417585234654,FOSL2/HMOX1/ADAM8,3
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,2/38,194/21728,0.04519324972863001,0.09843783263388202,0.053139417585234654,CAV1/SHB,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,2/38,194/21728,0.04519324972863001,0.09843783263388202,0.053139417585234654,HBEGF/RGS2,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/38,194/21728,0.04519324972863001,0.09843783263388202,0.053139417585234654,CAV1/PTGS2,2
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,2/38,194/21728,0.04519324972863001,0.09843783263388202,0.053139417585234654,CAV1/ELL2,2
BIOCARTA_ERK_PATHWAY,BIOCARTA_ERK_PATHWAY,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,MYC,1
NGUYEN_NOTCH1_TARGETS_UP,NGUYEN_NOTCH1_TARGETS_UP,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,TAGLN,1
REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,ATF3,1
REACTOME_G0_AND_EARLY_G1,REACTOME_G0_AND_EARLY_G1,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,MYC,1
REACTOME_INTEGRIN_SIGNALING,REACTOME_INTEGRIN_SIGNALING,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,PTPN1,1
REACTOME_METABOLISM_OF_PORPHYRINS,REACTOME_METABOLISM_OF_PORPHYRINS,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,HMOX1,1
REACTOME_PYROPTOSIS,REACTOME_PYROPTOSIS,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,IL1B,1
REACTOME_SIGNALING_BY_ALK,REACTOME_SIGNALING_BY_ALK,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,MYC,1
REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1/38,27/21728,0.04618909616736877,0.09944310550172582,0.05368209120250274,CAV1,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,2/38,198/21728,0.04687769598494101,0.10045652376347013,0.054229161924789215,BDKRB2/PPBP,2
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,2/38,199/21728,0.04730241587898099,0.10045652376347013,0.054229161924789215,CAV1/MYLK,2
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,2/38,199/21728,0.04730241587898099,0.10045652376347013,0.054229161924789215,CAV1/GPNMB,2
XU_GH1_AUTOCRINE_TARGETS_UP,XU_GH1_AUTOCRINE_TARGETS_UP,2/38,199/21728,0.04730241587898099,0.10045652376347013,0.054229161924789215,OLFML3/SLC26A2,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,3/38,466/21728,0.04754998433832617,0.10045652376347013,0.054229161924789215,SHB/DUSP1/MYC,3
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,2/38,200/21728,0.04772856703517051,0.10045652376347013,0.054229161924789215,MYC/F12,2
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,2/38,200/21728,0.04772856703517051,0.10045652376347013,0.054229161924789215,OLFML3/SLC26A2,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,3/38,467/21728,0.047800984571509275,0.10045652376347013,0.054229161924789215,DUSP1/HBEGF/ATF3,3
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,HMOX1,1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,GPNMB,1
DORN_ADENOVIRUS_INFECTION_12HR_UP,DORN_ADENOVIRUS_INFECTION_12HR_UP,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,ELL2,1
HWANG_PROSTATE_CANCER_MARKERS,HWANG_PROSTATE_CANCER_MARKERS,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,HSPA6,1
MOREIRA_RESPONSE_TO_TSA_UP,MOREIRA_RESPONSE_TO_TSA_UP,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,MYC,1
PID_TCR_CALCIUM_PATHWAY,PID_TCR_CALCIUM_PATHWAY,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,PTGS2,1
REACTOME_ATTENUATION_PHASE,REACTOME_ATTENUATION_PHASE,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,HSPA6,1
REACTOME_TRP_CHANNELS,REACTOME_TRP_CHANNELS,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,TRPV2,1
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,MYC,1
WILENSKY_RESPONSE_TO_DARAPLADIB,WILENSKY_RESPONSE_TO_DARAPLADIB,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,HMOX1,1
WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,IL6,1
WP_METASTATIC_BRAIN_TUMOR,WP_METASTATIC_BRAIN_TUMOR,1/38,28/21728,0.047859287142238305,0.10045652376347013,0.054229161924789215,MYC,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,2/38,201/21728,0.04815614344606298,0.10082692534019436,0.05442911476337908,PTPN1/ACTA2,2
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,2/38,201/21728,0.04815614344606298,0.10082692534019436,0.05442911476337908,NFIL3/HSPA6,2
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,2/38,202/21728,0.04858513911985506,0.10159813736049592,0.05484543597339576,CAV1/MYLK,2
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,ATF3,1
GILDEA_METASTASIS,GILDEA_METASTASIS,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,TAGLN,1
KEGG_THYROID_CANCER,KEGG_THYROID_CANCER,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,MYC,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,ATF3,1
LU_TUMOR_VASCULATURE_UP,LU_TUMOR_VASCULATURE_UP,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,HSPA6,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,MYC,1
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,PTPN1,1
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,HBEGF,1
REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,HBEGF,1
TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,RGS16,1
VALK_AML_CLUSTER_1,VALK_AML_CLUSTER_1,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,ATF3,1
WOTTON_RUNX_TARGETS_DN,WOTTON_RUNX_TARGETS_DN,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,RGS2,1
WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,1/38,29/21728,0.04952663032604465,0.10191290638344569,0.05501535684737147,ATF3,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,2/38,205/21728,0.04988058203453078,0.10238967513215572,0.05527272957644729,SPSB1/GPNMB,2
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,2/38,205/21728,0.04988058203453078,0.10238967513215572,0.05527272957644729,ATF3/PTGS2,2
DAZARD_UV_RESPONSE_CLUSTER_G2,DAZARD_UV_RESPONSE_CLUSTER_G2,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,ATF3,1
KEGG_ASTHMA,KEGG_ASTHMA,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,IL10,1
LY_AGING_PREMATURE_DN,LY_AGING_PREMATURE_DN,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,PTGS2,1
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,RGS2,1
PID_P38_ALPHA_BETA_PATHWAY,PID_P38_ALPHA_BETA_PATHWAY,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,DUSP1,1
SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,ATF3,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,PPBP,1
WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,PTGS2,1
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,1/38,30/21728,0.05119113044345125,0.10393350726397678,0.05610613212239187,IL6,1
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,3/38,485/21728,0.05243205873779611,0.10526566819769834,0.056825268802402434,IL1B/PRF1/PTGS2,3
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,2/38,211/21728,0.05250898606668197,0.10526566819769834,0.056825268802402434,SHB/OLFML3,2
PID_CD40_PATHWAY,PID_CD40_PATHWAY,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,MYC,1
REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,CAV1,1
REACTOME_EGFR_DOWNREGULATION,REACTOME_EGFR_DOWNREGULATION,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,HBEGF,1
REACTOME_HSF1_ACTIVATION,REACTOME_HSF1_ACTIVATION,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,HSPA6,1
REACTOME_NICOTINATE_METABOLISM,REACTOME_NICOTINATE_METABOLISM,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,PTGS2,1
SHIN_B_CELL_LYMPHOMA_CLUSTER_2,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,MYC,1
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,CAV1,1
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,MYC,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,SPSB1,1
VALK_AML_CLUSTER_13,VALK_AML_CLUSTER_13,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,CAV1,1
WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,IL1B,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,PTGS2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,ATF3,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/38,31/21728,0.052852792211501076,0.10526566819769834,0.056825268802402434,CNN2,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,2/38,213/21728,0.053396064784318395,0.10622138778353125,0.057341192211188274,MYLK/BDKRB2,2
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/38,214/21728,0.05384162990018286,0.10641837304064837,0.057447530207017726,SHB/MYLK,2
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,2/38,215/21728,0.054288537793662266,0.10641837304064837,0.057447530207017726,NFIL3/ATF3,2
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,MYC,1
DORSAM_HOXA9_TARGETS_DN,DORSAM_HOXA9_TARGETS_DN,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,MYC,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,HMOX1,1
MODY_HIPPOCAMPUS_NEONATAL,MODY_HIPPOCAMPUS_NEONATAL,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,ACTG2,1
NOJIMA_SFRP2_TARGETS_UP,NOJIMA_SFRP2_TARGETS_UP,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,HSPA6,1
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,IL1B,1
PID_IL12_STAT4_PATHWAY,PID_IL12_STAT4_PATHWAY,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,PRF1,1
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,HBEGF,1
REACTOME_PERK_REGULATES_GENE_EXPRESSION,REACTOME_PERK_REGULATES_GENE_EXPRESSION,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,ATF3,1
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,MYC,1
TAVOR_CEBPA_TARGETS_DN,TAVOR_CEBPA_TARGETS_DN,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,MYC,1
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,IL6,1
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,IL6,1
WP_MONOAMINE_TRANSPORT,WP_MONOAMINE_TRANSPORT,1/38,32/21728,0.05451162033962764,0.10641837304064837,0.057447530207017726,IL1B,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,2/38,217/21728,0.055186358823257786,0.10761018746095087,0.05809090402448188,DUSP1/MYC,2
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,2/38,218/21728,0.05563726045208785,0.10789078292682633,0.05824237708351537,SHB/HBEGF,2
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,HBEGF,1
JEPSEN_SMRT_TARGETS,JEPSEN_SMRT_TARGETS,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,HMOX1,1
PID_NCADHERIN_PATHWAY,PID_NCADHERIN_PATHWAY,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,PTPN1,1
SCHRAETS_MLL_TARGETS_UP,SCHRAETS_MLL_TARGETS_UP,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,ACTA2,1
SIMBULAN_UV_RESPONSE_NORMAL_DN,SIMBULAN_UV_RESPONSE_NORMAL_DN,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,MYC,1
WP_GASTRIC_CANCER_NETWORK_2,WP_GASTRIC_CANCER_NETWORK_2,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,MYC,1
WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_PART_2_OF_3,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,MYC,1
WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,ACTA2,1
WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,IL6,1
WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,TNFRSF11A,1
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,CAV1,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1/38,33/21728,0.0561676195296672,0.10789078292682633,0.05824237708351537,PPBP,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,3/38,500/21728,0.0564531904132687,0.1083151133358821,0.058471442171577515,TAGLN/ADAM8/GPNMB,3
BIOCARTA_INTEGRIN_PATHWAY,BIOCARTA_INTEGRIN_PATHWAY,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,CAV1,1
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,HMOX1,1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,ACTA2,1
PID_IL1_PATHWAY,PID_IL1_PATHWAY,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,IL1B,1
PID_IL2_PI3K_PATHWAY,PID_IL2_PI3K_PATHWAY,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,MYC,1
SIG_CD40PATHWAYMAP,SIG_CD40PATHWAYMAP,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,DUSP1,1
VALK_AML_CLUSTER_3,VALK_AML_CLUSTER_3,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,SERPINB8,1
VANTVEER_BREAST_CANCER_BRCA1_UP,VANTVEER_BREAST_CANCER_BRCA1_UP,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,MYC,1
WP_ENDOTHELIN_PATHWAYS,WP_ENDOTHELIN_PATHWAYS,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,MYLK,1
WP_OXIDATIVE_STRESS_RESPONSE,WP_OXIDATIVE_STRESS_RESPONSE,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,HMOX1,1
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,1/38,34/21728,0.057820794475870185,0.10948270918186682,0.05910174214436676,MYC,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,2/38,223/21728,0.05791145094634866,0.10948270918186682,0.05910174214436676,IL6/IL10,2
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,2/38,223/21728,0.05791145094634866,0.10948270918186682,0.05910174214436676,TAGLN/GPNMB,2
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,2/38,226/21728,0.05929150669507403,0.11130075533377692,0.0600831728714623,CNN2/MYC,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,SERPINB8,1
GENTILE_UV_RESPONSE_CLUSTER_D5,GENTILE_UV_RESPONSE_CLUSTER_D5,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,FOSL2,1
GENTILE_UV_RESPONSE_CLUSTER_D6,GENTILE_UV_RESPONSE_CLUSTER_D6,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,NFIL3,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,DUSP1,1
NAKAMURA_ADIPOGENESIS_EARLY_DN,NAKAMURA_ADIPOGENESIS_EARLY_DN,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,ACTG2,1
NAKAMURA_ADIPOGENESIS_LATE_DN,NAKAMURA_ADIPOGENESIS_LATE_DN,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,ACTG2,1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,PTPN1,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,1/38,35/21728,0.05947114986491364,0.11130075533377692,0.0600831728714623,HMOX1,1
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,MYC,1
HAN_JNK_SINGALING_UP,HAN_JNK_SINGALING_UP,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,DUSP1,1
HOUSTIS_ROS,HOUSTIS_ROS,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,HMOX1,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,SLC26A2,1
MARZEC_IL2_SIGNALING_DN,MARZEC_IL2_SIGNALING_DN,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,TNFRSF11A,1
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,HMOX1,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,MYC,1
WP_CAMKK2_PATHWAY,WP_CAMKK2_PATHWAY,1/38,36/21728,0.06111869037591422,0.11337077118455849,0.06120062369051736,HMOX1,1
REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,2/38,232/21728,0.06208587798906065,0.11503743985804933,0.06210033674033897,CAV1/MYC,2
BIOCARTA_IL2RB_PATHWAY,BIOCARTA_IL2RB_PATHWAY,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,MYC,1
GENTILE_UV_RESPONSE_CLUSTER_D7,GENTILE_UV_RESPONSE_CLUSTER_D7,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,PTPN1,1
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,RGS2,1
REACTOME_RHOH_GTPASE_CYCLE,REACTOME_RHOH_GTPASE_CYCLE,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,CAV1,1
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,RGS2,1
WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,PTGS2,1
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,1/38,37/21728,0.06276342068043772,0.11539926414899362,0.06229565932693513,IL1B,1
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,2/38,236/21728,0.06397368825610525,0.11675211430325312,0.06302596461052282,DUSP1/HMOX1,2
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,DUSP1,1
DORN_ADENOVIRUS_INFECTION_32HR_DN,DORN_ADENOVIRUS_INFECTION_32HR_DN,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,ELL2,1
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,ATF3,1
PID_ERBB4_PATHWAY,PID_ERBB4_PATHWAY,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,HBEGF,1
PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,PTGS2,1
REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,HSPA6,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,MYC,1
REACTOME_TRIGLYCERIDE_METABOLISM,REACTOME_TRIGLYCERIDE_METABOLISM,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,CAV1,1
RIZ_ERYTHROID_DIFFERENTIATION_6HR,RIZ_ERYTHROID_DIFFERENTIATION_6HR,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,NFIL3,1
WEINMANN_ADAPTATION_TO_HYPOXIA_DN,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,IL6,1
WP_SLEEP_REGULATION,WP_SLEEP_REGULATION,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,IL6,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/38,38/21728,0.06440534544251098,0.11675211430325312,0.06302596461052282,ACTA2,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,2/38,238/21728,0.06492493017277498,0.11756676544799793,0.06346573544058459,CAV1/PRF1,2
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,2/38,239/21728,0.06540236623647085,0.11768562351991277,0.06352989825835355,MYLK/MYC,2
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,2/38,239/21728,0.06540236623647085,0.11768562351991277,0.06352989825835355,CAV1/TAGLN,2
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,SLC26A2,1
CONRAD_STEM_CELL,CONRAD_STEM_CELL,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,MYC,1
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,ATF3,1
HAN_JNK_SINGALING_DN,HAN_JNK_SINGALING_DN,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,RGS2,1
HEIDENBLAD_AMPLICON_8Q24_DN,HEIDENBLAD_AMPLICON_8Q24_DN,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,ADAM8,1
LANDIS_ERBB2_BREAST_TUMORS_65_DN,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,ACTA2,1
PID_AURORA_B_PATHWAY,PID_AURORA_B_PATHWAY,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,MYLK,1
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,F12,1
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,PTPN1,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,RGS2,1
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,RGS2,1
SHIPP_DLBCL_CURED_VS_FATAL_UP,SHIPP_DLBCL_CURED_VS_FATAL_UP,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,SERPINB8,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SPIRA_SMOKERS_LUNG_CANCER_UP,1/38,39/21728,0.06604446931863761,0.11768562351991277,0.06352989825835355,PPBP,1
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,FOSL2,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,SPSB1,1
CROONQUIST_NRAS_SIGNALING_UP,CROONQUIST_NRAS_SIGNALING_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,GPNMB,1
KRASNOSELSKAYA_ILF3_TARGETS_UP,KRASNOSELSKAYA_ILF3_TARGETS_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,BDKRB2,1
MALONEY_RESPONSE_TO_17AAG_UP,MALONEY_RESPONSE_TO_17AAG_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,NFIL3,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,HBEGF,1
PID_FOXM1_PATHWAY,PID_FOXM1_PATHWAY,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,MYC,1
PID_IFNG_PATHWAY,PID_IFNG_PATHWAY,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,IL1B,1
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,MYLK,1
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,IL6,1
WENG_POR_TARGETS_LIVER_UP,WENG_POR_TARGETS_LIVER_UP,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,HMOX1,1
WP_IL5_SIGNALING_PATHWAY,WP_IL5_SIGNALING_PATHWAY,1/38,40/21728,0.06768079695780482,0.1190812341431965,0.06428328680534535,MYC,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,2/38,245/21728,0.06829205341389662,0.12003062903281934,0.06479579597121246,MYC/ACTA2,2
KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,HMOX1,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,RGS2,1
ONO_AML1_TARGETS_DN,ONO_AML1_TARGETS_DN,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,IL10,1
PID_AMB2_NEUTROPHILS_PATHWAY,PID_AMB2_NEUTROPHILS_PATHWAY,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,IL6,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,SLC26A2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,IL6,1
WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,1/38,41/21728,0.06931433300149725,0.12093907060157073,0.06528619742136639,IL1B,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/38,249/21728,0.07024199532740563,0.12200514629385385,0.0658616940558809,ASGR2/F12,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/38,250/21728,0.07073236752668313,0.12200514629385385,0.0658616940558809,RGS2/ADAM8,2
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,IL1B,1
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,RGS16,1
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,MYC,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,MYLK,1
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,PTPN1,1
REACTOME_RHOF_GTPASE_CYCLE,REACTOME_RHOF_GTPASE_CYCLE,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,CAV1,1
REACTOME_RND1_GTPASE_CYCLE,REACTOME_RND1_GTPASE_CYCLE,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,CAV1,1
REACTOME_RND3_GTPASE_CYCLE,REACTOME_RND3_GTPASE_CYCLE,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,CAV1,1
WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,ACTG2,1
WP_IL2_SIGNALING_PATHWAY,WP_IL2_SIGNALING_PATHWAY,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,MYC,1
WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING_PATHWAY,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,IL6,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/38,42/21728,0.07094508208370964,0.12200514629385385,0.0658616940558809,MYC,1
ABBUD_LIF_SIGNALING_1_UP,ABBUD_LIF_SIGNALING_1_UP,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,PTPN1,1
COWLING_MYCN_TARGETS,COWLING_MYCN_TARGETS,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,TAGLN,1
FUJII_YBX1_TARGETS_UP,FUJII_YBX1_TARGETS_UP,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,ACTA2,1
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,RGS2,1
HARRIS_BRAIN_CANCER_PROGENITORS,HARRIS_BRAIN_CANCER_PROGENITORS,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,CAV1,1
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,FOSL2,1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,DUSP1,1
REACTOME_RND2_GTPASE_CYCLE,REACTOME_RND2_GTPASE_CYCLE,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,CAV1,1
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,FOSL2,1
WP_IL6_SIGNALING_PATHWAY,WP_IL6_SIGNALING_PATHWAY,1/38,43/21728,0.07257304883095805,0.12353643982912066,0.0666883279266078,IL6,1
GNATENKO_PLATELET_SIGNATURE,GNATENKO_PLATELET_SIGNATURE,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,PPBP,1
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,IL6,1
NAKAYAMA_FRA2_TARGETS,NAKAYAMA_FRA2_TARGETS,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,RGS2,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,RGS16,1
PARK_HSC_MARKERS,PARK_HSC_MARKERS,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,RGS2,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,MYC,1
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,1/38,44/21728,0.07419823786228918,0.12541074512546355,0.0677001288689855,IL6,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/38,258/21728,0.07469609463809067,0.12612495818427608,0.06808568049036491,CAV1/DUSP1,2
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,DUSP1,1
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,PTPN1,1
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,IL1B,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,MYLK,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,HMOX1,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,MYC,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,PTGS2,1
ZHAN_V2_LATE_DIFFERENTIATION_GENES,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1/38,45/21728,0.07582065378929703,0.12699959509707254,0.06855783326842754,RGS16,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,2/38,261/21728,0.07620082623624022,0.12750887507063174,0.06883275644032846,PTPN1/PPBP,2
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,2/38,262/21728,0.07670458452279191,0.1277955709724298,0.06898752268048214,OLFML3/GPNMB,2
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,MYC,1
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,CAV1,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,PRF1,1
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,HBEGF,1
LANDIS_BREAST_CANCER_PROGRESSION_UP,LANDIS_BREAST_CANCER_PROGRESSION_UP,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,ELL2,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,ACTA2,1
NAKAJIMA_MAST_CELL,NAKAJIMA_MAST_CELL,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,GPNMB,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,HBEGF,1
PID_PS1_PATHWAY,PID_PS1_PATHWAY,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,MYC,1
PID_TNF_PATHWAY,PID_TNF_PATHWAY,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,CAV1,1
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,MYC,1
SILIGAN_BOUND_BY_EWS_FLT1_FUSION,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,NFIL3,1
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,1/38,46/21728,0.0774403012161291,0.1277955709724298,0.06898752268048214,PTGS2,1
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,FOSL2,1
DELACROIX_RAR_TARGETS_UP,DELACROIX_RAR_TARGETS_UP,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,DUSP1,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,MCDOWELL_ACUTE_LUNG_INJURY_DN,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,CAV1,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,SLC26A2,1
MELLMAN_TUT1_TARGETS_DN,MELLMAN_TUT1_TARGETS_DN,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,HMOX1,1
PID_LKB1_PATHWAY,PID_LKB1_PATHWAY,1/38,47/21728,0.07905718473950296,0.12969714440613855,0.07001404370455493,MYC,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,2/38,267/21728,0.07923950494265862,0.12974210242321915,0.07003831326412899,NFIL3/SERPINB8,2
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,2/38,267/21728,0.07923950494265862,0.12974210242321915,0.07003831326412899,MYLK/TAGLN,2
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,NFIL3,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,ACTA2,1
BROWNE_HCMV_INFECTION_2HR_DN,BROWNE_HCMV_INFECTION_2HR_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
BROWNE_HCMV_INFECTION_8HR_DN,BROWNE_HCMV_INFECTION_8HR_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
DAUER_STAT3_TARGETS_DN,DAUER_STAT3_TARGETS_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,HSPA6,1
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,ATF3,1
HOFMANN_CELL_LYMPHOMA_UP,HOFMANN_CELL_LYMPHOMA_UP,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,GPNMB,1
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,PTPN1,1
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,RGS16,1
REACTOME_HEME_SIGNALING,REACTOME_HEME_SIGNALING,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,HMOX1,1
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,MYC,1
SU_PANCREAS,SU_PANCREAS,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,IL10,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,IL1B,1
WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,IL1B,1
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1/38,48/21728,0.08067130894871388,0.12980253841411696,0.07007093825465921,IL6,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,1/38,49/21728,0.0822826784256484,0.13176241526095706,0.07112893304582064,MYLK,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,1/38,49/21728,0.0822826784256484,0.13176241526095706,0.07112893304582064,MYC,1
HENDRICKS_SMARCA4_TARGETS_DN,HENDRICKS_SMARCA4_TARGETS_DN,1/38,49/21728,0.0822826784256484,0.13176241526095706,0.07112893304582064,MYC,1
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,1/38,49/21728,0.0822826784256484,0.13176241526095706,0.07112893304582064,IL1B,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/38,49/21728,0.0822826784256484,0.13176241526095706,0.07112893304582064,MYLK,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,2/38,274/21728,0.08283263773240065,0.13251639751840602,0.07153595316154644,F12/RGS2,2
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,2/38,276/21728,0.0838685185173945,0.13268925752836194,0.07162926769323671,MYC/RGS16,2
BROWNE_HCMV_INFECTION_4HR_UP,BROWNE_HCMV_INFECTION_4HR_UP,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,PTGS2,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,MYC,1
CHIBA_RESPONSE_TO_TSA_UP,CHIBA_RESPONSE_TO_TSA_UP,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,HBEGF,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,IL10,1
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,TAGLN,1
REACTOME_SIGNALING_BY_EGFR,REACTOME_SIGNALING_BY_EGFR,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,HBEGF,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,HBEGF,1
SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,TAGLN,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,ATF3,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,MYC,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/38,50/21728,0.0838912977447972,0.13268925752836194,0.07162926769323671,MYC,1
BIOCARTA_NFAT_PATHWAY,BIOCARTA_NFAT_PATHWAY,1/38,51/21728,0.08549717147326386,0.13459376148281668,0.07265737069205941,HBEGF,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1/38,51/21728,0.08549717147326386,0.13459376148281668,0.07265737069205941,MYC,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/38,51/21728,0.08549717147326386,0.13459376148281668,0.07265737069205941,PRF1,1
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1/38,51/21728,0.08549717147326386,0.13459376148281668,0.07265737069205941,PTPN1,1
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,1/38,51/21728,0.08549717147326386,0.13459376148281668,0.07265737069205941,TAGLN,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,2/38,281/21728,0.08647584608645248,0.136006612389491,0.07342006601261447,HSPA6/PPBP,2
BROWNE_HCMV_INFECTION_1HR_UP,BROWNE_HCMV_INFECTION_1HR_UP,1/38,52/21728,0.08710030417077785,0.13647615480453967,0.07367353777036895,IL6,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/38,52/21728,0.08710030417077785,0.13647615480453967,0.07367353777036895,MYC,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/38,52/21728,0.08710030417077785,0.13647615480453967,0.07367353777036895,RGS2,1
WP_NETRINUNC5B_SIGNALING_PATHWAY,WP_NETRINUNC5B_SIGNALING_PATHWAY,1/38,52/21728,0.08710030417077785,0.13647615480453967,0.07367353777036895,IL10,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,2/38,285/21728,0.08857951626340602,0.13756821588218499,0.07426306202218187,NFIL3/ELL2,2
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,SLC26A2,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,ASGR2,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,HSPA6,1
HUPER_BREAST_BASAL_VS_LUMINAL_UP,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,IL1B,1
JI_RESPONSE_TO_FSH_DN,JI_RESPONSE_TO_FSH_DN,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,DUSP1,1
PEART_HDAC_PROLIFERATION_CLUSTER_UP,PEART_HDAC_PROLIFERATION_CLUSTER_UP,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,DUSP1,1
PID_CD8_TCR_PATHWAY,PID_CD8_TCR_PATHWAY,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,PRF1,1
REACTOME_RHOD_GTPASE_CYCLE,REACTOME_RHOD_GTPASE_CYCLE,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,CAV1,1
TIEN_INTESTINE_PROBIOTICS_6HR_UP,TIEN_INTESTINE_PROBIOTICS_6HR_UP,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,MYC,1
WP_WNT_SIGNALING_PATHWAY,WP_WNT_SIGNALING_PATHWAY,1/38,53/21728,0.08870070038970734,0.13756821588218499,0.07426306202218187,MYC,1
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,RGS2,1
BECKER_TAMOXIFEN_RESISTANCE_UP,BECKER_TAMOXIFEN_RESISTANCE_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,TAGLN,1
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,ATF3,1
BROWNE_HCMV_INFECTION_30MIN_UP,BROWNE_HCMV_INFECTION_30MIN_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,DUSP1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,PTGS2,1
DEMAGALHAES_AGING_UP,DEMAGALHAES_AGING_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,GPNMB,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,FOSL2,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,CAV1,1
SESTO_RESPONSE_TO_UV_C2,SESTO_RESPONSE_TO_UV_C2,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,ELL2,1
WIERENGA_STAT5A_TARGETS_GROUP2,WIERENGA_STAT5A_TARGETS_GROUP2,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,NFIL3,1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1/38,54/21728,0.09029836467506835,0.13863406125640648,0.07483843432474671,TAGLN,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,2/38,289/21728,0.09069868199718548,0.1391211468363422,0.07510137635972848,CAV1/MYLK,2
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,MYC,1
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,CAV1,1
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,MYC,1
REACTOME_RHOJ_GTPASE_CYCLE,REACTOME_RHOJ_GTPASE_CYCLE,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,CAV1,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,NFIL3,1
WP_RANKLRANK_SIGNALING_PATHWAY,WP_RANKLRANK_SIGNALING_PATHWAY,1/38,55/21728,0.0918933015645369,0.14018331522823252,0.07567476372729096,TNFRSF11A,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,2/38,292/21728,0.0922980418550159,0.14054474555195604,0.07586987363967336,ACTA2/PPBP,2
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/38,292/21728,0.0922980418550159,0.14054474555195604,0.07586987363967336,RGS16/FCGR3B,2
WANG_MLL_TARGETS,WANG_MLL_TARGETS,2/38,293/21728,0.09283303861858186,0.14094350910051748,0.07608513704153623,RGS16/IL6,2
DIRMEIER_LMP1_RESPONSE_LATE_UP,DIRMEIER_LMP1_RESPONSE_LATE_UP,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,HMOX1,1
HOQUE_METHYLATED_IN_CANCER,HOQUE_METHYLATED_IN_CANCER,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,PTGS2,1
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,GPNMB,1
LY_AGING_OLD_DN,LY_AGING_OLD_DN,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,PTGS2,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,IL6,1
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,HMOX1,1
REACTOME_REGULATED_NECROSIS,REACTOME_REGULATED_NECROSIS,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,IL1B,1
TANG_SENESCENCE_TP53_TARGETS_DN,TANG_SENESCENCE_TP53_TARGETS_DN,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,FOSL2,1
XU_GH1_EXOGENOUS_TARGETS_UP,XU_GH1_EXOGENOUS_TARGETS_UP,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,TNFRSF11A,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,1/38,56/21728,0.09348551558846263,0.14094350910051748,0.07608513704153623,MYC,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,2/38,296/21728,0.09444359368526183,0.1422599095528899,0.07679576578534637,ACTA2/GPNMB,2
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,HMOX1,1
KEGG_ACUTE_MYELOID_LEUKEMIA,KEGG_ACUTE_MYELOID_LEUKEMIA,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,MYC,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,IL6,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,CAV1,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,IL1B,1
ZAMORA_NOS2_TARGETS_UP,ZAMORA_NOS2_TARGETS_UP,1/38,57/21728,0.09507501126987827,0.1424424363837622,0.07689429872971042,HMOX1,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,2/38,300/21728,0.09660381113930817,0.14379085566923305,0.07762221210989549,DUSP1/ATF3,2
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,2/38,300/21728,0.09660381113930817,0.14379085566923305,0.07762221210989549,ELL2/ADAM8,2
KEGG_ARACHIDONIC_ACID_METABOLISM,KEGG_ARACHIDONIC_ACID_METABOLISM,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,PTGS2,1
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,PPBP,1
REACTOME_IRON_UPTAKE_AND_TRANSPORT,REACTOME_IRON_UPTAKE_AND_TRANSPORT,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,HMOX1,1
REACTOME_SIGNALING_BY_ERBB4,REACTOME_SIGNALING_BY_ERBB4,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,HBEGF,1
REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,MYC,1
SU_LIVER,SU_LIVER,1/38,58/21728,0.09666179312451129,0.14379085566923305,0.07762221210989549,F12,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,RGS16,1
CORRE_MULTIPLE_MYELOMA_DN,CORRE_MULTIPLE_MYELOMA_DN,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,OLFML3,1
MIKKELSEN_NPC_LCP_WITH_H3K4ME3,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,SERPINB8,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,MYC,1
REACTOME_ARACHIDONIC_ACID_METABOLISM,REACTOME_ARACHIDONIC_ACID_METABOLISM,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,PTGS2,1
REACTOME_RHOQ_GTPASE_CYCLE,REACTOME_RHOQ_GTPASE_CYCLE,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,CAV1,1
WP_COMPLEMENT_AND_COAGULATION_CASCADES,WP_COMPLEMENT_AND_COAGULATION_CASCADES,1/38,59/21728,0.09824586566079474,0.14524432919843883,0.07840683662621144,F12,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,1/38,60/21728,0.09982723337988153,0.14719244358389222,0.07945848172101394,IL6,1
NADLER_OBESITY_UP,NADLER_OBESITY_UP,1/38,60/21728,0.09982723337988153,0.14719244358389222,0.07945848172101394,DUSP1,1
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,1/38,60/21728,0.09982723337988153,0.14719244358389222,0.07945848172101394,DUSP1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,2/38,308/21728,0.10096706340382484,0.14874215584996184,0.08029505852324728,TAGLN/SERPINB8,2
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/38,61/21728,0.10140590077565226,0.1489955121045768,0.08043182711568356,IL6,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,1/38,61/21728,0.10140590077565226,0.1489955121045768,0.08043182711568356,MYC,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1/38,61/21728,0.10140590077565226,0.1489955121045768,0.08043182711568356,DUSP1,1
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,MYC,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,MYC,1
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,SLC26A2,1
PID_IL12_2PATHWAY,PID_IL12_2PATHWAY,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,IL1B,1
REACTOME_CA2_PATHWAY,REACTOME_CA2_PATHWAY,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,MYC,1
WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1/38,62/21728,0.10298187233472944,0.1505188797213541,0.08125418236018425,IL10,1
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,ACTA2,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,ACTG2,1
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,RGS16,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,RGS2,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,MYC,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,PTPN1,1
WORSCHECH_TUMOR_REJECTION_UP,WORSCHECH_TUMOR_REJECTION_UP,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,IL1B,1
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,MYC,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/38,63/21728,0.1045551525364874,0.15162760216330423,0.08185270086930296,MYC,1
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,2/38,315/21728,0.10483023251678036,0.15189501683876047,0.08199705857941571,FOSL2/NFIL3,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,2/38,317/21728,0.10594153683305804,0.15297816205153197,0.08258176980503754,ATF3/RGS2,2
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,1/38,64/21728,0.10612574585306278,0.15297816205153197,0.08258176980503754,ACTA2,1
PID_ERA_GENOMIC_PATHWAY,PID_ERA_GENOMIC_PATHWAY,1/38,64/21728,0.10612574585306278,0.15297816205153197,0.08258176980503754,MYC,1
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,1/38,64/21728,0.10612574585306278,0.15297816205153197,0.08258176980503754,IL10,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/38,64/21728,0.10612574585306278,0.15297816205153197,0.08258176980503754,MYC,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/38,64/21728,0.10612574585306278,0.15297816205153197,0.08258176980503754,ATF3,1
BROWNE_HCMV_INFECTION_6HR_UP,BROWNE_HCMV_INFECTION_6HR_UP,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,HBEGF,1
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,ELL2,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,RGS2,1
PID_CD8_TCR_DOWNSTREAM_PATHWAY,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,PRF1,1
REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,HMOX1,1
WP_FERROPTOSIS,WP_FERROPTOSIS,1/38,65/21728,0.10769365674936959,0.1544408176842415,0.08337135107039338,HMOX1,1
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,PTGS2,1
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,HMOX1,1
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,TRPV2,1
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,HMOX1,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,CAV1,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,RGS2,1
WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1/38,66/21728,0.10925888968310549,0.15575203422910783,0.08407918140003369,MYC,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,2/38,324/21728,0.10985675914118852,0.15647114928698197,0.08446737925374234,ACTG2/PTGS2,2
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,2/38,325/21728,0.11041927672042767,0.1569111811077644,0.0847049203906172,PRF1/PPBP,2
HOWLIN_PUBERTAL_MAMMARY_GLAND,HOWLIN_PUBERTAL_MAMMARY_GLAND,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,NFIL3,1
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,RGS16,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,MYC,1
TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,ATF3,1
VANHARANTA_UTERINE_FIBROID_DN,VANHARANTA_UTERINE_FIBROID_DN,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,ATF3,1
ZHANG_RESPONSE_TO_CANTHARIDIN_DN,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,1/38,67/21728,0.11082144910476732,0.1569111811077644,0.0847049203906172,MYC,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,2/38,327/21728,0.11154666885481203,0.1578046202126775,0.08518722310302591,RGS16/HMOX1,2
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,1/38,68/21728,0.1123813394576606,0.15858360875449157,0.08560774229072006,HBEGF,1
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,1/38,68/21728,0.1123813394576606,0.15858360875449157,0.08560774229072006,RGS2,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/38,68/21728,0.1123813394576606,0.15858360875449157,0.08560774229072006,MYC,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,2/38,329/21728,0.11267717512545503,0.1586002254917119,0.08561671245711266,MYC/HSPA6,2
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,2/38,329/21728,0.11267717512545503,0.1586002254917119,0.08561671245711266,MYC/NFIL3,2
REACTOME_SIGNALING_BY_WNT,REACTOME_SIGNALING_BY_WNT,2/38,329/21728,0.11267717512545503,0.1586002254917119,0.08561671245711266,CAV1/MYC,2
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,2/38,331/21728,0.11381076149981578,0.1595711510643811,0.08614084447088981,BDKRB2/PPBP,2
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/38,69/21728,0.11393856517791034,0.1595711510643811,0.08614084447088981,PTGS2,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1/38,69/21728,0.11393856517791034,0.1595711510643811,0.08614084447088981,MYLK,1
WATANABE_COLON_CANCER_MSI_VS_MSS_DN,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,1/38,69/21728,0.11393856517791034,0.1595711510643811,0.08614084447088981,SLC26A2,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/38,69/21728,0.11393856517791034,0.1595711510643811,0.08614084447088981,MYC,1
WP_RAC1PAK1P38MMP2_PATHWAY,WP_RAC1PAK1P38MMP2_PATHWAY,1/38,69/21728,0.11393856517791034,0.1595711510643811,0.08614084447088981,MYC,1
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,MYC,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,ACTA2,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,NFIL3,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,CAV1,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,HSPA6,1
WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,MYC,1
WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,1/38,70/21728,0.11549313069447364,0.16080714373503188,0.08680806690865193,HSPA6,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,2/38,336/21728,0.11665798124745887,0.16175779102213292,0.08732125215271778,TAGLN/GPNMB,2
BURTON_ADIPOGENESIS_2,BURTON_ADIPOGENESIS_2,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,SPSB1,1
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,IL6,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,HMOX1,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,ATF3,1
PEART_HDAC_PROLIFERATION_CLUSTER_DN,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,MYC,1
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,PTPN1,1
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,SLC26A2,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/38,71/21728,0.11704504042914932,0.16175779102213292,0.08732125215271778,MYC,1
LIN_MELANOMA_COPY_NUMBER_UP,LIN_MELANOMA_COPY_NUMBER_UP,1/38,72/21728,0.11859429879659145,0.16362887189809777,0.08833131246533604,MYC,1
LIU_NASOPHARYNGEAL_CARCINOMA,LIU_NASOPHARYNGEAL_CARCINOMA,1/38,72/21728,0.11859429879659145,0.16362887189809777,0.08833131246533604,ADAM8,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,2/38,341/21728,0.11952371691998154,0.1644085168237194,0.08875218598684995,MYLK/RGS2,2
CHESLER_BRAIN_QTL_CIS,CHESLER_BRAIN_QTL_CIS,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,RGS16,1
FURUKAWA_DUSP6_TARGETS_PCI35_UP,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,HMOX1,1
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,SERPINB8,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,PTPN1,1
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,MYC,1
MCCLUNG_COCAIN_REWARD_4WK,MCCLUNG_COCAIN_REWARD_4WK,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,DUSP1,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,MYC,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,CAV1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,1/38,73/21728,0.12014091020431794,0.1644085168237194,0.08875218598684995,CNN2,1
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,ATF3,1
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,IL6,1
LEE_LIVER_CANCER_DENA_DN,LEE_LIVER_CANCER_DENA_DN,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,TRPV2,1
REACTOME_RHOC_GTPASE_CYCLE,REACTOME_RHOC_GTPASE_CYCLE,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,CAV1,1
REACTOME_RHOG_GTPASE_CYCLE,REACTOME_RHOG_GTPASE_CYCLE,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,CAV1,1
REACTOME_SIGNALING_BY_NOTCH1,REACTOME_SIGNALING_BY_NOTCH1,1/38,74/21728,0.12168487905272418,0.1657090832628561,0.08945426709994872,MYC,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,2/38,345/21728,0.12182928961523663,0.16577096677946496,0.08948767350420135,MYC/IL6,2
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/38,75/21728,0.12322620973509202,0.16712866502532722,0.09022059591940682,MYC,1
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1/38,75/21728,0.12322620973509202,0.16712866502532722,0.09022059591940682,RGS2,1
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1/38,75/21728,0.12322620973509202,0.16712866502532722,0.09022059591940682,MYC,1
WP_PEPTIDE_GPCRS,WP_PEPTIDE_GPCRS,1/38,75/21728,0.12322620973509202,0.16712866502532722,0.09022059591940682,BDKRB2,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,1/38,76/21728,0.12476490663760276,0.16866926442129507,0.09105225334667243,OLFML3,1
KEGG_VEGF_SIGNALING_PATHWAY,KEGG_VEGF_SIGNALING_PATHWAY,1/38,76/21728,0.12476490663760276,0.16866926442129507,0.09105225334667243,PTGS2,1
MORI_MATURE_B_LYMPHOCYTE_DN,MORI_MATURE_B_LYMPHOCYTE_DN,1/38,76/21728,0.12476490663760276,0.16866926442129507,0.09105225334667243,RGS2,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1/38,76/21728,0.12476490663760276,0.16866926442129507,0.09105225334667243,IL1B,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,1/38,77/21728,0.12630097413934716,0.170059591385375,0.09180278963081673,OLFML3,1
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/38,77/21728,0.12630097413934716,0.170059591385375,0.09180278963081673,CAV1,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/38,77/21728,0.12630097413934716,0.170059591385375,0.09180278963081673,DUSP1,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/38,77/21728,0.12630097413934716,0.170059591385375,0.09180278963081673,HBEGF,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1/38,77/21728,0.12630097413934716,0.170059591385375,0.09180278963081673,RGS2,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/38,78/21728,0.1278344166123373,0.1715726344756931,0.09261957141531524,MYC,1
GUO_HEX_TARGETS_UP,GUO_HEX_TARGETS_UP,1/38,78/21728,0.1278344166123373,0.1715726344756931,0.09261957141531524,PTPN1,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/38,78/21728,0.1278344166123373,0.1715726344756931,0.09261957141531524,HBEGF,1
ROSS_AML_WITH_AML1_ETO_FUSION,ROSS_AML_WITH_AML1_ETO_FUSION,1/38,78/21728,0.1278344166123373,0.1715726344756931,0.09261957141531524,CAV1,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,2/38,357/21728,0.1288125279893928,0.17252131716245275,0.09313169611471919,RGS2/PPBP,2
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,2/38,357/21728,0.1288125279893928,0.17252131716245275,0.09313169611471919,MYC/IL6,2
CORRE_MULTIPLE_MYELOMA_UP,CORRE_MULTIPLE_MYELOMA_UP,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,IL1B,1
PID_MET_PATHWAY,PID_MET_PATHWAY,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,PTPN1,1
PID_MYC_ACTIV_PATHWAY,PID_MYC_ACTIV_PATHWAY,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,MYC,1
PID_P73PATHWAY,PID_P73PATHWAY,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,MYC,1
REACTOME_SIGNALING_BY_MET,REACTOME_SIGNALING_BY_MET,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,PTPN1,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/38,79/21728,0.12936523842151681,0.17252131716245275,0.09313169611471919,RGS2,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/38,80/21728,0.13089344392477242,0.17400517347142366,0.09393272208135296,ACTA2,1
PID_BETA_CATENIN_NUC_PATHWAY,PID_BETA_CATENIN_NUC_PATHWAY,1/38,80/21728,0.13089344392477242,0.17400517347142366,0.09393272208135296,MYC,1
SCHUHMACHER_MYC_TARGETS_UP,SCHUHMACHER_MYC_TARGETS_UP,1/38,80/21728,0.13089344392477242,0.17400517347142366,0.09393272208135296,MYC,1
SCIBETTA_KDM5B_TARGETS_DN,SCIBETTA_KDM5B_TARGETS_DN,1/38,80/21728,0.13089344392477242,0.17400517347142366,0.09393272208135296,CAV1,1
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,2/38,361/21728,0.13116159637066857,0.17422337345033295,0.09405051236061965,F12/ACTA2,2
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/38,81/21728,0.1324190374729456,0.17519896348118788,0.09457716237570489,MYC,1
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1/38,81/21728,0.1324190374729456,0.17519896348118788,0.09457716237570489,DUSP1,1
GRABARCZYK_BCL11B_TARGETS_UP,GRABARCZYK_BCL11B_TARGETS_UP,1/38,81/21728,0.1324190374729456,0.17519896348118788,0.09457716237570489,PRF1,1
REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1/38,81/21728,0.1324190374729456,0.17519896348118788,0.09457716237570489,ELL2,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/38,81/21728,0.1324190374729456,0.17519896348118788,0.09457716237570489,F12,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,2/38,364/21728,0.13293013295273468,0.1757363636115474,0.09486726557254942,CAV1/RGS2,2
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,IL6,1
REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,HSPA6,1
REACTOME_SIGNALING_BY_NOTCH4,REACTOME_SIGNALING_BY_NOTCH4,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,ACTA2,1
RIZ_ERYTHROID_DIFFERENTIATION,RIZ_ERYTHROID_DIFFERENTIATION,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,FOSL2,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,CAV1,1
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,MYC,1
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,1/38,82/21728,0.1339420234098435,0.17610116892581465,0.09506419739655918,PRF1,1
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1/38,83/21728,0.1354624060722488,0.17768169942914389,0.09591741072090156,ATF3,1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/38,83/21728,0.1354624060722488,0.17768169942914389,0.09591741072090156,IL6,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/38,83/21728,0.1354624060722488,0.17768169942914389,0.09591741072090156,TAGLN,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,1/38,84/21728,0.13698018978993243,0.1789606812611919,0.09660783987642663,RGS16,1
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/38,84/21728,0.13698018978993243,0.1789606812611919,0.09660783987642663,ADAM8,1
LEE_AGING_CEREBELLUM_UP,LEE_AGING_CEREBELLUM_UP,1/38,84/21728,0.13698018978993243,0.1789606812611919,0.09660783987642663,HMOX1,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/38,84/21728,0.13698018978993243,0.1789606812611919,0.09660783987642663,SLC26A2,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,2/38,371/21728,0.1370785397361846,0.1789606812611919,0.09660783987642663,MYC/SERPINB8,2
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,2/38,371/21728,0.1370785397361846,0.1789606812611919,0.09660783987642663,CAV1/ASGR2,2
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,PTGS2,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,IL6,1
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,ADAM8,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,MYC,1
REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,MYC,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,ACTG2,1
SMID_BREAST_CANCER_LUMINAL_A_UP,SMID_BREAST_CANCER_LUMINAL_A_UP,1/38,85/21728,0.13849537888566255,0.17982927103370913,0.09707672824380591,DUSP1,1
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,1/38,86/21728,0.14000797767521744,0.1810913996957446,0.09775805960009086,ELL2,1
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,1/38,86/21728,0.14000797767521744,0.1810913996957446,0.09775805960009086,MYC,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/38,86/21728,0.14000797767521744,0.1810913996957446,0.09775805960009086,HBEGF,1
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,1/38,86/21728,0.14000797767521744,0.1810913996957446,0.09775805960009086,MYC,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/38,86/21728,0.14000797767521744,0.1810913996957446,0.09775805960009086,DUSP1,1
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/38,87/21728,0.14151799046739677,0.18276224674856562,0.0986600282526428,IL1B,1
SMITH_TERT_TARGETS_DN,SMITH_TERT_TARGETS_DN,1/38,87/21728,0.14151799046739677,0.18276224674856562,0.0986600282526428,TAGLN,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,HSPA6,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,SLC26A2,1
REACTOME_RAC2_GTPASE_CYCLE,REACTOME_RAC2_GTPASE_CYCLE,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,CAV1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,MYC,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,DUSP1,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/38,88/21728,0.14302542156402998,0.18385846593994645,0.09925179716726723,MYC,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,2/38,383/21728,0.14425800606262873,0.18494133770854274,0.09983636078029111,HBEGF/ELL2,2
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/38,89/21728,0.14453027525998952,0.18494133770854274,0.09983636078029111,MYC,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1/38,89/21728,0.14453027525998952,0.18494133770854274,0.09983636078029111,MYC,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,1/38,89/21728,0.14453027525998952,0.18494133770854274,0.09983636078029111,NFIL3,1
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,1/38,89/21728,0.14453027525998952,0.18494133770854274,0.09983636078029111,GPNMB,1
WNT_SIGNALING,WNT_SIGNALING,1/38,89/21728,0.14453027525998952,0.18494133770854274,0.09983636078029111,MYC,1
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,2/38,385/21728,0.14546255924319648,0.18599220361248406,0.10040364675765832,CAV1/BDKRB2,2
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/38,90/21728,0.1460325558432014,0.18605322077795028,0.10043658548201684,MYC,1
REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,1/38,90/21728,0.1460325558432014,0.18605322077795028,0.10043658548201684,MYC,1
TIEN_INTESTINE_PROBIOTICS_2HR_DN,TIEN_INTESTINE_PROBIOTICS_2HR_DN,1/38,90/21728,0.1460325558432014,0.18605322077795028,0.10043658548201684,PTGS2,1
WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1/38,90/21728,0.1460325558432014,0.18605322077795028,0.10043658548201684,MYC,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,2/38,386/21728,0.14606566287940576,0.18605322077795028,0.10043658548201684,FOSL2/SERPINB8,2
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1/38,91/21728,0.14753226759465543,0.1877785320828631,0.1013679554181803,CAV1,1
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/38,92/21728,0.14902941478841591,0.18925266851447814,0.1021637343308322,NFIL3,1
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,1/38,92/21728,0.14902941478841591,0.18925266851447814,0.1021637343308322,CAV1,1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1/38,92/21728,0.14902941478841591,0.18925266851447814,0.1021637343308322,ATF3,1
CAMPS_COLON_CANCER_COPY_NUMBER_UP,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,DUSP1,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,BDKRB2,1
HOOI_ST7_TARGETS_UP,HOOI_ST7_TARGETS_UP,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,ATF3,1
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,PTPN1,1
REACTOME_MAPK6_MAPK4_SIGNALING,REACTOME_MAPK6_MAPK4_SIGNALING,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,MYC,1
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,FOSL2,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/38,93/21728,0.15052400169163482,0.19014155568136373,0.10264357978337249,MYC,1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1/38,94/21728,0.1520160325645591,0.19144876281626802,0.10334924572453998,HSPA6,1
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,1/38,94/21728,0.1520160325645591,0.19144876281626802,0.10334924572453998,FCGR3B,1
REACTOME_RAC3_GTPASE_CYCLE,REACTOME_RAC3_GTPASE_CYCLE,1/38,94/21728,0.1520160325645591,0.19144876281626802,0.10334924572453998,CAV1,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/38,94/21728,0.1520160325645591,0.19144876281626802,0.10334924572453998,IL6,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1/38,95/21728,0.15350551166054482,0.19303433335691636,0.10420517979801487,ATF3,1
REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1/38,95/21728,0.15350551166054482,0.19303433335691636,0.10420517979801487,IL10,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,2/38,399/21728,0.15395444205521244,0.19345363123967055,0.10443152819159593,SHB/RGS16,2
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/38,96/21728,0.15499244322606465,0.19461195082733004,0.10505682058801352,MYC,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,2/38,401/21728,0.15517580017677335,0.19469622868621375,0.1051023160669019,PRF1/SLC26A2,2
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/38,97/21728,0.1564768315007231,0.19618165626026288,0.1059041902451317,MYC,1
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,1/38,98/21728,0.15795868071726282,0.19774349043454054,0.10674731078288788,MYC,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/38,98/21728,0.15795868071726282,0.19774349043454054,0.10674731078288788,MYC,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/38,99/21728,0.1594379951015783,0.19929749387697288,0.1075862040787555,SLC26A2,1
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,1/38,99/21728,0.1594379951015783,0.19929749387697288,0.1075862040787555,F12,1
REACTOME_CLEC7A_DECTIN_1_SIGNALING,REACTOME_CLEC7A_DECTIN_1_SIGNALING,1/38,100/21728,0.16091477887272543,0.20084370686424374,0.10842089187518328,IL1B,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1/38,100/21728,0.16091477887272543,0.20084370686424374,0.10842089187518328,PELO,1
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,NFIL3,1
KEGG_GNRH_SIGNALING_PATHWAY,KEGG_GNRH_SIGNALING_PATHWAY,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,HBEGF,1
PUJANA_BREAST_CANCER_LIT_INT_NETWORK,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,MYC,1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,HSPA6,1
REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,TNFRSF11A,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/38,101/21728,0.16238903624293255,0.20178162886269435,0.10892720766256368,MYLK,1
BURTON_ADIPOGENESIS_3,BURTON_ADIPOGENESIS_3,1/38,102/21728,0.1638607714176108,0.20285793948595573,0.10950822939100453,ADAM8,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1/38,102/21728,0.1638607714176108,0.20285793948595573,0.10950822939100453,CAV1,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/38,102/21728,0.1638607714176108,0.20285793948595573,0.10950822939100453,IL1B,1
REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,1/38,102/21728,0.1638607714176108,0.20285793948595573,0.10950822939100453,ATF3,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/38,102/21728,0.1638607714176108,0.20285793948595573,0.10950822939100453,MYC,1
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,1/38,103/21728,0.16532998859536596,0.20422399033719613,0.11024566076961605,IL6,1
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1/38,103/21728,0.16532998859536596,0.20422399033719613,0.11024566076961605,GPNMB,1
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,1/38,103/21728,0.16532998859536596,0.20422399033719613,0.11024566076961605,GPNMB,1
CHICAS_RB1_TARGETS_LOW_SERUM,CHICAS_RB1_TARGETS_LOW_SERUM,1/38,104/21728,0.1667966919680074,0.20558091173393112,0.11097816382054788,SERPINB8,1
REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1/38,104/21728,0.1667966919680074,0.20558091173393112,0.11097816382054788,MYC,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/38,104/21728,0.1667966919680074,0.20558091173393112,0.11097816382054788,CAV1,1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1/38,105/21728,0.1682608857205612,0.2066253545322141,0.11154198243090142,CAV1,1
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,1/38,105/21728,0.1682608857205612,0.2066253545322141,0.11154198243090142,DUSP1,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/38,105/21728,0.1682608857205612,0.2066253545322141,0.11154198243090142,HBEGF,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/38,105/21728,0.1682608857205612,0.2066253545322141,0.11154198243090142,HBEGF,1
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,1/38,105/21728,0.1682608857205612,0.2066253545322141,0.11154198243090142,RGS2,1
MACAEVA_PBMC_RESPONSE_TO_IR,MACAEVA_PBMC_RESPONSE_TO_IR,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,ACTA2,1
REACTOME_STIMULI_SENSING_CHANNELS,REACTOME_STIMULI_SENSING_CHANNELS,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,TRPV2,1
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,SLC26A2,1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,BDKRB2,1
WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,MYC,1
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,1/38,106/21728,0.16972257403127733,0.20750752664407993,0.1120182029142276,MYC,1
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1/38,107/21728,0.17118176107164396,0.20883426787691453,0.1127344138923925,RGS16,1
KIM_MYCN_AMPLIFICATION_TARGETS_DN,KIM_MYCN_AMPLIFICATION_TARGETS_DN,1/38,107/21728,0.17118176107164396,0.20883426787691453,0.1127344138923925,MYLK,1
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1/38,107/21728,0.17118176107164396,0.20883426787691453,0.1127344138923925,PTGS2,1
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1/38,108/21728,0.17263845100639597,0.2103050221350642,0.11352836701588069,IL10,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1/38,108/21728,0.17263845100639597,0.2103050221350642,0.11352836701588069,ELL2,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/38,109/21728,0.17409264799352653,0.21161479346092668,0.11423541717702185,FOSL2,1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1/38,109/21728,0.17409264799352653,0.21161479346092668,0.11423541717702185,SLC26A2,1
SESTO_RESPONSE_TO_UV_C0,SESTO_RESPONSE_TO_UV_C0,1/38,109/21728,0.17409264799352653,0.21161479346092668,0.11423541717702185,HMOX1,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2/38,432/21728,0.17434254300678237,0.2117648727602324,0.11431643406192592,HBEGF/MYC,2
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/38,110/21728,0.1755443561842963,0.21276179204681356,0.114854598188979,ATF3,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/38,110/21728,0.1755443561842963,0.21276179204681356,0.114854598188979,IL6,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/38,110/21728,0.1755443561842963,0.21276179204681356,0.114854598188979,MYC,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/38,112/21728,0.17844032274820265,0.21611535835375228,0.11666494443102796,RGS2,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/38,113/21728,0.17988458939030005,0.21751038434232917,0.11741801737631469,HBEGF,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1/38,113/21728,0.17988458939030005,0.21751038434232917,0.11741801737631469,CAV1,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,2/38,441/21728,0.17998172698416012,0.21751038434232917,0.11741801737631469,SHB/ATF3,2
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/38,114/21728,0.1813263837739768,0.21897742813367782,0.11820996748897361,MYC,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,2/38,445/21728,0.18249759944327357,0.22023305408320115,0.11888778850430154,FOSL2/HMOX1,2
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,1/38,115/21728,0.1827657100169945,0.2202392548765941,0.11889113586111193,MYC,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1/38,115/21728,0.1827657100169945,0.2202392548765941,0.11889113586111193,CAV1,1
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,1/38,116/21728,0.18420257223044734,0.22181114916319145,0.11973968712093101,PTGS2,1
DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,1/38,117/21728,0.1856369745187707,0.22321746756564317,0.12049885601815397,MYLK,1
WP_WNT_SIGNALING,WP_WNT_SIGNALING,1/38,117/21728,0.1856369745187707,0.22321746756564317,0.12049885601815397,MYC,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/38,451/21728,0.1862818659644703,0.22383222775501274,0.12083072027749,MYC/SERPINB8,2
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1/38,118/21728,0.1870689209797527,0.22461680476063495,0.12125425626984158,PTPN1,1
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1/38,119/21728,0.18849841570454506,0.22600919563716032,0.12200590671002089,SLC26A2,1
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,1/38,119/21728,0.18849841570454506,0.22600919563716032,0.12200590671002089,FOSL2,1
MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,2/38,459/21728,0.1913460659387477,0.22893668643860912,0.12358624581352096,SPSB1/ASGR2,2
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,1/38,121/21728,0.19135006627704643,0.22893668643860912,0.12358624581352096,RGS2,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1/38,121/21728,0.19135006627704643,0.22893668643860912,0.12358624581352096,ATF3,1
MISSIAGLIA_REGULATED_BY_METHYLATION_DN,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1/38,122/21728,0.1927722302739675,0.23030919094785707,0.12432716105213462,CAV1,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/38,122/21728,0.1927722302739675,0.23030919094785707,0.12432716105213462,MYC,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,2/38,463/21728,0.19388567351591374,0.2311809033727914,0.12479773511216202,BDKRB2/PPBP,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1/38,123/21728,0.19419195883314477,0.2311809033727914,0.12479773511216202,IL6,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/38,123/21728,0.19419195883314477,0.2311809033727914,0.12479773511216202,PTGS2,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/38,123/21728,0.19419195883314477,0.2311809033727914,0.12479773511216202,RGS2,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/38,123/21728,0.19419195883314477,0.2311809033727914,0.12479773511216202,MYC,1
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,1/38,124/21728,0.19560925601270251,0.23220801121281126,0.1253521958408829,ELL2,1
REACTOME_CYTOPROTECTION_BY_HMOX1,REACTOME_CYTOPROTECTION_BY_HMOX1,1/38,124/21728,0.19560925601270251,0.23220801121281126,0.1253521958408829,HMOX1,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/38,124/21728,0.19560925601270251,0.23220801121281126,0.1253521958408829,SLC26A2,1
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1/38,124/21728,0.19560925601270251,0.23220801121281126,0.1253521958408829,IL6,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/38,125/21728,0.19702412586418894,0.23339137964817291,0.125991010286115,MYC,1
LIU_VMYB_TARGETS_UP,LIU_VMYB_TARGETS_UP,1/38,125/21728,0.19702412586418894,0.23339137964817291,0.125991010286115,TRPV2,1
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1/38,125/21728,0.19702412586418894,0.23339137964817291,0.125991010286115,SLC26A2,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/38,126/21728,0.1984365724325896,0.23423626414699616,0.1264471019024476,PTGS2,1
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1/38,126/21728,0.1984365724325896,0.23423626414699616,0.1264471019024476,ELL2,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/38,126/21728,0.1984365724325896,0.23423626414699616,0.1264471019024476,CNN2,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/38,126/21728,0.1984365724325896,0.23423626414699616,0.1264471019024476,DUSP1,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/38,126/21728,0.1984365724325896,0.23423626414699616,0.1264471019024476,HSPA6,1
KEGG_SPLICEOSOME,KEGG_SPLICEOSOME,1/38,127/21728,0.19984659975633579,0.2355686520702762,0.12716636111759136,HSPA6,1
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,1/38,127/21728,0.19984659975633579,0.2355686520702762,0.12716636111759136,PPBP,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,2/38,474/21728,0.20089357153095694,0.2366362393209233,0.12774267373239473,RGS16/IL10,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,1/38,128/21728,0.20125421186731485,0.23689445177635446,0.1278820638340226,HMOX1,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/38,481/21728,0.2053701458769902,0.24100129567030268,0.13009904979154124,PTPN1/RGS2,2
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/38,131/21728,0.20546259714459236,0.24100129567030268,0.13009904979154124,RGS16,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/38,131/21728,0.20546259714459236,0.24100129567030268,0.13009904979154124,ACTA2,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/38,131/21728,0.20546259714459236,0.24100129567030268,0.13009904979154124,IL6,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/38,131/21728,0.20546259714459236,0.24100129567030268,0.13009904979154124,CAV1,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,2/38,482/21728,0.20601066561678408,0.2414750629168043,0.13035480222814447,NFIL3/ELL2,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/38,132/21728,0.20686058859287237,0.24162586185011242,0.13043620759104263,RGS16,1
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,1/38,132/21728,0.20686058859287237,0.24162586185011242,0.13043620759104263,MYLK,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/38,132/21728,0.20686058859287237,0.24162586185011242,0.13043620759104263,PELO,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/38,132/21728,0.20686058859287237,0.24162586185011242,0.13043620759104263,PPBP,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/38,132/21728,0.20686058859287237,0.24162586185011242,0.13043620759104263,PTPN1,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,2/38,485/21728,0.20793367836752913,0.24257935305341072,0.13095092805836908,DUSP1/TAGLN,2
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/38,133/21728,0.20825618489003261,0.24257935305341072,0.13095092805836908,IL6,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/38,133/21728,0.20825618489003261,0.24257935305341072,0.13095092805836908,ELL2,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1/38,133/21728,0.20825618489003261,0.24257935305341072,0.13095092805836908,ACTA2,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/38,134/21728,0.2096493900289158,0.24403247275777207,0.1317353615704171,PTPN1,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/38,136/21728,0.21242864277087337,0.2470958171119534,0.13338903811416686,ATF3,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/38,137/21728,0.2138146983273158,0.24836312045648679,0.1340731629047115,PTPN1,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/38,137/21728,0.2138146983273158,0.24836312045648679,0.1340731629047115,GPNMB,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,2/38,495/21728,0.21435865132138365,0.24882241230999144,0.13432110113073537,ATF3/RGS16,2
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/38,138/21728,0.21519837863223745,0.24962415803947213,0.1347539052668698,IL1B,1
LIU_SOX4_TARGETS_UP,LIU_SOX4_TARGETS_UP,1/38,139/21728,0.21657968764622426,0.2510525791054849,0.13552500578263096,HBEGF,1
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,RGS16,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,ATF3,1
REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,IL1B,1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,ADAM8,1
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,IL1B,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1/38,140/21728,0.21795862932344157,0.25160627437406247,0.13582390553798565,ELL2,1
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,1/38,141/21728,0.21933520761164393,0.25302098674208234,0.13658760572596937,NFIL3,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/38,142/21728,0.22070942645218472,0.25443103187020605,0.13734878641100207,F12,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,1/38,143/21728,0.22208128978002784,0.25566059132752345,0.1380125360253528,SLC26A2,1
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,1/38,143/21728,0.22208128978002784,0.25566059132752345,0.1380125360253528,CAV1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1/38,144/21728,0.2234508015237553,0.25688407175860684,0.13867300401611515,PTPN1,1
WP_ECTODERM_DIFFERENTIATION,WP_ECTODERM_DIFFERENTIATION,1/38,144/21728,0.2234508015237553,0.25688407175860684,0.13867300401611515,MYC,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/38,145/21728,0.22481796560557943,0.25810150266576115,0.13933020630943524,ACTA2,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/38,145/21728,0.22481796560557943,0.25810150266576115,0.13933020630943524,HBEGF,1
REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,1/38,146/21728,0.22618278594135288,0.25931291338245455,0.1399841587403164,MYC,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/38,146/21728,0.22618278594135288,0.25931291338245455,0.1399841587403164,BDKRB2,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/38,147/21728,0.2275452664405755,0.260340383393418,0.14053881497875637,TAGLN,1
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,1/38,147/21728,0.2275452664405755,0.260340383393418,0.14053881497875637,PPBP,1
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1/38,147/21728,0.2275452664405755,0.260340383393418,0.14053881497875637,FOSL2,1
REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1/38,148/21728,0.22890541100640938,0.26153926564511304,0.1411860042037091,MYC,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/38,148/21728,0.22890541100640938,0.26153926564511304,0.1411860042037091,MYC,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/38,149/21728,0.2302632235356843,0.26255336924593,0.14173344489065443,PTPN1,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/38,149/21728,0.2302632235356843,0.26255336924593,0.14173344489065443,MYC,1
REACTOME_RHOA_GTPASE_CYCLE,REACTOME_RHOA_GTPASE_CYCLE,1/38,149/21728,0.2302632235356843,0.26255336924593,0.14173344489065443,CAV1,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/38,150/21728,0.2316187079189107,0.26373986115851494,0.14237394547378746,IL1B,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/38,150/21728,0.2316187079189107,0.26373986115851494,0.14237394547378746,IL1B,1
KEGG_WNT_SIGNALING_PATHWAY,KEGG_WNT_SIGNALING_PATHWAY,1/38,151/21728,0.23297186804028835,0.2647407591366913,0.14291425740670408,MYC,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/38,151/21728,0.23297186804028835,0.2647407591366913,0.14291425740670408,ELL2,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/38,151/21728,0.23297186804028835,0.2647407591366913,0.14291425740670408,ELL2,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/38,152/21728,0.23432270777771547,0.26591499696996845,0.1435481429047622,DUSP1,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/38,152/21728,0.23432270777771547,0.26591499696996845,0.1435481429047622,ACTA2,1
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/38,155/21728,0.2383613433709869,0.27013210429391277,0.14582465205874065,TRPV2,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/38,155/21728,0.2383613433709869,0.27013210429391277,0.14582465205874065,CAV1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,1/38,156/21728,0.2397029402259402,0.2712854222151688,0.14644724441968893,PTGS2,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/38,156/21728,0.2397029402259402,0.2712854222151688,0.14644724441968893,MYC,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/38,157/21728,0.2410422359922767,0.27224932251319184,0.14696758399926585,HMOX1,1
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1/38,157/21728,0.2410422359922767,0.27224932251319184,0.14696758399926585,MYC,1
REACTOME_CELLULAR_RESPONSE_TO_STARVATION,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,1/38,157/21728,0.2410422359922767,0.27224932251319184,0.14696758399926585,ATF3,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/38,159/21728,0.24371393961408427,0.27489619451420283,0.1483964374471015,CAV1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,1/38,159/21728,0.24371393961408427,0.27489619451420283,0.1483964374471015,GPNMB,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/38,160/21728,0.24504635513147777,0.27602733345341307,0.14900705699071917,ACTG2,1
REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1/38,160/21728,0.24504635513147777,0.27602733345341307,0.14900705699071917,HMOX1,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,1/38,161/21728,0.24637648488412056,0.27715286244519943,0.14961464813223965,CNN2,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/38,161/21728,0.24637648488412056,0.27715286244519943,0.14961464813223965,PTPN1,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/38,162/21728,0.24770433268744996,0.2784595686251535,0.1503200436443091,MYC,1
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,1/38,163/21728,0.24902990235071054,0.27957445471678294,0.15092188945905205,SERPINB8,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/38,163/21728,0.24902990235071054,0.27957445471678294,0.15092188945905205,CAV1,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,1/38,164/21728,0.25035319767696496,0.28012131336600954,0.15121709862146254,HBEGF,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/38,164/21728,0.25035319767696496,0.28012131336600954,0.15121709862146254,BDKRB2,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/38,164/21728,0.25035319767696496,0.28012131336600954,0.15121709862146254,IL1B,1
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1/38,164/21728,0.25035319767696496,0.28012131336600954,0.15121709862146254,RGS16,1
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,1/38,164/21728,0.25035319767696496,0.28012131336600954,0.15121709862146254,HMOX1,1
GAVIN_FOXP3_TARGETS_CLUSTER_P3,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1/38,165/21728,0.2516742224631028,0.28122369754883064,0.1518121955660302,ACTG2,1
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,1/38,165/21728,0.2516742224631028,0.28122369754883064,0.1518121955660302,PPBP,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/38,166/21728,0.25299298049985086,0.2825088282248335,0.15250594403464696,IL1B,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/38,167/21728,0.2543094755717832,0.2837897212409972,0.15319740489930345,ELL2,1
IBRAHIM_NRF2_DOWN,IBRAHIM_NRF2_DOWN,1/38,168/21728,0.25562371145732965,0.2850663892749848,0.15388658500374672,PTGS2,1
OHGUCHI_LIVER_HNF4A_TARGETS_DN,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1/38,169/21728,0.2569356919287873,0.2863388449638847,0.15457349116982055,F12,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/38,170/21728,0.25824542075232737,0.28760710090435393,0.15525813019754284,GPNMB,1
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,1/38,171/21728,0.2595529016880087,0.2888711696527672,0.15594050886518587,NFIL3,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,1/38,173/21728,0.2621611349055093,0.29138679559835967,0.15729851212505327,RGS2,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,HOLLERN_SQUAMOUS_BREAST_TUMOR,1/38,173/21728,0.2621611349055093,0.29138679559835967,0.15729851212505327,SERPINB8,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/38,174/21728,0.26346189467695846,0.29263837770816015,0.1579741501657876,SPSB1,1
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1/38,175/21728,0.2647604215398275,0.29388582245143213,0.15864755474361675,ADAM8,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/38,176/21728,0.2660567192237455,0.29512914218528064,0.15931873252924184,MYC,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1/38,177/21728,0.2673507914522858,0.2961723384144039,0.15988187820768138,SLC26A2,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/38,177/21728,0.2673507914522858,0.2961723384144039,0.15988187820768138,PTGS2,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1/38,178/21728,0.2686426419429736,0.2972103205115461,0.16044220915595797,MYC,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/38,178/21728,0.2686426419429736,0.2972103205115461,0.16044220915595797,PTGS2,1
BENPORATH_NOS_TARGETS,BENPORATH_NOS_TARGETS,1/38,179/21728,0.26993227440729695,0.2980465126118803,0.16089360837932767,OLFML3,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1/38,179/21728,0.26993227440729695,0.2980465126118803,0.16089360837932767,F12,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/38,179/21728,0.26993227440729695,0.2980465126118803,0.16089360837932767,OLFML3,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/38,180/21728,0.2712196925507153,0.29927074112150737,0.1615544802032206,RGS2,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/38,181/21728,0.2725049000726697,0.30029322869850117,0.1621064467883818,HMOX1,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/38,181/21728,0.2725049000726697,0.30029322869850117,0.1621064467883818,HSPA6,1
WANG_CLIM2_TARGETS_DN,WANG_CLIM2_TARGETS_DN,1/38,182/21728,0.2737879006665914,0.30150870060259083,0.16276259155860207,F12,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,1/38,183/21728,0.2750686980199134,0.3023228800415715,0.16320210774907143,MYLK,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/38,183/21728,0.2750686980199134,0.3023228800415715,0.16320210774907143,TRPV2,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/38,183/21728,0.2750686980199134,0.3023228800415715,0.16320210774907143,PTGS2,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,1/38,184/21728,0.2763472958140767,0.30333009206328865,0.16374582817430633,IL1B,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/38,184/21728,0.2763472958140767,0.30333009206328865,0.16374582817430633,CAV1,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1/38,185/21728,0.27762369772454176,0.3043322602674132,0.16428682580971435,PPBP,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/38,185/21728,0.27762369772454176,0.3043322602674132,0.16428682580971435,TRPV2,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1/38,186/21728,0.2788979074207987,0.30512997709329703,0.16471745503418203,CNN2,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/38,186/21728,0.2788979074207987,0.30512997709329703,0.16471745503418203,MYC,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/38,186/21728,0.2788979074207987,0.30512997709329703,0.16471745503418203,ATF3,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/38,187/21728,0.28016992856637524,0.3061217419104231,0.16525283663852533,F12,1
RAO_BOUND_BY_SALL4_ISOFORM_A,RAO_BOUND_BY_SALL4_ISOFORM_A,1/38,187/21728,0.28016992856637524,0.3061217419104231,0.16525283663852533,PTGS2,1
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,1/38,188/21728,0.2814397648188466,0.30730873929046154,0.16589361008672834,HBEGF,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/38,189/21728,0.2827074198298435,0.3080903892094911,0.16631556595817934,IL1B,1
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,1/38,189/21728,0.2827074198298435,0.3080903892094911,0.16631556595817934,PPBP,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/38,189/21728,0.2827074198298435,0.3080903892094911,0.16631556595817934,PTGS2,1
IVANOVA_HEMATOPOIESIS_STEM_CELL,IVANOVA_HEMATOPOIESIS_STEM_CELL,1/38,190/21728,0.2839728972450659,0.3092682723572727,0.16695141929608628,SERPINB8,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1/38,191/21728,0.28523620070428624,0.3102406728439477,0.16747634750853171,HMOX1,1
SHEPARD_CRASH_AND_BURN_MUTANT_DN,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1/38,191/21728,0.28523620070428624,0.3102406728439477,0.16747634750853171,NFIL3,1
FUJII_YBX1_TARGETS_DN,FUJII_YBX1_TARGETS_DN,1/38,193/21728,0.2877563002842508,0.3125757477147342,0.16873688439086043,SLC26A2,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/38,193/21728,0.2877563002842508,0.3125757477147342,0.16873688439086043,MYLK,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/38,194/21728,0.28901310365500565,0.31373749100591997,0.16936402499549738,CAV1,1
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1/38,195/21728,0.29026774756979645,0.3148953867742287,0.16998908860271011,NFIL3,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,1/38,196/21728,0.29152023563891594,0.31604944640465,0.17061208135842534,IL6,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1/38,197/21728,0.2927705714667871,0.3171996812463573,0.1712330093892355,DUSP1,1
WHITFIELD_CELL_CYCLE_G2_M,WHITFIELD_CELL_CYCLE_G2_M,1/38,198/21728,0.29401875865197435,0.3183461026128358,0.17185187880246722,CNN2,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,1/38,199/21728,0.2952648007871913,0.3194887217820061,0.1724686956862487,DUSP1,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/38,200/21728,0.2965087014593121,0.320627549996351,0.17308346610957773,PTGS2,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,1/38,202/21728,0.2989900927326098,0.32289387835404343,0.17430689175561562,MYC,1
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,1/38,202/21728,0.2989900927326098,0.32289387835404343,0.17430689175561562,RGS2,1
HAMAI_APOPTOSIS_VIA_TRAIL_DN,HAMAI_APOPTOSIS_VIA_TRAIL_DN,1/38,203/21728,0.30022759047841296,0.3238127585649335,0.17480292826851712,F12,1
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,1/38,203/21728,0.30022759047841296,0.3238127585649335,0.17480292826851712,PTPN1,1
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,1/38,205/21728,0.302696208006351,0.32626521776746326,0.1761268324036141,HBEGF,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,1/38,207/21728,0.305156345272531,0.32849413774517316,0.17733006398938178,ADAM8,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/38,207/21728,0.305156345272531,0.32849413774517316,0.17733006398938178,MYC,1
REACTOME_PROGRAMMED_CELL_DEATH,REACTOME_PROGRAMMED_CELL_DEATH,1/38,208/21728,0.3063832426694755,0.3296030388383889,0.17792867893930936,IL1B,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,1/38,209/21728,0.30760803062386965,0.3307082485847122,0.1785253011998541,CNN2,1
CHANDRAN_METASTASIS_UP,CHANDRAN_METASTASIS_UP,1/38,210/21728,0.3088307126646843,0.3318097778789905,0.1791199366523506,HSPA6,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/38,211/21728,0.31005129231515094,0.33248137940325084,0.1794824854092019,SERPINB8,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/38,211/21728,0.31005129231515094,0.33248137940325084,0.1794824854092019,MYC,1
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,1/38,211/21728,0.31005129231515094,0.33248137940325084,0.1794824854092019,MYC,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,1/38,213/21728,0.31248615850931916,0.3348780009616824,0.18077624686635363,SLC26A2,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,1/38,215/21728,0.3149126572777672,0.33726259650911766,0.18206351635590393,HBEGF,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/38,216/21728,0.31612277762469454,0.3383422699817018,0.18264635344181107,MYC,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,1/38,219/21728,0.31974066436705717,0.34155970205026837,0.18438321072187305,ATF3,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1/38,219/21728,0.31974066436705717,0.34155970205026837,0.18438321072187305,PRF1,1
REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1/38,219/21728,0.31974066436705717,0.34155970205026837,0.18438321072187305,MYC,1
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1/38,221/21728,0.3221422283755302,0.3439058206048522,0.18564970928488173,RGS2,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,1/38,222/21728,0.32333991263282913,0.34496455647133045,0.1862212436819311,SLC26A2,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/38,224/21728,0.3257291029288327,0.3472923280749808,0.18747783806215773,ELL2,1
SANSOM_APC_TARGETS_REQUIRE_MYC,SANSOM_APC_TARGETS_REQUIRE_MYC,1/38,225/21728,0.32692061586078525,0.3483409870017909,0.18804393265328415,MYC,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,1/38,227/21728,0.32929749448365686,0.35065054244127475,0.1892906934529804,RGS2,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1/38,228/21728,0.3304828670342188,0.35168920094175127,0.1898513895421614,SERPINB8,1
KONDO_EZH2_TARGETS,KONDO_EZH2_TARGETS,1/38,229/21728,0.3316661996413208,0.35272437104711896,0.19041020250084853,MYLK,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/38,230/21728,0.33284749572084227,0.3535317408575845,0.19084604266876048,RGS2,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/38,230/21728,0.33284749572084227,0.3535317408575845,0.19084604266876048,ADAM8,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/38,233/21728,0.336379198869336,0.35705650070097456,0.19274880383480733,RGS16,1
REACTOME_NEDDYLATION,REACTOME_NEDDYLATION,1/38,234/21728,0.33755238288622214,0.3580748836823445,0.1932985546476883,SPSB1,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/38,236/21728,0.3398926957083369,0.36010136958346894,0.19439250681677916,PELO,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/38,236/21728,0.3398926957083369,0.36010136958346894,0.19439250681677916,IL1B,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,1/38,237/21728,0.3410598312733417,0.3611094926566671,0.1949367190523658,CAV1,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,1/38,238/21728,0.34222495743832315,0.36211421586177595,0.19547909594674973,SPSB1,1
SANSOM_APC_MYC_TARGETS,SANSOM_APC_MYC_TARGETS,1/38,241/21728,0.345708313167146,0.3655690811584404,0.19734412613674804,MYC,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/38,242/21728,0.3468654353386754,0.3665612644746255,0.19787973365825814,OLFML3,1
CHYLA_CBFA2T3_TARGETS_DN,CHYLA_CBFA2T3_TARGETS_DN,1/38,243/21728,0.3480205648861543,0.3673184916095201,0.19828850544702453,ELL2,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/38,243/21728,0.3480205648861543,0.3673184916095201,0.19828850544702453,RGS2,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/38,246/21728,0.3514740311452621,0.3707298502319358,0.2001300495517567,SLC26A2,1
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,1/38,248/21728,0.3537664399311633,0.3729130188072363,0.20130858328698573,IL1B,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/38,249/21728,0.35490968365940445,0.37388284284874373,0.20183212066430217,SLC26A2,1
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,1/38,250/21728,0.35605095802138287,0.37461391625993484,0.20222677396215807,MYC,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/38,250/21728,0.35605095802138287,0.37461391625993484,0.20222677396215807,CAV1,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1/38,253/21728,0.35946299789207037,0.37796642904533456,0.2040365514846456,ELL2,1
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,1/38,254/21728,0.3605964277444613,0.37892033655707197,0.20455149668658276,DUSP1,1
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1/38,257/21728,0.36398501290054885,0.3822413144880372,0.20634425083753272,SLC26A2,1
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1/38,258/21728,0.36511065071479976,0.3831831703930386,0.20685269025459238,BDKRB2,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/38,262/21728,0.36959383596427964,0.38764538211657384,0.20926151342538066,HSPA6,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,1/38,263/21728,0.3707098069990954,0.3885725448832821,0.2097620210870318,CAV1,1
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,1/38,265/21728,0.37293598137571005,0.3901734970670296,0.21062625858952294,TRPV2,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/38,265/21728,0.37293598137571005,0.3901734970670296,0.21062625858952294,SLC26A2,1
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,1/38,265/21728,0.37293598137571005,0.3901734970670296,0.21062625858952294,FOSL2,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/38,266/21728,0.37404619116500915,0.39084676868458534,0.2109897089081281,SERPINB8,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/38,266/21728,0.37404619116500915,0.39084676868458534,0.2109897089081281,MYLK,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/38,268/21728,0.37626087202492975,0.3929158108739136,0.21210663411826663,SLC26A2,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1/38,272/21728,0.38066736858437145,0.39702231779503244,0.21432343816869312,BDKRB2,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/38,272/21728,0.38066736858437145,0.39702231779503244,0.21432343816869312,MYC,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/38,278/21728,0.3872203329792985,0.40360551197282196,0.21787722531635767,HMOX1,1
MULLIGHAN_MLL_SIGNATURE_2_DN,MULLIGHAN_MLL_SIGNATURE_2_DN,1/38,280/21728,0.3893896143998451,0.4056141816665053,0.21896155981242932,PRF1,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1/38,285/21728,0.39478015650621856,0.4109737490042984,0.2218547999338208,CAV1,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1/38,286/21728,0.3958526908555522,0.41183432123170804,0.22231936021243504,PRF1,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,1/38,289/21728,0.3990592018312672,0.4149125779437446,0.22398108685227125,SLC26A2,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,1/38,290/21728,0.40012435180703165,0.41524677154695044,0.22416149364262716,IL6,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,1/38,290/21728,0.40012435180703165,0.41524677154695044,0.22416149364262716,OLFML3,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/38,290/21728,0.40012435180703165,0.41524677154695044,0.22416149364262716,MYC,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/38,293/21728,0.4033087839776346,0.4180335477490953,0.2256658711808156,CAV1,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/38,293/21728,0.4033087839776346,0.4180335477490953,0.2256658711808156,SLC26A2,1
REACTOME_DEUBIQUITINATION,REACTOME_DEUBIQUITINATION,1/38,297/21728,0.40752910036659995,0.4221467180668243,0.22788627231384265,MYC,1
MUELLER_PLURINET,MUELLER_PLURINET,1/38,299/21728,0.40962834524425096,0.42405901006435126,0.22891857950999386,MYC,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/38,300/21728,0.4106752500405887,0.4248802000111094,0.22936188016310635,MYC,1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1/38,301/21728,0.4117203471331057,0.42569850706663703,0.229803624553176,ADAM8,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,1/38,303/21728,0.4138051303503779,0.4275901254391629,0.23082477156464473,MYC,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/38,305/21728,0.4158827191339004,0.42947198184296126,0.23184064880006522,ASGR2,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/38,307/21728,0.4179531376423772,0.431344119255072,0.2328512794596115,HBEGF,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/38,308/21728,0.41898566557149297,0.4321434666454746,0.23328278890712503,SPSB1,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,1/38,309/21728,0.42001640995563305,0.4329399918004217,0.23371277483523165,PELO,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,1/38,310/21728,0.4210453737924924,0.43373370301502134,0.23414124172185602,RGS2,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,1/38,314/21728,0.4251434834497191,0.4376861307795203,0.2362748696556845,ACTA2,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,1/38,318/21728,0.42921334289562296,0.4416046371929782,0.23839018592224243,CNN2,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,1/38,322/21728,0.43325514164432244,0.4454894795913076,0.2404873294384498,MYLK,1
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,1/38,323/21728,0.4342612289384229,0.4459764307000971,0.24075019888225196,SLC26A2,1
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,1/38,323/21728,0.4342612289384229,0.4459764307000971,0.24075019888225196,MYC,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/38,333/21728,0.4442269329620674,0.455931441612416,0.2461241843488235,IL6,1
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,1/38,335/21728,0.44619946056404447,0.4576755030280309,0.2470656761043699,MYC,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,1/38,341/21728,0.4520762316731257,0.46341963773101935,0.25016651614199253,SHB,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,1/38,342/21728,0.45304977182351713,0.46413355829014746,0.2505519098640922,MYLK,1
MIKKELSEN_NPC_HCP_WITH_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,1/38,345/21728,0.4559602976586614,0.4668297668571258,0.25200739653119947,TNFRSF11A,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/38,359/21728,0.469344552150359,0.48023953869997027,0.25924635584809075,HSPA6,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,1/38,361/21728,0.471230222853982,0.48187461738731363,0.2601290157647777,RGS2,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/38,367/21728,0.4768481730152031,0.48702481085394217,0.26290923017975576,DUSP1,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/38,367/21728,0.4768481730152031,0.48702481085394217,0.26290923017975576,ATF3,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1/38,377/21728,0.4860825263861348,0.4958515418372569,0.26767413947412644,TAGLN,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1/38,377/21728,0.4860825263861348,0.4958515418372569,0.26767413947412644,SPSB1,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/38,378/21728,0.4869971844348131,0.4964822178504637,0.2680145955277602,HSPA6,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/38,382/21728,0.4906399921201515,0.49989171946548283,0.26985513716942644,OLFML3,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/38,384/21728,0.49245193857098124,0.5011281877924627,0.2705226163794033,ELL2,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/38,384/21728,0.49245193857098124,0.5011281877924627,0.2705226163794033,CNN2,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/38,385/21728,0.49335555674631415,0.501742900759002,0.270854455146572,DUSP1,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,1/38,387/21728,0.4951580962305262,0.503270516496439,0.27167910364206826,PPBP,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,1/38,395/21728,0.5023060154064551,0.5102259404522815,0.27543383054109033,TNFRSF11A,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/38,399/21728,0.5058429247884891,0.5135072115277086,0.27720514985219274,DUSP1,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,1/38,400/21728,0.5067233209091717,0.5140893776637568,0.27751941895564314,CAV1,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1/38,403/21728,0.5093553556663428,0.5164468648554021,0.2787920546179358,SHB,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1/38,407/21728,0.5128434729047946,0.5196689758714645,0.2805314377210295,ELL2,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/38,410/21728,0.5154437035751172,0.5219880311295775,0.28178332678102563,RGS16,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/38,411/21728,0.5163074402888868,0.5225468051262147,0.2820849681718262,HSPA6,1
MOOTHA_PGC,MOOTHA_PGC,1/38,421/21728,0.5248627683131736,0.5308847445196653,0.28658601448068655,DUSP1,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/38,423/21728,0.5265560651133723,0.5322760465086895,0.2873370771097969,FOSL2,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/38,425/21728,0.5282434855862175,0.5336597336290194,0.2880840290258148,IL10,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/38,428/21728,0.5307636415717449,0.5358825193686997,0.2892839491831661,DUSP1,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/38,433/21728,0.5349348000999399,0.5394435822801922,0.29120630773208805,IL6,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,1/38,433/21728,0.5349348000999399,0.5394435822801922,0.29120630773208805,HMOX1,1
VECCHI_GASTRIC_CANCER_EARLY_UP,VECCHI_GASTRIC_CANCER_EARLY_UP,1/38,436/21728,0.5374201423279517,0.5416237896506132,0.29238324292843787,F12,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1/38,438/21728,0.539069847459531,0.5429597080545486,0.29310440799299753,ATF3,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,1/38,445/21728,0.5447988258143357,0.5484002603599833,0.2960413660010845,HMOX1,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/38,450/21728,0.5488484429619052,0.551813410540931,0.2978838772378067,SHB,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/38,450/21728,0.5488484429619052,0.551813410540931,0.2978838772378067,CAV1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/38,453/21728,0.5512613525706149,0.5539068779578764,0.2990139878496879,RGS2,1
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1/38,459/21728,0.5560495338473262,0.5583830750565176,0.3014303607060793,F12,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,1/38,461/21728,0.557634511346781,0.5596391890388606,0.30210844517478785,DUSP1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/38,463/21728,0.5592139786048071,0.5608882719539233,0.302782734082275,CNN2,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/38,467/21728,0.5623564568976347,0.5637026123899092,0.30430199154308374,PPBP,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1/38,470/21728,0.5646989894274939,0.565712205317615,0.3053868244259741,HMOX1,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,1/38,472/21728,0.5662538903929948,0.5669308227186289,0.3060446672209284,SLC26A2,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1/38,484/21728,0.5754703568281307,0.5758141264558656,0.3108401160255074,ACTA2,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/38,493/21728,0.5822572893867668,0.5822572893867668,0.3143183105000677,ELL2,1
